0001493152-21-006123.txt : 20210316 0001493152-21-006123.hdr.sgml : 20210316 20210316164503 ACCESSION NUMBER: 0001493152-21-006123 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 77 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210316 DATE AS OF CHANGE: 20210316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Viewbix Inc. CENTRAL INDEX KEY: 0000797542 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 680080601 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-15746 FILM NUMBER: 21746476 BUSINESS ADDRESS: STREET 1: 14 ARYEH SHENKAR STREET CITY: HERZLIYA STATE: L3 ZIP: 4672514 BUSINESS PHONE: 855-879-8439 MAIL ADDRESS: STREET 1: 14 ARYEH SHENKAR STREET CITY: HERZLIYA STATE: L3 ZIP: 4672514 FORMER COMPANY: FORMER CONFORMED NAME: Virtual Crypto Technologies, Inc. DATE OF NAME CHANGE: 20180312 FORMER COMPANY: FORMER CONFORMED NAME: Emerald Medical Applications Corp. DATE OF NAME CHANGE: 20151006 FORMER COMPANY: FORMER CONFORMED NAME: ZAXIS INTERNATIONAL INC DATE OF NAME CHANGE: 19950916 10-K 1 form10-k.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 10-K

 

 

 

[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2020

 

Commission file number 000-15746

 

VIEWBIX INC.

 

(Exact Name of Registrant As Specified In Its Charter)

 

Delaware   68-0080601
(State of Incorporation)   (I.R.S. Employer Identification No.)

 

14 Aryeh Shenkar Street, Herzliya, Israel   4672514
(Address of Principal Executive Offices)   (ZIP Code)

 

Registrant’s Telephone Number, Including Area Code: 1 (855) 879-8439

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, Par Value $0.0001   VBIX   OTCQB

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [  ] No [X]

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes [  ] No [X]

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [  ]

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes [  ] No [X]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer [  ] Accelerated filer [  ] Non-Accelerated filer [X] Smaller reporting company [X]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes [  ] No [X]

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes [  ] No [X]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [  ] No [X]

 

The aggregate market value of the registrant’s common stock held by non-affiliates of the registrant was $344,778 as of June 30, 2020, based upon the closing price of the common stock on that date, which was $0.0170.

 

As of March 15, 2021, there were 34,753,669 shares of common stock outstanding.

 

 

 

 

 

 

TABLE OF CONTENTS

 

Item   Description   Page
         
PART I    
         
ITEM 1.   DESCRIPTION OF BUSINESS   4
ITEM 1A.   RISK FACTORS   6
ITEM 1B.   UNRESOLVED STAFF COMMENTS   17
ITEM 2.   PROPERTIES   17
ITEM 3.   LEGAL PROCEEDINGS   17
ITEM 4.   MINE SAFETY DISCLOSURES   18
         
PART II    
         
ITEM 5.   MARKET FOR REGISTRANT’S COMMON EQUITY RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASE OF EQUITY   19
ITEM 6.   SELECTED FINANCIAL DATA   20
ITEM 7.   MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND PLAN OF OPERATION   20
ITEM 7A.   QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK   25
ITEM 8.   FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA   25
ITEM 9.   CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE   48
ITEM 9A.   CONTROLS AND PROCEDURES   48
ITEM 9B.   OTHER INFORMATION   49
         
PART III    
         
ITEM 10.   DIRECTORS EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE   50
ITEM 11.   EXECUTIVE COMPENSATION   51
ITEM 12.   SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS   52
ITEM 13.   CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE   53
ITEM 14.   PRINCIPAL ACCOUNTING FEES AND SERVICES   53
         
PART IV    
         
ITEM 15.   EXHIBITS AND FINANCIAL STATEMENT SCHEDULES   55

 

2

 

 

Cautionary Statement regarding Forward-Looking Statements

 

This Annual Report on Form 10-K includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Registrant has based these forward-looking statements on its current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about the Registrant that may cause its actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may”, “will”, “should”, “could”, “would”, “expect”, “plan”, “anticipate”, “believe”, “estimate”, “continue”, or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in this Annual Report on Form 10-K and in the Registrant’s other Securities and Exchange Commission filings.

 

3

 

 

PART I

 

ITEM 1. DESCRIPTION OF BUSINESS

 

Overview and recent developments

 

Viewbix Inc. (f/k/a Virtual Crypto Technologies, Inc., f/k/a Emerald Medical Applications Corp.) (the “Registrant” or the “Company”) was incorporated in the State of Ohio in 1989 under a predecessor name, Zaxis International, Inc. (“Zaxis”). On August 25, 1995, Zaxis merged with a subsidiary of The InFerGene Company, a Delaware corporation, which entity changed its name to Zaxis International, Inc. and the Company was reincorporated in Delaware under the name of Zaxis International, Inc. On December 30, 2014, Zaxis entered into an agreement with Emerald Medical Applications Ltd., a private limited liability company organized under the laws of the State of Israel (“Emerald Israel”).

 

On March 16, 2015, Zaxis and Emerald Israel executed a share exchange agreement, which closed on July 14, 2015, and Emerald Israel became the Company’s wholly-owned subsidiary. Emerald Israel was engaged in the business of developing Emerald Israel’s DermaCompare technology and the development, sale and service of imaging solutions utilizing its DermaCompare software for use in derma imaging and analytics for the detection of skin cancer. On January 29, 2018, the Company ceased the DermaCompare operations of its former subsidiary.

 

On January 17, 2018, the Company formed a new wholly-owned subsidiary under the laws of the State of Israel, Virtual Crypto Technologies Ltd. (the “VCT Israel”), to develop and market software and hardware products facilitating and supporting the purchase and/or sale of cryptocurrencies through ATMs, tablets, personal computers (“PCs”) and/or mobile devices. On February 12, 2018, the Registrant filed a definitive information statement to change its name from Emerald Medical Applications Corp. to Virtual Crypto Technologies, Inc. to reflect its new operations and business focus, and, effective as of March 7, 2018, the Financial Industry Regulatory Authority (“FINRA”) approved the Registrant’s name change and its trading symbol was changed from “MRLA” to “VRCP” on the OTCQB.

 

During the period commencing January 16, 2018 through March 23, 2018, the Registrant raised $1.9 million in equity capital through the offering of units (the “Unit Offering”) at a price of $0.07 per unit, each unit consisting of: (i) one (1) share of the Company’s common stock, par value $0.0001 (the “Shares”); (ii) one (1) warrant to purchase a share of the Company’s common stock, par value $0.0001 exercisable for a period of twelve months at an exercise price of $0.14 per Share (the “Class F Warrants”); and (iii) one (1) warrant to purchase a share of the Company’s common stock, par value $0.0001 exercisable for a period of twelve months at an exercise price of $0.28 per Share (the “Class G Warrants”). The proceeds of the Unit Offering were utilized by the Registrant to fund the operations of Virtual Crypto Israel including, but not limited to, the costs associated with the development of the products.

 

Transaction with Gix Internet Ltd.

 

On February 7, 2019, the Registrant entered into a share exchange agreement (the “Share Exchange Agreement”) with Gix Internet Ltd., formerly known as Algomizer Ltd. (TASE:GIX), a company organized under the laws of the State of Israel (“Gix”), pursuant to which on July 25, 2019 (the “Closing Date”) Gix assigned, transferred and delivered its 99.83% holdings in Viewbix Ltd. (“Viewbix Israel”) to the Company in exchange for shares of restricted common stock, par value $0.0001 per share of the Company (the “Common Stock”), representing 65% of the issued and outstanding share capital of the Company on a fully diluted basis as of the Closing Date, following the conversion of certain convertible notes of the Company and excluding certain warrants to purchase shares of the Common Stock expiring in 2020 and additional warrants as further described below (the “Fully Diluted Share Capital”). In addition, upon the earlier of: (a) the launch of a live video product to an American consumer in the United States by Viewbix Israel, or (b) the launch of an interactive television product to an American consumer in the United States by Viewbix Israel, the Company will issue to Gix an additional 1,642,193 shares of restricted common stock of the Company representing 5% of the Fully Diluted Share Capital immediately following the Closing Date.

 

4

 

 

On July 24, 2019, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of Delaware reflecting its name change from Virtual Crypto Technologies, Inc. to Viewbix Inc. to reflect its new operations and business focus and, effective on August 7, 2019, FINRA approved the Registrant’s name change and its trading symbol was changed from “VRCP” to “VBIX” on the OTCQB.

 

On the Closing Date, (i) the Company issued 20,281,085 shares of its common stock to Gix in exchange for consideration consisting of 99.83% holdings in Viewbix Israel, and (ii) convertible notes representing 3,434,889 shares of Common Stock then currently issued to holders were converted. The shares of Common Stock were issued under Regulation S. The Company also issued a total of 7,298,636 warrants to Gix to purchase shares of Common Stock, whereby (i) 3,649,318 of such warrants were issued with an exercise price of $0.48, and (ii) 3,649,318 of such warrants were issued with an exercise price of $0.80.

 

Following the Closing Date, Viewbix Israel became a subsidiary of the Registrant. Viewbix Israel was incorporated in February 2006 in Israel.

 

On January 27, 2020, VCT Israel was sold to a third party for NIS 50,000 ($14,459).

 

Viewbix Business Overview

 

Viewbix is an interactive video technology and data platform that provides its client with deep insights into their video marketing performance as well as the effectiveness of its messaging. Viewbix allow companies to add a layer with interactive content on top of a video that allows viewers to engage and interact with the video. The platform measures exactly when a view takes an action while watching a video and collects and reports the results to the client.

 

Viewbix developed the interactive video platform based on Software as a Service (“SaaS”) business model with interactive elements, and the ability to collect and analyze information about each interactive action performed during the viewing of the video clip. The interactive elements and information gathered allows the client to analyze user viewing habits and optimize real-time throughout the campaign while increasing the effectiveness of online and live video marketing.

 

Viewbix has adapted its technology platform to work on most nonproprietary platforms on the Internet, including, but not limited to, online video campaigns, brand and image videos, online tutorials, live and real-time video streaming (e.g. music concerts and sporting events), video presentations, and more. Using the Viewbix platform, video creators can integrate advances features into their videos, specifically the inclusion of “click” buttons that trigger a particular action, into a given video, like the insertion of a smart form for retrieving the contact information of the viewer. Viewbix then collects all the data around the cross section of the viewing data and engagement data and offers its clients the opportunity to download and analyze the results. Viewbix also offers a full service option where the Viewbix account managers will analyze the data and report results and suggestions to its clients.

 

Notwithstanding the foregoing, the Company initiated certain cost reduction measures during fiscal year-ended December 31, 2020. On January 1, 2020, each of the Company’s former Chief Executive Officer and Chief Operating Officer tendered their resignations from their respective positions. Moreover, due to the Company’s failure to meet predetermined sales targets set forth in the Share Exchange Agreement, the Company determined to reduce the size of its sales team and, likewise, the R&D team was replaced with a more cost-effective consultant. These decisions, and future decisions related to cost-reduction measures, may impact the Company’s ability to sell and support its products in the future and, accordingly, may materially impact the Company’s business operations.

 

Industry Overview

 

Video marketing remains one of the fastest growing industries, and, accordingly is increasingly crowded with competition. According to a study published by Cisco, by 2022 online videos will represent 82% of online consumer traffic. Globally, three trillion minutes (or five million years) of video content will cross the Internet each month by 2022, which is the equivalent of 1.1 million minutes of video streamed or downloaded every second.

 

Competition

 

While there are many companies that offer hosting and streaming services, Viewbix focuses on providing expanded value to its clients that reaches beyond the hosting and streaming platforms. Viewbix has several direct competitors, including Hapyak, which operates primarily via websites, and Innovid, which focuses on advertisements. Additionally, video hosting companies, such as Wistia and Vidyard, both offer certain interactive elements similar to Viewbix. However, Viewbix’s proprietary component is its focus on interactivity and deep data, which results can thereafter be analyzed and applied.

 

5

 

 

Intellectual Property and Other Proprietary Rights

 

Our commercial success depends, in part, on obtaining and maintaining patent and other intellectual property protection, in the United States and internationally, for the technologies used in our products. We cannot be sure that any of our patents will be commercially useful in protecting our technology. Our commercial success also depends in part on our non-infringement of the patents or proprietary rights of third parties. The patent positions can be highly uncertain and involve complex and evolving legal and factual questions.

 

We have four patents that have been granted to us in the U.S. which we consider material to our business and operating success, including the following:

 

  U.S. Patent No. 10,467,684: the granted patent relates to novel techniques implemented by Viewbix which enables businesses to configure their video players to incorporate interactivity functions, such as call-to-actions, into their video publishing and delivery workflows;
  U.S. Patent No. 8,706,562: the granted patent relates to video e-commerce networking, modules and methods used to configure a video or playlist that is delivered to viewers where the content displayed in the video player is dynamic and can be automatically customized based on the publisher site;
  U.S. Patent No. 8,706,558: the granted patent relates video e-commerce networking, modules and methods to display a video or playlist that is delivered to a viewer where the content displayed in the video player is dynamic and automatically customized based on the publisher site; and
  U.S. Patent No. 9,792,645: the granted patent provides a unique method to facilitate video interactions between a publisher and end users, and measures the data produced through that interaction.

 

We also protect our proprietary technology and processes, in part, by confidentiality and invention assignment agreements with our employees, consultants, scientific advisors and other contractors. These agreements may be breached, and we may not have adequate remedies for any breach. We also rely on trade secrets to protect our product candidates. However, our trade secrets may otherwise become known or be independently discovered by competitors. To the extent that our employees, consultants, scientific advisors or other contractors use intellectual property owned by others in their work for us, disputes may arise as to the rights in related or resulting know-how and inventions.

 

Product Development

 

Viewbix has been focusing its R&D efforts on the expansion of its interactive live capabilities also collecting the engagement data for each session and relating back to a live stream. This would greatly enhance our client’s feedback on its stream for both real time and future stream optimizations.

 

Employees

 

As of December 31, 2020, Viewbix has two employees in management and finance in Israel. Additionally, Viewbix retains the services of two R&D service providers, and a sales and marketing consultant which is based in the UK.

 

ITEM 1A. RISK FACTORS

 

The shares of our Common Stock are highly speculative in nature, involve a high degree of risk and should be purchased only by persons who can afford to lose their entire amount invested in the Common Stock. Accordingly, prospective investors should carefully consider, along with other matters referred to herein, the following risk factors in evaluating our business before purchasing any shares of Common Stock. If any of the following risks actually occurs, our business, financial condition or operating results could be materially adversely affected. In such case, you may lose all or part of your investment. You should carefully consider the risks described below and the other information in this Prospectus before investing in our Common Stock.

 

Summary Risk Factors

 

Our business is subject to numerous risks and uncertainties, including those highlighted in the section titled “Risk Factors” immediately following this prospectus summary. These risks include, among others, the following:

 

 

 

We initiated certain cost-reduction measures during the previous fiscal year, which could have long-term adverse effects on our business and we may not realize the operational or financial benefits from such actions;
     
  The COVID-19 pandemic has adversely affected, and will may continue to adversely affect, our business, financial condition, liquidity and results of operations;
     
  Our success depends, in part, upon the continued demand of video as an integral part of corporate marketing and internal communications plans and the continued growth and acceptance of videos as effective alternatives to traditional online and offline marketing products and services;
     
  Due to our evolving business model and rapid changes in the Internet and the nature of services, it is difficult to accurately predict our future performance and may be difficult to increase revenue or profitability;

 

6

 

 

  Our customers may reduce or terminate their business relationship with us at any time. If customers representing a significant portion of our revenue reduce or terminate their relationship with us, it could have a material adverse effect on our business, results of operations and financial condition;
     
  Because we have sustained significant turnover to key management positions, we may not have the leadership and personnel with expertise to guide us to profitable operations;
     
  Large and established internet and technology companies, such as Google and Facebook, play a substantial role in the digital advertising market and may significantly impair our ability to operate in this industry;
     
  The advertising/marketing industry is highly competitive. If we cannot compete effectively in this market, our revenues are likely to decline;
     
  If we cannot enforce and protect our intellectual property rights, our business could be adversely affected;
     
  We may in the future be, subject to claims of intellectual property infringement that could adversely affect our business;
     
  Patent terms may be inadequate to protect our competitive position for an adequate amount of time;
     
  We may not be able to protect our systems, technology and infrastructure from cyberattacks;
     
  Our business depends on our ability to collect and use data, and any limitation on the collection and use of this data could significantly diminish the value of our platform and cause us to lose customers and revenue;
     
  Shares of Common Stock issuable upon the conversion of warrants may substantially increase the number of shares of Common Stock available for sale in the public market and depress the price of our Common Stock;
     
  We are subject to compliance with securities law, which exposes us to potential liabilities, including potential rescission rights;
     
  The availability of a large number of authorized but unissued shares of Common Stock may, upon their issuance, lead to dilution of existing stockholders;
     
  We have never paid cash dividends and do not anticipate doing so in the foreseeable future;
     
  Our Common Stock is subject to the “Penny Stock” rules of the SEC and the trading market in our stock is limited, which makes transactions in our stock cumbersome and may reduce the value of an investment;
     
  Since our Common Stock is thinly traded, sale of your holding may take a considerable amount of time;
     
  Shares of Common Stock eligible for future sale may adversely affect the market;
     
  If we fail to maintain effective internal controls over financial reporting, the price of our Common Stock may be adversely affected;
     
  We are required to comply with certain provisions of Section 404 of the Sarbanes-Oxley Act of 2002 and if we fail to comply in a timely manner, our business could be harmed and our stock price could decline;
     
  Our annual and quarterly results may fluctuate, which may cause substantial fluctuations in our Common Stock price;

 

7

 

 

  Delaware law contains provisions that could discourage, delay or prevent a change in control of our company, prevent attempts to replace or remove current management and reduce the market price of our stock;
     
  Political, economic and military instability in Israel may impede our ability to operate and harm our financial results; and
     
  Exchange rate fluctuations between foreign currencies and the U.S. Dollar may negatively affect our earnings.

 

Risks Associated with Our Business and Industry

 

We initiated certain cost-reduction measures during the previous fiscal year, which could have long-term adverse effects on our business and we may not realize the operational or financial benefits from such actions.

 

We initiated certain cost-reduction measures during the previous fiscal year, and we may engage in similar activities in the future. This decision may distract management, could slow improvements in our platform and limit our ability to attract customers. It remains unclear how and to what extent this decision will impact our future business and operating success.

 

The COVID-19 pandemic has adversely affected, and may continue to adversely affect, our business, financial condition, liquidity and results of operations.

 

The COVID-19 pandemic has resulted in a widespread health crisis that has adversely affected businesses, economies and financial markets worldwide, placed constraints on the operations of businesses, decreased consumer mobility and activity, and caused significant economic volatility in the United States, Israel and international capital markets. The extent to which COVID-19 impacts our results will depend on future developments, which are highly uncertain and cannot be predicted, including actions to contain COVID-19 or treat its impact and the efficacy and scale of the various vaccines currently deployed in Israel and across the world, among others. Our business has been affected in various ways, including in our operations, and we cannot predict the length and severity of the pandemic. We have followed guidance by the U.S. and Israeli governments and the other local governments in which we operate to protect our employees and our operations during the pandemic and have implemented a remote environment for certain of our employees, and, as a result, may experience inefficiencies in our employees’ ability to collaborate. The COVID-19 pandemic could also affect the health of our consumers. In addition, the COVID-19 pandemic has caused an economic recession, high unemployment rates and other disruptions, both in the United States, Israel and the rest of the world. Any of these impacts, including the prolonged continuation of these impacts, could adversely affect our business.

 

We cannot predict the other potential impacts of the COVID-19 pandemic on our business or operations, and there is no guarantee that any near-term trends in our results of operations will continue, particularly if the COVID-19 pandemic and the adverse consequences thereof continue for a long period of time. Additional waves of infections, a continuation of the current environment, or any further adverse impacts caused by the COVID-19 pandemic could further deteriorate employment rates and the economy, detrimentally affecting our consumer base and divert consumers’ discretionary income to other uses, including for essential items. These events could adversely impact our cash flows, results of operations and financial conditions and heighten many of the other risks described in these “Risk Factors.”

 

Our success depends, in part, upon the continued demand of video as an integral part of corporate marketing and internal communications plans and the continued growth and acceptance of videos as effective alternatives to traditional online and offline marketing products and services.

 

We provide a platform that allows companies to understand what messages are resonating with their video viewers and how to leverage that data to enrich and empower a more effective video experience. Our revenues are derived from the sale of our platform. If the demand for video advertising does not continue to grow or customers do not embrace our platform, this could have a material adverse effect on our business and financial condition.

 

8

 

 

Our success also depends, in part, on our ability to compete for a share of available video advertising/marketing expenditures as more traditional offline and emerging media companies continue to enter the online advertising/marketing market, as well as on the continued growth and acceptance of online advertising generally. If for any reason online advertising is not perceived as effective (relative to traditional advertising), web browsers, software programs and/or other applications that limit or prevent advertising from being displayed become commonplace and/or the industry fails to effectively manage click fraud, the market for online advertising will be negatively impacted. Any lack of growth in the market for online advertising/marketing (particularly for paid listings) could adversely affect our business, financial condition and results of operations.

 

Due to our evolving business model and rapid changes in the Internet and the nature of services, it is difficult to accurately predict our future performance and may be difficult to increase revenue or profitability.

 

We developed our platform based on SaaS business model. We do not have an extensive history of ongoing operations in using our business model from which to predict our future performance, and making such predictions, particularly with regard to the effect of our efforts to aggressively increase the distribution and profitability is very complex and challenging. If we are unable to continuously improve our platform, this could have a negative effect on our competitiveness and ability to service and attract customers. If we are unsuccessful in doing so in a timely fashion, we may not be able to achieve revenue growth or increase our profitability.

 

Our customers may reduce or terminate their business relationship with us at any time. If customers representing a significant portion of our revenue reduce or terminate their relationship with us, it could have a material adverse effect on our business, results of operations and financial condition.

 

We generally engage with two types of customers: small companies who change from time to time and a number of large companies with whom the engagement is for shorter periods of time. We do not enter into long-term contracts with our customers, and such customers do business with us on a non-exclusive basis. Accordingly, our business is highly vulnerable to adverse economic conditions, market evolution and development of new or more compelling offerings by our competitors, which could either lead to reduced advertising spend generally or motivate our current or potential customers to migrate to our competitors. Any reduction in spending by, or loss of, existing or potential customers would negatively impact our revenue and operating results.

 

Furthermore, the discretionary, non-exclusive nature of our relationships with customers subjects us to increased pricing pressure. Although we believe our rates are competitive, our competitors may be able to offer more favorable pricing or other advantageous terms. As a result, we may be compelled to reduce our rates or offer other incentives in order to maintain our current customers and attract new customers. If a significant number of customers are able to compel us to charge lower rates or provide rate concessions or incentives, there is no assurance that we would be able to compensate for such price reductions or conserve our profit margins.

 

Because we have sustained significant turnover to key management positions, we may not have the leadership and personnel with expertise to guide us to profitable operations.

 

We have sustained significant turnover to our management team. Our success depends in part upon our ability to retain the services of our executive officers and employees. The loss of the services of our executive officers or other employees would have a material adverse effect on our business, operating results and financial condition.

 

Risks Related to our Competition

 

Large and established internet and technology companies, such as Google and Facebook, play a substantial role in the digital advertising market and may significantly impair our ability to operate in this industry.

 

Google is a substantial player in the digital advertising market along with other players such as Microsoft. In addition, a small number of social network companies, such as Facebook, account for a large portion of digital advertising budgets. The high concentration of power among Google, Facebook and some other large market participants causes us to be subject to any unilateral changes they may make with respect to advertising on their respective platforms, which may be more lucrative than alternative methods of advertising or partnerships with other publishers that are not subject to such changes. Furthermore, we could have limited ability to respond to, and adjust for, changes implemented by large market participants.

 

9

 

 

These companies, along with other large and established Internet and technology companies, may also leverage their power to make changes to their web browsers, operating systems, platforms, networks or other products or services in a way that impacts the entire digital advertising marketplace.

 

The advertising/marketing industry is highly competitive. If we cannot compete effectively in this market, our revenues are likely to decline.

 

We face intense competition in the marketplace. We operate in a dynamic market that is subject to rapid development and introduction of new technologies, products and solutions, changing branding objectives, evolving customer demands and industry guidelines, all of which affect our ability to remain competitive. There are a large number of companies and advertising technology companies that offer products or services similar to ours and that compete with us for finite advertising budgets. There is also a large number of niche companies that are competitive with us, as they provide a subset of the services that we provide. Some of our existing and potential competitors may be better established, benefit from greater name recognition, may offer solutions and technologies that we do not offer or that are more evolved than ours, and may have significantly more financial, technical, sales and marketing resources than we do. In addition, some competitors, particularly those with a larger and more diversified revenue base and a broader offering, may have greater flexibility than we do to compete aggressively on the basis of price and other contract terms as well as respond to market changes. Additionally, companies that do not currently compete with us in this space may change their services to be competitive if there is a revenue opportunity, and new or stronger competitors may emerge through consolidations or acquisitions. If our platform is not perceived as competitively differentiated or we fail to develop adequately to meet market evolution, we could lose customers and market share or be compelled to reduce our prices and harm our operational results.

 

Risks Related to our Intellectual Property

 

If we cannot enforce and protect our intellectual property rights, our business could be adversely affected.

 

We rely on patents, copyright, trademark, domain name and trade secret laws in the United States and similar laws in other countries, as well as licenses and other agreements with our employees, and other parties, to establish and maintain our intellectual property rights in the technology, products and services used in our operations. These laws and agreements may not guarantee that our intellectual property rights will be protected and our intellectual property rights could be challenged or invalidated. Amendments to or interpretations of U.S. patent laws or new rulings around U.S. patent laws may adversely impact our ability to protect our new technologies, content, products and services and to defend against claims of patent infringement. In addition, such intellectual property rights may not be sufficient to permit us to take advantage of current industry trends or otherwise to provide competitive advantages, which could result in costly redesign efforts, discontinuance of offerings, decreased traffic and associated revenue or otherwise adversely affect our business.

 

We may in the future be, subject to claims of intellectual property infringement that could adversely affect our business.

 

Many companies (including patent holding companies) and individuals own patents, copyrights, trademarks, and trade secrets and frequently enter into litigation based on allegations of infringement or other violations of intellectual property rights. As we develop and offer our platform through various distribution channels we may experience an increase in the number of intellectual property claims against us. These claims, whether meritorious or not, may result in litigation, may be time-consuming and costly to resolve, and may require expensive changes in our methods of doing business. These intellectual property infringement claims may require us to enter into royalty or licensing agreements on unfavorable terms or to incur substantial monetary liability. Additionally, these claims may result in our being enjoined preliminarily or permanently from further use of certain intellectual property or may require us to cease or significantly alter certain of our operations.

 

10

 

 

Some of our commercial agreements may require us to indemnify third parties against intellectual property infringement claims, which may require us to use substantial resources to defend against or settle such claims or, potentially, to pay damages. These third parties may also discontinue the use of our platform, as a result of injunctions or otherwise, which could result in loss of revenues and adversely impact our business. Additionally, we may be exposed to liability or substantially increased costs if a commercial partner does not honor its contractual obligation to indemnify us for intellectual property infringement claims made by third parties or if any amounts received are not adequate to cover our liabilities or the costs associated with defense of such claims. The occurrence of any of these events could adversely affect our business.

 

Patent terms may be inadequate to protect our competitive position for an adequate amount of time.

 

Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest U.S. non-provisional or international patent application filing date. Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Even if patents covering our products are obtained, once the patent life has expired, we may be open to competition from competitive products, including generics. As a result, our patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours.

 

Risks Related to Cyber and Data Collection

 

We may not be able to protect our systems, technology and infrastructure from cyberattacks.

 

We may be under attack by perpetrators of malicious technology-related events, such as the use of botnets, malware or other destructive or disruptive software, distributed denial of service attacks, phishing, attempts to misappropriate user information and other similar malicious activities. The incidence of events of this nature (or any combination thereof) is on the rise worldwide. While we continuously develop and maintain systems designed to detect and prevent events of this nature from impacting our platform, we have invested (and continue to invest) heavily in these efforts. These efforts are costly and require ongoing monitoring and updating as technologies change and efforts to overcome preventative security measures become more sophisticated.

 

Any event of this nature that we experience could damage our systems, technology and infrastructure, prevent us from providing our services, compromise the integrity of our services, damage our reputation and/or be costly to remedy, as well as subject us to investigations by regulatory authorities, fines and/or litigation that could result in liability to third parties.

 

Our business depends on our ability to collect and use data, and any limitation on the collection and use of this data could significantly diminish the value of our platform and cause us to lose customers and revenue.

 

Our platform receives, collects, stores, processes, transfers and uses certain data about how viewers engaged with videos and helps companies to leverage that data to become a better story teller and optimize the videos. Our ability to access and utilize such data is crucial.

 

Our ability to either collect or use data could be restricted by new laws or regulations. We are subject to numerous federal, state, local, and international laws, directives and regulations regarding privacy, data protection, and data security and the collection, storing, sharing, use, processing, transfer, disclosure and protection of personal information and other data, the scope of which are changing, subject to differing interpretations, and may be inconsistent among jurisdictions or conflict with other legal and regulatory requirements. We are also subject to certain contractual obligations to third parties related to privacy, data protection and data security. We strive to comply with our applicable policies and applicable laws, regulations, contractual obligations and other legal obligations relating to privacy, data protection and data security to the extent possible. However, the regulatory framework for privacy, data protection and data security worldwide is, and is likely to remain for the foreseeable future, uncertain and complex, and it is possible that these or other actual or alleged obligations may be interpreted and applied in a manner that we do not anticipate or that is inconsistent from one jurisdiction to another and may conflict with other legal obligations or our practices. Further, any significant change to applicable laws, regulations or industry practices regarding the collection, use, retention, security or disclosure of data, or their interpretation, or any changes regarding the manner in which the consent of users or other data subjects for the collection, use, retention or disclosure of such data must be obtained, could increase our costs and require us to modify our services and features, possibly in a material manner, which we may be unable to complete, and may limit our ability to store and process user data or develop new services and features.

 

11

 

 

If we were found in violation of any applicable laws or regulations relating to privacy, data protection or security, our business may be materially and adversely affected and we would likely have to change our business practices and potentially the services and features available through our platform. In addition, these laws and regulations could impose significant costs on us and could constrain our ability to use and process data in manners that may be commercially desirable. In addition, if a breach of data security were to occur or to be alleged to have occurred, if any violation of laws and regulations relating to privacy, data protection or data security were to be alleged, or if we had any actual or alleged defect in our safeguards or practices relating to privacy, data protection, or data security, our solutions may be perceived as less desirable and our business, prospects, financial condition and results of operations could be materially and adversely affected.

 

We also expect that there will continue to be new laws, regulations and industry standards concerning privacy, data protection and information security proposed and enacted in various jurisdictions. For example, the European Union’s (“EU”), data protection landscape is currently unstable, resulting in possible significant operational costs for internal compliance and risks to our business. The EU has adopted the General Data Protection Regulation (“GDPR”), which became effective in May 2018, and contains numerous requirements and changes from previously existing EU laws, including more robust obligations on data processors and heavier documentation requirements for data protection compliance programs by companies. Among other requirements, the GDPR regulates the transfer of personal data subject to the GDPR to third countries that have not been found to provide adequate protection to such personal data, including the United States. Failure to comply with the GDPR could result in penalties for noncompliance.

 

In addition to the GDPR, the European Commission has another draft regulation in the approval process that focuses on a person’s right to conduct a private life. The proposed legislation, known as the Regulation of Privacy and Electronic Communications (“ePrivacy Regulation”), would replace the current the current ePrivacy Directive. Originally planned to be adopted and implemented at the same time as the GDPR, the ePrivacy Regulation is still being negotiated.

 

Additionally, in June 2018, California passed the California Consumer Privacy Act (“CCPA”), which provides new data privacy rights for consumers and new operational requirements for companies. Specifically, the CCPA provides that covered companies must provide new disclosures to California consumers and afford such consumers new abilities to opt-out of certain sales of personal information. The CCPA became operative January 1, 2020. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. We cannot fully predict the impact of the CCPA on our business or operations, but it may require us to modify our data practices and policies and to incur substantial costs and expenses in an effort to comply. Some observers have noted the CCPA could mark the beginning of a trend toward more stringent privacy legislation in the United States, which could increase our potential liability and adversely affect our business. Further in March 2017, the United Kingdom (“U.K.”) formally notified the European Council of its intention to leave the EU pursuant to Article 50 of the Treaty on European Union (“Brexit”). The U.K. ceased to be an EU Member State on January 31, 2020, but enacted, a Data Protection Act substantially implementing the GDPR, effective in May 2018, which was further amended to align more substantially with the GDPR following Brexit. It is unclear how U.K. data protection laws or regulations will develop in the medium to longer term and how data transfers to and from the U.K. will be regulated. In addition, some countries are considering or have enacted legislation requiring local storage and processing of data that could increase the cost and complexity of delivering our services.

 

In addition, failure to comply with the Israeli Privacy Protection Law 1981, and its regulations as well as the guidelines of the Israeli Privacy Protection Authority, may expose us to administrative fines, civil claims (including class actions) and in certain cases criminal liability. Current pending legislation may result in a change of the current enforcement measures and sanctions.

 

12

 

 

Any failure or perceived failure by us to comply with our posted privacy policies, our privacy-related obligations to users or other third parties, or any other legal obligations or regulatory requirements relating to privacy, data protection or data security may result in governmental investigations or enforcement actions, litigation, claims or public statements against us by consumer advocacy groups or others and could result in significant liability, cause our users to lose trust in us, and otherwise materially and adversely affect our reputation and business. Furthermore, the costs of compliance with, and other burdens imposed by, the laws, regulations, other obligations and policies that are applicable to the businesses of our users may limit the adoption and use of, and reduce the overall demand for, our platform. Additionally, if third parties we work with violate applicable laws, regulations or contractual obligations, such violations may put our users’ data at risk, could result in governmental investigations or enforcement actions, fines, litigation, claims, or public statements against us by consumer advocacy groups or others and could result in significant liability, cause our users to lose trust in us and otherwise materially and adversely affect our reputation and business. Further, public scrutiny of, or complaints about, technology companies or their data handling or data protection practices, even if unrelated to our business, industry or operations, may lead to increased scrutiny of technology companies, including us, and may cause government agencies to enact additional regulatory requirements, or to modify their enforcement or investigation activities, which may increase our costs and risks.

 

Risks Related to Our Common Stock

 

Shares of Common Stock issuable upon the conversion of warrants may substantially increase the number of shares of Common Stock available for sale in the public market and depress the price of our Common Stock.

 

As of December 31, 2020, we had outstanding: (i) Class J Warrants exercisable to purchase 3,649,318 shares of Common Stock at an exercise price of $0.48 per share of Common Stock; and (ii) Class K Warrants exercisable to purchase 3,649,318 shares of Common Stock, at an exercise price of $0.80 per share of Common Stock.

 

To the extent any of these warrants are exercised and any additional warrants are issued and subsequently exercised, there will be further dilution to our stockholders. Until the warrants expire, these warrant holders will have an opportunity to profit from any increase in the market price of our Common Stock without assuming the risks of ownership. Holders of options and warrants may exercise these securities at a time when we could obtain additional capital on terms more favorable.

 

The exercise price of the warrants will dilute the voting interest of the owners of presently outstanding shares of Common Stock by adding a substantial number of additional shares of our Common Stock. We have reserved shares of Common Stock for issuance upon the exercise of the warrants and may increase the shares reserved for these purposes in the future.

 

The shares of our Common Stock, which are issuable upon the exercise of any outstanding warrants may be sold in the public market pursuant to Rule 144, if applicable. The sale of our Common Stock issued or issuable upon the exercise of the warrants and options described above, or the perception that such sales could occur, may adversely affect the market price of our Common Stock.

 

We are subject to compliance with securities law, which exposes us to potential liabilities, including potential rescission rights.

 

We have offered and sold our Common Stock to investors pursuant to certain exemptions from the registration requirements of the Securities Act of 1933, as amended (the “Act”) as well as those of various state securities laws. The basis for relying on such exemptions is factual; that is, the applicability of such exemptions depends upon our conduct and that of those persons contacting prospective investors and making the offering. We have not received a legal opinion to the effect that any of our prior offerings were exempt from registration under any federal or state law. Instead, we have relied upon the operative facts as the basis for such exemptions, including information provided by investors themselves.

 

13

 

 

If any prior offering did not qualify for such exemption, an investor would have the right to rescind its purchase of the securities if it so desired. It is possible that if an investor should seek rescission, such investor would succeed. A similar situation prevails under state law in those states where the securities may be offered without registration in reliance on the partial preemption from the registration or qualification provisions of such state statutes. If investors were successful in seeking rescission, we would face severe financial demands that could adversely affect our business and operations. Additionally, if we did not in fact qualify for the exemptions upon which it has relied, we may become subject to significant fines and penalties imposed by the U.S. Securities and Exchange Commission (the “SEC”) and state securities agencies.

 

The availability of a large number of authorized but unissued shares of Common Stock may, upon their issuance, lead to dilution of existing stockholders.

 

We are authorized to issue 490,000,000 shares of Common Stock, of which, as of December 31, 2020, 34,753,669 shares of Common Stock were outstanding. Additional shares of Common Stock may be issued by our board of directors without further stockholder approval. The issuance of large numbers of shares, possibly at below market prices, is likely to result in substantial dilution to the interests of other stockholders. In addition, issuances of large numbers of shares of Common Stock may adversely affect the market price of our Common Stock.

 

Our Certificate of Incorporation authorizes 10,000,000 shares of preferred stock, par value $0.0001 per share of which none were issued and outstanding as of December 31, 2020. The board of directors is authorized to provide for the issuance of these unissued shares of preferred stock in one or more series, and to fix the number of shares and to determine the rights, preferences and privileges thereof. Accordingly, the board of directors may issue preferred stock which may convert into large numbers of shares of common stock and consequently lead to further dilution of other stockholders.

 

We have never paid cash dividends and do not anticipate doing so in the foreseeable future.

 

We have never declared or paid cash dividends on our Common Shares. We currently plan to retain any earnings to finance the growth of our business rather than to pay cash dividends. Payments of any cash dividends in the future will depend on our financial condition, results of operations and capital requirements, as well as other factors deemed relevant by our board of directors.

 

Our Common Stock is subject to the “Penny Stock” rules of the SEC and the trading market in our stock is limited, which makes transactions in our stock cumbersome and may reduce the value of an investment.

 

The SEC has adopted Rule 15g-9 which establishes the definition of a “penny stock,” for the purposes relevant to us, as any equity security that has a market price of less than $5.00 per share or with an exercise price of less than $5.00 per share, subject to certain exceptions. For any transaction involving a penny stock, unless exempt, the rules require:

 

That a broker or dealer approve a person’s account for transactions in penny stocks; and
   
The broker or dealer receives from the investor a written agreement to the transaction, setting forth the identity and quantity of the penny stock to be purchased.

 

In order to approve a person’s account for transactions in penny stocks, the broker or dealer must:

 

Obtain financial information and investment experience objectives of the person; and
   
Make a reasonable determination that the transactions in penny stocks are suitable for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.

 

The broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the SEC relating to the penny stock market, which, in highlight form:

 

14

 

 

Sets forth the basis on which the broker or dealer made the suitability determination; and
   
That the broker or dealer received a signed, written agreement from the investor prior to the transaction.

 

Generally, brokers may be less willing to execute transactions in securities subject to the “penny stock” rules. This may make it more difficult for investors to dispose of our Common Stock and cause a decline in the market value of our Common Stock.

 

Disclosure also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading and about the commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and the rights and remedies available to an investor in cases of fraud in penny stock transactions. Finally, monthly statements have to be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks.

 

Since our Common Stock is thinly traded, sale of your holding may take a considerable amount of time.

 

The shares of our Common Stock are thinly-traded on the OTCQB Market, meaning that the number of persons interested in purchasing our Common Stock at or near bid prices at any given time may be relatively small or non-existent. As a consequence, there may be periods of several days or more when trading activity in our shares is minimal or non-existent, as compared to a seasoned issuer which has a large and steady volume of trading activity that will generally support continuous sales without an adverse effect on share price. We cannot give you any assurance that a broader or more active public trading market for our Common Stock will develop or be sustained, or that current trading levels will be sustained. Due to these conditions, we can give you no assurance that you will be able to sell your shares at or near bid prices or at all if you need money or otherwise desire to liquidate your shares.

 

Shares of Common Stock eligible for future sale may adversely affect the market.

 

From time to time, certain of our stockholders may be eligible to sell all or some of their shares of Common Stock by means of ordinary brokerage transactions in the open market pursuant to Rule 144 promulgated under the Act, subject to certain limitations. In general, pursuant to amended Rule 144, non-affiliate stockholders may sell freely after six months, subject only to the current public information requirement. Affiliates may sell after six months, subject to the Rule 144 volume, manner of sale (for equity securities), current public information and notice requirements. Any substantial sales of our common stock pursuant to Rule 144 may have a material adverse effect on the market price of our Common Stock.

 

If we fail to maintain effective internal controls over financial reporting, the price of our Common Stock may be adversely affected.

 

We identified a material weakness in our period and our financial reporting process. Our internal control over financial reporting may have material weaknesses and conditions that could require correction or remediation, the disclosure of which may have an adverse impact on the price of our Common Stock. We are required to establish and maintain appropriate internal controls over financial reporting. Failure to establish those controls, or any failure of those controls once established, could adversely affect our public disclosures regarding our business, prospects, financial condition or results of operations. In addition, management’s assessment of internal controls over financial reporting may identify material weaknesses and conditions that need to be addressed in our internal controls over financial reporting or other matters that may raise concerns for investors. Any actual or perceived weaknesses and conditions that need to be addressed in our internal control over financial reporting or disclosure of management’s assessment of our internal controls over financial reporting may have an adverse impact on the price of our Common Stock.

 

We are required to comply with certain provisions of Section 404 of the Sarbanes-Oxley Act of 2002 and if we fail to comply in a timely manner, our business could be harmed and our stock price could decline.

 

Rules adopted by the SEC pursuant to Section 404 of the Sarbanes-Oxley Act of 2002 require an annual assessment of internal controls over financial reporting, and for certain issuers an attestation of this assessment by the issuer’s independent registered public accounting firm. The standards that must be met for management to assess the internal controls over financial reporting as effective are complex, and require significant documentation, testing, and possible remediation to meet the detailed standards.

 

15

 

 

We expect to incur expenses and to devote resources to Section 404 compliance on an ongoing basis. It is difficult for us to predict how long it will take or costly it will be to complete the assessment of the effectiveness of our internal control over financial reporting for each year and to remediate any deficiencies in our internal control over financial reporting. As a result, we may not be able to complete the assessment and remediation process on a timely basis. In addition, although attestation requirements by our independent registered public accounting firm are not presently applicable to us, we could become subject to these requirements in the future and we may encounter problems or delays in completing the implementation of any resulting changes to internal controls over financial reporting. In the event that our Chief Executive Officer and Chief Financial Officer, which currently is the same individual, determines that our internal control over financial reporting is not effective as defined under Section 404, we cannot predict how the market prices of our shares of Common Stock will be affected; however, we believe that there is a risk that investor confidence and share value may be negatively affected.

 

Our annual and quarterly results may fluctuate, which may cause substantial fluctuations in our Common Stock price.

 

Our annual and quarterly operating results may in the future fluctuate significantly depending on factors including the timing of purchase orders, new product releases by us and other companies, gain or loss of significant customers, price discounting of our product, the timing of expenditures, product delivery requirements and economic conditions. Revenues related to our product are required to be recognized upon satisfaction of all applicable revenue recognition criteria. The recognition of revenues from our product is dependent on a number of factors, including, but not limited to, the terms of any license agreement and the timing of implementation of our products by our customers.

 

Any unfavorable change in these or other factors could have a material adverse effect on our operating results for a particular quarter or year, which may cause downward pressure on our common stock price. We expect quarterly and annual fluctuations to continue for the foreseeable future.

 

Delaware law contains provisions that could discourage, delay or prevent a change in control of our company, prevent attempts to replace or remove current management and reduce the market price of our stock.

 

Provisions in our certificate of incorporation and bylaws may discourage, delay or prevent a merger or acquisition involving us that our stockholders may consider favorable. For example, our certificate of incorporation authorizes our board of directors to issue up to ten million shares of “blank check” preferred stock. As a result, without further stockholder approval, the board of directors has the authority to attach special rights, including voting and dividend rights, to this preferred stock. With these rights, preferred stockholders could make it more difficult for a third party to acquire us.

 

We are also subject to the anti-takeover provisions of the Delaware General Corporation Law (the “DGCL”). Under these provisions, if anyone becomes an “interested stockholder,” we may not enter into a “business combination” with that person for three years without special approval, which could discourage a third party from making a takeover offer and could delay or prevent a change in control of us. An “interested stockholder” is, generally, a stockholder who owns 15% or more of our outstanding voting stock or an affiliate of ours who has owned 15% or more of our outstanding voting stock during the past three years, subject to certain exceptions as described in the DGCL.

 

16

 

 

Risks Related to our Operations in Israel

 

Political, economic and military instability in Israel may impede our ability to operate and harm our financial results.

 

Our offices and management team are located in the Tel-Aviv metropolitan area, Israel. Accordingly, political, economic, and military conditions in Israel and the surrounding region may directly affect our business and operations. In recent years, Israel has been engaged in sporadic armed conflicts with Hamas, an Islamist terrorist group that controls the Gaza Strip, with Hezbollah, an Islamist terrorist group that controls large portions of southern Lebanon, and with Iranian-backed military forces in Syria. In addition, Iran has threatened to attack Israel and may be developing nuclear weapons. Some of these hostilities were accompanied by missiles being fired from the Gaza Strip against civilian targets in various parts of Israel, including areas in which our employees and some of our consultants are located, and negatively affected business conditions in Israel. Any hostilities involving Israel or the interruption or curtailment of trade between Israel and its trading partners could adversely affect our operations and results of operations Our commercial insurance does not cover losses that may occur as a result of events associated with war and terrorism. Although the Israeli government currently covers the reinstatement value of direct damages that are caused by terrorist attacks or acts of war, we cannot assure you that this government coverage will be maintained or that it will sufficiently cover our potential damages. Any losses or damages incurred by us could have a material adverse effect on our business. Any armed conflicts or political instability in the region would likely negatively affect business conditions and could harm our results of operations.

 

Further, in the past, the State of Israel and Israeli companies have been subjected to economic boycotts. Several countries still restrict business with the State of Israel and with Israeli companies. These restrictive laws and policies may have an adverse impact on our operating results, financial condition or the expansion of our business. A campaign of boycotts, divestment and sanctions has been undertaken against Israel, which could also adversely impact our business.

 

In addition, many Israeli citizens are obligated to perform several days, and in some cases more, of annual military reserve duty each year until they reach the age of 40 (or older, for reservists who are military officers or who have certain occupations) and, in the event of a military conflict, may be called to active duty. In response to increases in terrorist activity, there have been periods of significant call-ups of military reservists. It is possible that there will be military reserve duty call-ups in the future. Our operations could be disrupted by such call-ups, which may include the call-up of members of our management. Such disruption could materially adversely affect our business, prospects, financial condition and results of operations.

 

Exchange rate fluctuations between foreign currencies and the U.S. Dollar may negatively affect our earnings.

 

Our reporting and functional currency is the U.S. dollar. Our revenues are currently primarily payable in U.S. dollars and Euros and we expect our future revenues to be denominated primarily in U.S. dollars and Euros. However, certain amount of our expenses are in NIS and as a result, we are exposed to the currency fluctuation risks relating to the recording of our expenses in U.S. dollars. We may, in the future, decide to enter into currency hedging transactions. These measures, however, may not adequately protect us from material adverse effects.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS

 

None.

 

ITEM 2. PROPERTIES

 

None.

 

ITEM 3. LEGAL PROCEEDING

 

We are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations, except as set forth below. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of the Company, threatened against or affecting the Company, our Common Stock, our officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect, other than as set forth below.

 

17

 

 

On August 7, 2019, Viewbix Ltd. was named as a co-defendant in a civil lawsuit filed with the Jerusalem District Court (the “Jerusalem Court”) by three shareholders of Viewbix Ltd. (in this section, the “Shareholders”), alleging that they were entitled to receive certain preferred shares in Viewbix Ltd., pursuant to a certain 2007 loan agreement by and between Viewbix Ltd. and the petitioning Shareholders, following the sale of Viewbix Ltd. shares to Gix (the “Conversion”). The Shareholders sought declaratory recourse from the Jerusalem Court, pursuant to which the Shareholders demanded, inter alia, shares in Gix on a post-Conversion basis or in an alternative form of compensation. On February 27, 2020, the parties presented their respective arguments before the Jerusalem Court, and the Jerusalem Court determined that the Company is entitled to file a motion for dismissal of the claims by the Shareholders by March 31, 2020, which was subsequently postponed to August 9, 2020. On September 24, 2020, the parties submitted before the Jerusalem Court a settlement proposal, which was thereafter approved by the Jerusalem Court on the same date (the “Settlement”). The Settlement provided, inter alia, that in exchange for the voluntary waiver of claims held by the Shareholders, Gix instructed the trustee holding the instant shares of Gix, which were issued by Gix as part of the transaction where Gix acquired share capital of Viewbix in November 2018, to issue 63,350 shares of Common Stock owned by Gix to the Shareholders, whereby the remaining shares in the trust account will be used to indemnify Gix for any expenses related to the instant litigation. Since the aforementioned compensation was provided in the form of shares of Common Stock previously owned by Gix, the settlement has no effect on the Company’s financial statements.

 

In June 2017, a lawsuit was filed with the Regional Labor Court in Tel Aviv (the “Tel Aviv Court”) against Emerald Israel, and other defendants, claiming certain damages in the total amount of approximately $225,000, under the assertion of wrongful termination by Emerald Israel. We believe these claims to be unsubstantiated and wholly without merit and accordingly filed our response with the Tel Aviv Court in October of 2017. The dispute was initially heard by the Tel Aviv Court on February 13, 2020. In a supplemental hearing on February 11, 2021, the plaintiff provided a certified confirmation of payment of approximately $14,668 by the National Insurance Institute of Israel for one month’s prior notice of termination, redemption of 16.8 days of vacation and severance pay. The plaintiff’s summaries were filed on March 11, 2021, and the defendant’s summaries will be filed within 30 days of receiving the plaintiff’s summaries.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

None.

 

18

 

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON STOCK, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASE OF EQUITY

 

Market Information

 

Our Common Stock is currently quoted on the OTCQB market under the symbol VBIX. The following table, adjusted for a one-for-fifteen (1:15) reverse split that became effective on May 20, 2019, sets forth for the respective periods indicated the prices of our Common Stock in the OTC Link Alternative Trading System. Such prices are based on inter-dealer bid and asked prices, without markup, markdown, commissions, or adjustments and may not represent actual transactions.

 

During the fiscal year ended December 31, 2020 and the fiscal years ended December 31, 2019, we had the following trading history:

 

    Fiscal 2020   Fiscal 2019 
    High   Low   High   Low 
First Quarter ended March 31   $0.05   $0.02   $0.051  $0.031
Second Quarter ended June 30   $0.03   $0.01   $1.12   $0.05 
Third Quarter ended September 30   $0.03   $0.01   $0.86   $0.12 
Fourth Quarter ended December 31   $0.02   $0.01   $0.12   $0.03 

 

  1 Adjusted for a one-for-fifteen (1:15) reverse split that became effective on May 20, 2019 (prior to the Recapitalization Transaction).

 

Holders of Common Stock

 

As of December 31, 2020, there were approximately 2,697 stockholders of record of our Common Stock and 34,753,669 shares of our Common Stock outstanding.

 

Our transfer agent is Transfer Online, 512 SE Salmon Street, Portland, OR 97214-3444, Phone: (503) 227-2950.

 

Dividends

 

Holders of Common Stock are entitled to dividends if declared by our board of directors, out of funds legally available therefore. We have never declared cash dividends on our Common Stock and our board of directors does not anticipate paying cash dividends in the foreseeable future as it intends to retain future earnings to finance the growth of our businesses.

 

Outstanding Warrants

 

The following table summarizes information of outstanding warrants as of December 31, 2020:

 

   Warrants   Warrant Term  Exercise Price   Exercisable 
                
Class J Warrants   3,649,318   July 2029  $0.48    3,649,318 
Class K Warrants   3,649,318   July 2029  $0.80    3,649,318 

 

In connection with the Share Exchange Agreement, upon the earlier of: (a) the launch of a live video product to an American consumer in the United States by Viewbix Israel, or (b) the launch of an interactive television product to an American consumer in the United States by Viewbix Israel, we will issue to Gix an additional 1,642,193 shares of restricted Common Stock of the Company.

 

Securities Authorized for Issuance Under Equity Compensation Plans

 

The following table summarizes information of outstanding options as of December 31, 2020:

 

   Number of
securities to be
issued upon
exercise of
outstanding
options, warrants
and rights
   Weighted-average exercise price of outstanding
options, warrants
and rights
   Number of
securities
remaining
available for future
issuance
 
Plan Category               
Equity compensation plans approved by security holders 2017 Employee Incentive Plan               -                     -    133,333 

 

19

 

 

Recent Sales of Unregistered Securities

 

On December 18, 2020, we entered into a Stock Subscription Agreement (the “Subscription”) with certain investors (the “Investors”) in connection with the sale and issuance of an aggregate of 3,000,000 shares of Common Stock, at a purchase price of US$0.01 per share, and for an aggregate purchase price of US$30,000. In addition, and on the same date, we entered into a Loan Agreement (the “Loan Agreement”) with the Investors, pursuant to which the Investors lent an aggregate of $69,000 (the “Principal Amount”). In accordance with the terms of the Loan, we repaid the interest on the Principal Amount (8% compounded annually) to the Investors in the form of an issuance of an aggregate of 552,000 shares of Common Stock, at a price per share of $0.01. The shares of Common Stock were issued to the Investors pursuant to Regulation S of the Securities Act of 1933, as amended.

 

ITEM 6. SELECTED FINANCIAL DATA

 

Not required for smaller reporting companies.

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND PLAN OF OPERATION

 

Overview

 

The following plan of operation provides information which management believes is relevant to an assessment and understanding of our results of operations and financial condition. The discussion should be read along with our consolidated financial statements and notes thereto. This section includes a number of forward-looking statements that reflect our current views with respect to future events and financial performance. Forward-looking statements are often identified by words like believe, expect, estimate, anticipate, intend, project and similar expressions, or words which refer to future events. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our predictions.

 

Organizational Background

 

The Registrant was incorporated in the State of Ohio in 1989 under a predecessor name, Zaxis International, Inc. On August 25, 1995, Zaxis International, Inc. merged with a subsidiary of The InFerGene Company, a Delaware corporation, which entity changed its name to Zaxis International, Inc. and the Company was reincorporated in Delaware under the name of Zaxis International, Inc. On December 30, 2014, Zaxis entered into an agreement with Emerald Medical Applications Ltd., a private limited liability company organized under the laws of the State of Israel.

 

Emerald Medical Applications Ltd.

 

On March 16, 2015, Zaxis and Emerald Israel executed a share exchange agreement, which closed on July 14, 2015, and Emerald Israel became the Company’s wholly-owned subsidiary. Emerald Israel was engaged in the business of developing Emerald Israel’s DermaCompare technology and the development, sale and service of imaging solutions utilizing its DermaCompare software for use in derma imaging and analytics for the detection of skin cancer. On January 29, 2018, the Company ceased the DermaCompare operations of its former subsidiary.

 

On January 29, 2018, the Company ceased the DermaCompare operations of Emerald Israel and on May 2, 2018, the District Court of Lod, Israel issued a winding-up order for Emerald Israel and appointed an Israeli attorney to serve as special executor for Emerald Israel.

 

Virtual Crypto Technologies Ltd.

 

On January 17, 2018, the Company formed VCT Israel to develop and market software and hardware products facilitating, allowing and supporting purchase and/or sale of cryptocurrencies through ATMs, tablets, personal computers (“PCs”) and/or mobile devices.

 

On January 24, 2018, VCT Israel entered into a binding term sheet (the “Chiron Term Sheet”) with Chiron Refineries Ltd. (“Chiron”), a public company listed on the Tel-Aviv Stock Exchange (TASE: CHR). Pursuant to the Chiron Term Sheet: (i) VCT Israel agreed to appoint a wholly-owned subsidiary of Chiron, to be organized under the laws of the Turkish Republic of Northern Cyprus (the “Distributor”), as the exclusive distributor of VCT Israel’s Products in Turkey, including the territory of Turkish Republic of Northern Cyprus (collectively, the “Territory”); and (ii) the Distributor shall have the right to appoint sub-distributors within the Territory. The appointment of the Distributor was subject to the payment by the distributor to VCT Israel of $250 thousand as an appointment fee, of which $150 thousand was to be deemed an advance payment by the distributor made on account of future purchases of the Company’s products.

 

20

 

 

VCT Israel further granted the Distributor an option, exercisable by the Distributor within 12 months from the date on which the ATM product, including the related software and hardware, was fully tested and ready for installation and operation, to be appointed as an exclusive distributor of the products for the Federal Republic of Nigeria. If the option was exercised, the Distributor was required to pay VCT Israel an appointment fee not more than $250 thousand. In November 2018, Chiron reported that it had encountered financial difficulties and as such the Company will no longer pursue the transactions contemplated by the Chiron Term Sheet.

 

During the year 2018, $100 thousand was paid by the Distributor to VCT Israel, which has been recognized as revenues for the year ended December 31, 2018.

 

On January 27, 2020, VCT Israel was sold to a third party for NIS 50,000 ($14,459).

 

Transaction with Gix (the “Recapitalization Transaction”)

 

On February 7, 2019, the Registrant entered into the Share Exchange Agreement with Gix, pursuant to which on the Closing Date Gix assigned, transferred and delivered its 99.83% holdings in Viewbix Israel to the Company in exchange for shares of restricted common stock of the Company, representing 65% of the issued and outstanding share capital of the Company on a fully diluted basis as of the Closing Date, following the conversion of certain convertible notes of the Company and excluding certain warrants to purchase shares of the Common Stock expiring in 2020 and additional warrants as further described below (the “Fully Diluted Share Capital”). In addition, upon the earlier of: (a) the launch of a live video product to an American consumer in the United States by Viewbix Israel, or (b) the launch of an interactive television product to an American consumer in the United States by Viewbix Israel, the Company will issue to Gix an additional 1,642,193 shares of restricted common stock of the Company representing 5% of the Fully Diluted Share Capital immediately following the Closing Date.

 

On July 24, 2019, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of Delaware reflecting its name change from Virtual Crypto Technologies, Inc. to Viewbix Inc. to reflect its new operations and business focus and, effective on August 7, 2019, FINRA approved the Registrant’s name change and its trading symbol was changed from “VRCP” to “VBIX” on the OTCQB.

 

On the Closing Date, the Company (i) issued 20,281,085 shares of its Common Stock to Gix in exchange for consideration consisting of for its 99.83% holdings in Viewbix Israel, and (ii) convertible notes representing 3,434,889 shares of Common Stock then currently issued to holders were converted. The shares of common stock were issued under Regulation S. The Company also issued a total of 7,298,636 warrants to Gix to purchase the Company’s Common Stock, whereby (i) 3,649,318 of such warrants were issued with an exercise price of $0.48, and (ii) 3,649,318 of such warrants were issued with an exercise price of $0.80.

 

Following the Closing Date, and as a result of the Recapitalization Transaction, Viewbix Israel became a subsidiary of the Registrant.

 

As the shareholders of Viewbix Israel received the largest ownership interest in the Company, Viewbix Israel was determined to be the “accounting acquirer” in the Recapitalization Transaction. As a result, the historical financial statements of the Company were replaced with the historical financial statements of Viewbix Israel. The number of shares of Common Stock prior to the Recapitalization Transaction have been retroactively adjusted based on the equivalent number of shares of Common Stock received by the accounting acquirer in the Recapitalization Transaction.

 

Viewbix Israel was incorporated in Israel in February 2006. Viewbix Israel developed an interactive video platform based on SaaS business model with interactive elements, and the ability to collect and analyze information about each interactive action performed during the viewing of the video clip. The interactive elements and information gathered, allowing the advertiser to analyze user viewing habits and optimize real-time throughout the campaign while increasing the effectiveness of online and live video advertising.

 

21

 

 

On July 25, 2019, the following changes were made to the Company’s management: (i) Mr. Eyal Ben Ami resigned from the Company’s board of directors; (ii) Mr. Alon Dayan resigned as the Company’s chief executive officer, however remained a member of the board of directors; (iii) Mr. Gadi Levin resigned as the Company’s chief financial officer, and transitioned to the role of senior accounting consultant; (iv) Mr. Noam Band was appointed to the board of directors; (v) Mr. Jonathan Stefansky was appointed as chief executive officer of the Company and elected as a member of the board of directors; (vi) Mr. Amihay Hadad was appointed as chief financial officer of the Company; and (vii) Mr. Hillel Scheinfeld was appointed as chief operating officer of the Company.

 

On July 25, 2019, the Company ceased the operations of VCT Israel.

 

Pursuant to a Tax Ruling issued by the Israeli Tax Authority, the Registrant ceased the options of VCT Israel on the Closing Date.

 

In connection with certain cost reduction measures that the Company is currently implementing, on January 1, 2020, Mr. Jonathan Stefansky tendered his resignation from the board of directors. On the same date, the Company and Mr. Stefansky reached a mutual understanding that Mr. Stefansky will step down as the Company’s chief executive officer, which entered into effect on March 1, 2020. Similarly, on January 1, 2020, the Company and Mr. Hillel Scheinfeld reached a similar mutual understanding and agreed Mr. Scheinfeld will step down as the Company’s chief operating officer, which also entered into effect on March 1, 2020.

 

On January 1, 2020, Mr. Amihay Hadad, the Company’s current chief financial officer, was appointed to serve as a member of the board of directors, and on February 20, 2020, Mr. Hadad was appointed to serve as chief executive officer of the Company.

 

No new compensatory arrangements were entered into in connection with the aforementioned leadership changes.

 

Results of Operations during the year ended December 31, 2020 as compared to the year ended December 31, 2019

 

Revenues for the year ended December 31, 2020 was $96 thousand as compared to $208 thousand for the year end December 31, 2019. The reason for the decrease during the fiscal year ended December 31, 2020 is due to the Company’s cost-reduction measures implemented beginning on January 1, 2020.

 

Cost of revenues for the year ended December 31, 2020 was $5 thousand which is a slight increase to $2 thousand for the year end December 31, 2019.

 

Research and development costs for the year ended December 31, 2020 was $108 thousand as compared to $233 thousand for the year end December 31, 2019. The reason for the decrease during the fiscal year ended December 31, 2020 is due to the Company’s cost-reduction measures implemented beginning on January 1, 2020.

 

Sales and marketing expenses for the year ended December 31, 2020 was $8 thousand as compared to $257 thousand for the year end December 31, 2019. The reason for the decrease during the year ended December 31, 2020 is due to the Company’s cost-reduction measures implemented beginning on January 1, 2020.

 

General and Administration expenses for the year ended December 31, 2020 was $437 thousand as compared to $720 thousand for the year end December 31, 2019. The reason for the decrease in 2020 is due to certain cost reduction measures initiated by the Company as of the beginning of January 2020. Additionally, during the fiscal year-ended December 31, 2020, the Company was no longer obligated to pay recapitalization expenses in connection with the Recapitalization Transaction and the Share Exchange Agreement which were paid by the Company during the fiscal year-ended December 31, 2019.

 

22

 

 

Our net financial income was $13 thousand for the year ended December 31, 2020, compared to net financial expenses of $98 thousand for the year end December 31, 2019. The reason for the change is due to the US dollar exchange rate difference for the fiscal year ended December 31, 2020 as compared to the fiscal year end December 31, 2019.

 

Our tax on income was $2 thousand for the year ended December 31, 2020, as compared to $15 thousand for the year end December 31, 2019. The reason for the decrease is due to the fact that during the fiscal year ended December 31, 2019 the Company recognized a one-time tax expense related to prior years.

 

Liquidity and Capital Resources

 

As of December 31, 2020, we had current assets of $225 thousand consisting of $148 thousand in cash and cash equivalents, $15 thousand in trade receivables, $20 thousand in other accounts receivables and, $42 thousand in prepaid expenses.

 

We had $2,303 thousand in current liabilities consisting of $177 in other accounts payable and accrued liabilities, $22 trade payable, and $2,054 payable to our parent company.

 

As of December 31, 2019, we had current assets of $225 thousand consisting of $89 thousand in cash and cash equivalents and restricted cash, $119 thousand in other receivables and $17 thousand in prepaid expenses. We had $1,923 thousand in current liabilities, which consisted of $246 in accounts payable and accrued liabilities and $66 trade payable, and $1,611 payable to our parent company.

 

We had a negative working capital of $2,078 thousand and $1,698 thousand as of December 31, 2020 and December 31, 2019, respectively.

 

Our total liabilities as of December 31, 2020 were $2,303 thousand compared to $1,923 thousand as of December 31, 2019.

 

During the fiscal year ended December 31, 2020, we had negative cash flow from operations of $53 thousand which was mainly the result of a net loss of $443 thousand, depreciation expense of $5 thousand, offset by gains from the sale of a subsidiary and decrease in working capital of $385 thousand.

 

During the fiscal year ended December 31, 2019, we had negative cash flow from operations of $135 thousand which was mainly the result of a net loss of $1,117 thousand, depreciation expense of $1 thousand, offset by decrease in working capital of $981.

 

During the fiscal year ended December 31, 2020, we had a positive cash flow effect from investing activities of $13 thousand as compared to a negative cash flow effect from investing activities of $1 thousand as during the year ended December 31, 2019.

 

During the fiscal year ended December 31, 2020, we had a positive cash flow from financing activities of $99 thousand, which related to the Loan Agreement and issuance of shares we have made during the fiscal year ended December 2020, compared to a positive cash flow from financing activities of $174 thousand during the fiscal year ended December 31, 2019, which related to the cash acquired in connection with the Recapitalization Transaction.

 

There are no limitations in the Company’s Certificate of Incorporation on the Company’s ability to borrow funds or raise funds through the issuance of shares of its common stock to affect a business combination. The Company’s limited resources and lack of having cash-generating business operations may make it difficult to borrow funds or raise capital. The Company’s limitations to borrow funds or raise funds through the issuance of restricted capital stock required to effect or facilitate a business combination may have a material adverse effect on the Company’s financial condition and future prospects, including the ability to complete a business combination.

 

23

 

 

Until such time as the Company can generate substantial revenues, the Company expects to finance its cash needs through a combination of the sale of its equity and/or convertible debt securities, debt financing and strategic alliances and collaborations. The Company does not have any committed external source of funds. To the extent that the Company raises additional capital through the sale of its equity and/or convertible debt securities, the ownership interest of its shareholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our common shareholders. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. To the extent that debt financing ultimately proves to be available, any borrowing will subject us to various risks traditionally associated with indebtedness, including the risks of interest rate fluctuations and insufficiency of cash flow to pay principal and interest, including debt of an acquired business. If the Company raises funds through additional collaborations or strategic alliances with third parties, we may have to relinquish valuable rights to our future revenue streams and/or distribution arrangements. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. If the Company is unable to raise additional funds through equity and/or debt financings when needed or on attractive terms, the Company may be required to delay, limit, reduce or terminate the operations of some or all of its business segments.

 

Going Concern

 

The Company has incurred $443 thousand in net losses for the year ended December 31, 2020, has $2,078 thousand shareholders’ deficit as of December 31, 2020 and $1,693 thousand in total shareholders’ deficit as of December 31, 2019 and $53 thousand negative cash flows from operations for the year ended December 31, 2020, and $135 thousand negative cash flows from operations for the year ended December 31, 2019. Management expects the Company to continue to generate substantial operating losses and to continue to fund its operations primarily through utilization of its current financial resources and through additional raises of capital.

 

Such conditions raise substantial doubts about the Company’s ability to continue as a going concern. Management’s plan includes raising funds from outside potential investors. However, there is no assurance such funding will be available to the Company or that it will be obtained on terms favorable to the Company or will provide the Company with sufficient funds to meet its objectives. These financial statements do not include any adjustments relating to the recoverability and classification of assets, carrying amounts or the amount and classification of liabilities that may be required should the Company be unable to continue as a going concern.

 

Availability of Additional Capital

 

Our potential financing transactions may include the issuance of equity and/or debt securities including convertible debt, obtaining credit facilities, or other financing mechanisms. In the event that we seek to raise funds through additional private placements of equity or convertible debt, the trading price of our common stock could be adversely affected. Further, any adverse conditions in the financial markets could make it more difficult to obtain future financing through the issuance of equity or debt securities when and if needed. Even if we are able to raise a sufficient amount of funds that may be required, it is possible that we could incur unexpected costs and expenses or experience unexpected cash requirements that would force us to seek additional and/or alternative financing. Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or is not available on acceptable terms, we may have to curtail our plan of operations.

 

The Company has only limited capital. Additional financing is necessary for the Company to continue as a going concern. Our independent auditors have issued an unqualified audit opinion for the year ended December 31, 2020 with an explanatory paragraph on going concern.

 

In view of these matters, realization of a major portion of the assets in the accompanying balance sheet is dependent upon continued operations of the Company. Management believes that actions presently being taken to obtain additional equity financing will provide the opportunity to continue as a going concern.

 

24

 

 

Off-Balance Sheet Arrangements

 

As of December 31, 2020, and 2019, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K promulgated under the Securities Act of 1934.

 

Contractual Obligations and Commitments

 

As of December 31, 2020, and 2019, we did not have any contractual obligations.

 

Critical Accounting Policies

 

Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the U.S. The preparation of our consolidated financial statements and disclosures requires us to make judgments, estimates, and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported revenue and expenses during the reporting periods. We base our estimates on historical experience, known trends and events and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions and conditions.

 

Our significant accounting policies are described in more detail in the notes to our audited consolidated financial statements appearing elsewhere in this Annual Report on Form 10-K.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK

 

Not required for smaller reporting companies.

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

25

 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Directors of

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Viewbix Inc. and its subsidiary (the “Company”) as of December 31, 2020 and 2019 and the related consolidated statements of comprehensive loss, stockholders’ deficit and cash flows for each of the two years in the period ended December 31, 2020, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2020, in conformity with accounting principles generally accepted in the United States of America.

 

Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company’s substantial net losses, shareholders’ deficit and negative cash flows from operations raise substantial doubt about its ability to continue as a going concern. Management’s plans concerning these matters are also described in Note 1 to the financial statements. The financial statements do not include any adjustments that might result from the outcome of’ these uncertainties

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matter

 

Critical audit matters are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.

 

/s/ Brightman Almagor Zohar & Co.

Certified Public Accountants

A Firm in the Deloitte Global Network

 

Tel Aviv, Israel

March 16, 2021

 

We have served as the Company’s auditor since 2019

 

 

26

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Consolidated Balance Sheets

U.S. dollars in thousands (except share and per share data)

 

      

As of

December 31,

  

As of

December 31

 
   Note   2020   2019 
ASSETS               
                
CURRENT ASSETS               
Cash and cash equivalents       $148   $87 
Restricted cash        -    2 
Trade receivables        15    - 
Other accounts receivable   3    20    119 
Prepaid expenses        42    17 
                
Total current assets       $225   $225 
                
NON CURRENT ASSETS               
Property and equipment, net   4   $-   $5 
                
Total assets       $225   $230 
LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS’ DEFICIT               
                
CURRENT LIABILITIES               
Trade payables       $22   $66 
Other accounts payable and accrued liabilities   5    177    246 
Payable to parent company   6    2,054    1,611 
Short term loan   7    50    - 
                
Total current liabilities       $2,303   $1,923 
                
Commitments and contingencies   9           
                
STOCKHOLDERS’ DEFICIT   8           
                
Share Capital               
Common stock, $0.0001 par value; 490,000,000 shares authorized; 34,753,669 shares issued and outstanding at December 31, 2020 and 31,201,669 at December 31, 2019        3    3 
Additional paid-in capital   7    13,073    13,015 
Accumulated deficit        (15,154)   (14,711)
                
Total stockholders’ deficit       $(2,078)  $(1,693)
                
Total liabilities, temporary equity and stockholders’ deficit       $225   $230 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

27

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Consolidated Statements of Comprehensive Loss

U.S. dollars in thousands (except share and per share data)

 

       Year ended   Year ended 
       December 31,   December 31, 
   Note   2020   2019 
             
Revenues   10    96    208 
Cost of revenues        5    2 
Gross profit        91    206 
Expenses:               
Research and development   11    108    233 
Sales and marketing   12    8    257 
General and administrative   13    437    720 
Gain from sale of a subsidiary        (8)   - 
Total operating expenses        545    1,210 
Loss from operations        (454)   (1,004)
Finance income   14    (20)   (12)
Finance expense   14    7    110 
Loss Before taxes on income        (441)   (1,102)
Taxes on income   15    2    15 
Net Loss        (443)   (1,117)
Basic and diluted net loss per share:        (0.014)   (0.08)
Weighted average shares outstanding - basic and diluted   16    31,201,669    13,746,064 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

28

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Consolidated Statements of Changes in Stockholders’ Deficit

U.S. dollars in thousands (except share and per share data)

 

   Ordinary shares   Additional paid-in   Accumulated   Total shareholders’ 
   Number   Amount   capital   deficit   deficit 
                     
Balance as of January 1, 2020   31,201,669        3    13,015    (14,711)   (1,693)
Issuance of shares   3,552,000         58         58 
Net loss for the period                  (443)   (443)
Balance as of December 31, 2020   34,753,669    3    13,073    (15,154)   (2,078)

 

                                                   Total          Additional   Accumulated     
   Preferred A-1   Preferred A-2   Preferred B   Preferred C   Preferred C-1   Preferred C-2   temporary   Ordinary shares   paid-in   shareholders’   Total 
   Number   Amount   Number   Amount   Number   Amount   Number   Amount   Number   Amount   Number   Amount   equity   Number   Amount   capital   deficit   deficit 
                                                                         
Balance as of January 1, 2019   199,870     *    4,881,654    10    4,556,094    9    7,222,305    15    2,755,706    11    392,407    1    46    279,049    1    12,872    (13,594)   (721)
Effect of reverse recapitalization   (199,870)    (*)    (4,881,654)   (10)   (4,556,094)   (9)   (7,222,305)   (15)   (2,755,708)   (11)   (392,407)   (1)   (46)   30,928,620    2    143    -    145 
Net loss for the period   -    -    -    -    -    -    -    -    -    -    -    -    -    -    -    -    (1,117)   (1,117)
Balance as of December 21, 2019   -    -    -    -    -    -    -    -    -    -    -    -    -    31,201,669    3    13,015    (14,711)   (1,693)

 

*) Represents an amount less than $1.

The accompanying notes are an integral part of these consolidated financial statements.

 

29

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Consolidated Statements of Cash Flows

U.S. dollars in thousands (except share and per share data)

 

  

For the year ended

December 31

 
   2020   2019 
     
Cash flows from operating activities          
           
Net loss for the period   (443)   (1,117)
           
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:          
Gain from sale of a subsidiary   (8)   - 
Depreciation   5    1 
Changes in operating assets and liabilities:          
Decrease (Increase) in trade receivables and prepaid expenses   (40)   5 
Decrease (Increase) in other accounts receivable   100    (21)
Increase (decrease) in trade payables   (55)   36 
Increase in payable to parent company (See Note 6)   443    822 
Increase (decrease) in other accounts payables and accrued liabilities   (55)   139 
           
Net cash used in operating activities   (53)   (135)
           
Cash flows from investing activities          
Cash received from the sale of a subsidiary   13    - 
Purchase of property and equipment   -    (2)
Proceeds from sale of property and equipment   -    1 
           
Net cash used in investing activities   13    (1)
           
Cash flows from financing activities          
           
Cash acquired in connection with the reverse recapitalization   -    174 
Issuance of shares   49    - 
Short term loan received   50    - 
           
Net cash provided by financing activities   99    174 
           
Increase (decrease) in cash and cash equivalents and restricted cash   59    38 
           
Cash and cash equivalents and restricted cash at the beginning of the period   89    51 
           
Cash and cash equivalents and restricted cash at the end of the period  $148   $89 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

30

 

 

Viewbix Inc. (Formerly known as Virtual Crypto Technologies, Inc.)

Condensed Consolidated Statements of Cash Flows

U.S. dollars in thousands (except share and per share data)

(Unaudited)

 

Supplemental Cash Flow Information:

 

  

As of

February 12, 2020

 
     
Current assets excluding cash and cash equivalents   6 
Current liabilities   (1)
Gain from sale of a subsidiary   8 
      
Cash received from the sale of a subsidiary   13 

 

Assets acquired (liabilities assumed): 

As of

July 25, 2019

 
     
Current assets excluding cash and cash equivalents   20 
Current liabilities   (95)
Reverse recapitalization effect on equity   (99)
      
Cash acquired in connection with Recapitalization Transaction   174 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

31

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

 

Note 1. General

 

  A. Organizational Background
     
    Viewbix Inc. (formerly known as Virtual Crypto Technologies, Inc.) (the “Company”) was incorporated in the State of Ohio in 1989 under a predecessor name, Zaxis International, Inc. (“Zaxis”). On August 25, 1995, Zaxis merged with a subsidiary of The InFerGene Company, a Delaware corporation, which entity changed its name to Zaxis International, Inc. and the Company was reincorporated in Delaware under the name of Zaxis International, Inc. On December 30, 2014, Zaxis entered into an agreement with Emerald Medical Applications Ltd., a private limited liability company organized under the laws of the State of Israel (“Emerald Israel”).
     
  B. Emerald Medical Applications Ltd.
     
   

On March 16, 2015, Zaxis and Emerald Israel executed a share exchange agreement, which closed on July 14, 2015, and Emerald Israel became the Company’s wholly-owned subsidiary. Emerald Israel was engaged in the business of developing Emerald Israel’s DermaCompare technology and the development, sale and service of imaging solutions utilizing its DermaCompare software for use in derma imaging and analytics for the detection of skin cancer. On January 29, 2018, the Company ceased the DermaCompare operations of its former subsidiary.

 

On May 2, 2018, the District Court of Lod, Israel issued a winding-up order for Emerald Israel and appointed an Israeli attorney as special executor for Emerald Israel.

     
  C.

Virtual Crypto Technologies Ltd.

     
   

On January 17, 2018, the Company formed a new wholly-owned subsidiary under the laws of the State of Israel, Virtual Crypto Technologies Ltd. (the “VCT Israel”), to develop and market software and hardware products facilitating, allowing and supporting purchase and/or sale of cryptocurrencies through ATMs, tablets, personal computers (“PCs”) and/or mobile devices.

 

VCT Israel ceased its business operation prior to consummation of the Recapitalization Transaction. On January 27, 2020, Virtual Crypto Israel was sold to a third party for NIS 50,000 ($14,459).

 

32

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

 

NOTE. 1 GENERAL (Cont.)

 

  D. Transaction with Gix Internet Ltd. (formerly known as Algomizer Ltd.), or Gix (the “Recapitalization Transaction”)
     
    On June 6, 2020, Algomizer changed its name to Gix Internet Ltd., or Gix.
     
    On February 7, 2019, the Company entered into a share exchange agreement (the “Share Exchange Agreement”) with Gix Internet Ltd. (TASE:ALMO), a company organized under the laws of the State of Israel (“Gix”), pursuant to which on July 25, 2019 (the “Closing Date”), Gix assigned, transferred and delivered its 99.83% holdings in Viewbix Ltd. (“Viewbix Israel”) to the Company in exchange for shares of restricted common stock of the Company, representing 65% of the issued and outstanding share capital of the Company on a fully diluted basis as of the Closing Date following the conversion of certain convertible notes of the Company and excluding certain warrants to purchase shares of the Common Stock expiring in 2020 and additional warrants as further described below (the “Fully Diluted Share Capital”). In addition, upon the earlier of: (a) the launch of a live video product to an American consumer in the United States by Viewbix Israel, or (b) the launch of an interactive television product to an American consumer in the United States by Viewbix Israel, the Company will issue to Gix an additional 1,642,193 shares of restricted common stock of the Company representing 5% of the Fully Diluted Share Capital immediately following the Closing Date.
     
    On July 24, 2019, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of Delaware reflecting its name change from Virtual Crypto Technologies, Inc. to Viewbix Inc. to reflect its new operations and business focus and, effective on August 7, 2019, FINRA approved the Registrant’s name change and its trading symbol was changed from “VRCP” to “VBIX” on the OTCQB.
     
    On the Closing Date, the Company (i) issued 20,281,085 shares of its common stock to Gix in exchange for consideration consisting of consideration for its 99.83% holdings in Viewbix Israel, and (ii) 3,434,889 shares of its common stock to holders of convertible notes, which were issued by the Company prior to the Reverse Recapitalization, and which were converted upon the Closing Date. The shares of common stock were issued under Regulation S. The Company also issued a total of 7,298,636 warrants to Gix to purchase the Company’s common stock, whereby (i) 3,649,318 of such warrants were issued with an exercise price of $0.48, and (ii) 3,649,318 of such warrants were issued with an exercise price of $0.80.

 

33

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

 

NOTE. 1 GENERAL (Cont.)

 

  D. Transaction with Gix Internet Ltd. (formerly known as Algomizer Ltd.), or Gix (the “Recapitalization Transaction”): (Cont.)
     
    As a result of the Recapitalization Transaction, Viewbix Israel became a subsidiary of the Company. As the shareholders of Viewbix Israel received the largest ownership interest in the Company, Viewbix Israel was determined to be the “accounting acquirer” in the Recapitalization Transaction. As a result, the historical financial statements of the Company were replaced with the historical financial statements of Viewbix Israel. The number of shares prior to the reverse recapitalization have been retroactively adjusted based on the equivalent number of shares received by the accounting acquirer in the Recapitalization Transaction.
     
    The Company and its subsidiaries are collectively referred to as the “Company”. Viewbix Israel was incorporated on February 2006 in Israel. The Company has developed an interactive video platform based on Software as a Service (“SaaS”) business model with interactive elements, and the ability to collect and analyze information about each interactive action performed during the viewing of the video clip. The interactive elements and information gathered, allowing the advertiser to analyze user viewing habits and optimize real-time throughout the campaign while increasing the effectiveness of online and live video advertising.
     
    On January 1, 2020, the Company announced certain cost reduction measures due the Company not achieving certain revenues goals.
     
  E. Stock Subscription Agreement and Loan Agreement
     
    On December 18, 2020, the company entered into a Stock Subscription Agreement (the “Subscription”) with certain investors (the “Investors”) in connection with the sale and issuance of an aggregate of 3,000,000 shares of Common Stock, at a purchase price of $0.01 per share, and for an aggregate purchase price of $30,000. In addition, and on the same date, the company entered into a Loan Agreement (the “Loan”) with the Investors, pursuant to which the Investors lent an aggregate amount of $69,000 (the “Principal Amount”). In accordance with the terms of the Loan, the company repaid the interest on the Principal Amount (8% compounded annually) to the Investors as an issuance of 552,000 shares of Common Stock, at a price per share of $0.01. The shares of Common Stock were issued to the Investors pursuant to Regulation S of the Securities Act of 1933, as amended.

 

34

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

 

NOTE. 1 GENERAL (Cont.)

 

  F. Going Concern
     
    The Company has incurred $ 443 in net loss for the year ended December 31, 2020, has $2,078 stockholders’ deficit as of December 31, 2020 and $1,693 in total stockholders’ deficit as of December 31, 2019 and $61 in negative cash flows from operations for the year ended December 31, 2020. On July 25, 2019, the Company ceased the operations of VCT Israel and since January 2020, the Company has significantly reduced its operations and expenses of Viewbix Israel. Management expects the Company to continue to generate substantial operating losses and to continue to fund its operations primarily through utilization of its current financial resources and through additional raises of capital.
     
    Such conditions raise substantial doubts about the Company’s ability to continue as a going concern. Management’s plan includes raising funds from outside potential investors. However, there is no assurance such funding will be available to the Company or that it will be obtained on terms favorable to the Company or will provide the Company with sufficient funds to meet its objectives. These financial statements do not include any adjustments relating to the recoverability and classification of assets, carrying amounts or the amount and classification of liabilities that may be required should the Company be unable to continue as a going concern.

 

NOTE. 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The significant accounting policies used in the preparation of the financial statements are as follows:

 

Functional currency

 

The functional currency of the Company and its subsidiary is the US dollar, which is the currency of the primary economic environment in which it operates. In accordance with ASC 830, “Foreign Currency Matters” (ASC 830), balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing at the applicable balance sheet date. For foreign currency transactions included in the statement of operations, the exchange rates applicable on the relevant transaction dates are used. Gains or losses arising from changes in the exchange rates used in the translation of such transactions are carried as financing income or expenses.

 

35

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

 

NOTE. 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

Principles of consolidation

 

The consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions have been eliminated in consolidation.

 

Cash and cash equivalents

 

The Group considers all short-term investments, which are highly liquid investments with original maturities of three months or less at the date of purchase, to be cash equivalents.

 

Property and equipment

 

1. Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. When an asset is retired or otherwise disposed of, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected in the statements of operations.

 

2. Rates of depreciation:

 

    %  
Computers     33  
Furniture and office equipment     7-15  

 

Impairment of long-lived assets

 

The Company’s long-lived assets are reviewed for impairment in accordance with ASC 360, “Property, Plant and Equipment”, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. To date the Group did not incur any material impairment losses.

 

36

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

 

NOTE. 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

Share-based compensation

 

The Company applies ASC 718-10, “Share-Based Payment,” which requires the measurement and recognition of compensation expenses for all share-based payment awards made to employees and directors (including employee stock options under the Company’s stock plans) based on estimated fair values.

 

ASC 718-10 requires companies to estimate the fair value of equity-based payment awards on the date of grant. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company’s statement of operations.

 

The Company recognizes compensation expenses for the value of non-employee awards based on the straight-line method over the requisite service period of each award, net of estimated forfeitures.

 

The Company estimates the fair value of stock options granted as equity awards using a Black-Scholes options pricing model. The option-pricing model requires a number of assumptions, of which the most significant are share price, expected volatility and the expected option term (the time from the grant date until the options are exercised or expire). Expected volatility is estimated based on volatility of similar companies in the technology sector. The Company has historically not paid dividends and has no foreseeable plans to issue dividends. The risk-free interest rate is based on the yield from governmental zero-coupon bonds with an equivalent term. The expected option term is calculated for options granted to employees and directors using the “simplified” method. Grants to non-employees are based on the contractual term. Changes in the determination of each of the inputs can affect the fair value of the options granted and the results of operations of the Company.

 

Earnings per Common Share

 

Earnings or loss per share (“EPS”) is the amount of earnings attributable to each share of common stock. For convenience, the term is used to refer to either earnings or loss per share. EPS is computed pursuant to ASC 260-10-45. Pursuant to ASC 260-10-45-10 through 260-10-45-16 Basic EPS is computed by dividing income available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Income available to common stockholders shall be computed by deducting both the dividends declared in the period on preferred stock (whether or not paid) from income from continuing operations (if that amount appears in the income statement) and also from net income. The computation of diluted EPS is similar to the computation of basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.

 

Revenue recognition

 

The Company applies the provisions of Accounting Standards Codification (or “ASC”) 606, Revenue from Contracts with Customers (“ASC 606”). The Company adopted the provisions of ASC 606 effective January 1, 2018 using the modified retrospective application method for all uncompleted contracts as of that date. The adoption of ASC 606 did not have a material impact on the Company’s consolidated financial statements. In addition, the adoption of ASC 606 had no impact on the Company’s trade receivables, deferred revenues and accumulated deficit balances balance as of December 31, 2018 or on the Company’s revenues, cost of revenues or its operating expenses during 2018, compared to ASC 605.

 

The Company generates revenues primarily by granting customers the right to access software products through the Company’s cloud-based SaaS subscription offerings. Under a SaaS subscription agreement, the customer receives a right to access the software for a specified period of time in an environment hosted, supported, and maintained by the Company. SaaS subscription services are a single performance obligation satisfied over time, and associated revenue is generally recognized ratably over the contract term once the software is made available to the customer. The SaaS subscription offerings are typically sold with one year subscription terms, generally invoiced in advance of each annual subscription period, and are non-cancelable during the committed subscription term.

 

Research and development expenses, net:

 

Research and development expenses are charged to the statement of operations as incurred.

 

37

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

 

Note 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

Income Taxes:

 

The Company accounts for income taxes in accordance with ASC 740, “Income Taxes”, and (“ASC 740”). ASC 740 prescribes the use of the asset and liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities and for carry forward tax losses. Deferred taxes are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more-likely-than-not that some portion or all of the deferred tax asset will not be realized.

 

In addition, ASC 740 prescribes a recognition threshold and measurement attribute for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The first step is to evaluate the tax position taken or expected to be taken in a tax return. This is done by determining if the weight of available evidence indicates that it is more-likely-than-not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement.

 

Contingencies

 

The Company records accruals for loss contingencies arising from claims, litigation and other sources when it is probable that a liability has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.

 

38

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

 

Note 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

Recently issued accounting pronouncements

 

Financial Instruments – Credit Losses

 

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments—Credit Losses (Topic 326).” The guidance replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The guidance will be effective for the Company’s fiscal year beginning January 1, 2023, including interim periods within that year. The Company is currently evaluating the potential effect of the adoption of ASU 2019-10 on our financial position and results of operations. The Company does not expect the adoption of this ASU to have a material impact on the Company’s financial statements.

 

Accounting for Income Taxes

 

In December 2019, the FASB issued a new standard to simplify the accounting for income taxes. The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences related to changes in ownership of equity method investments and foreign subsidiaries. The guidance also simplifies aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard will be effective for us beginning July 1, 2021, with early adoption permitted. Adoption of the standard will not have a material impact on our consolidated financial statements.

 

39

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

 

Note 3.Other Accounts receivables

 

Composition:

 

  

As of

December 30

  

As of

December 31

 
   2 0 2 0   2 0 1 9 
         
Government authorities  $20   $118 
Other   -    1 
   $20   $119 

 

Note 4. Property and equipment

 

Composition:

 

  

As of

December 30

  

As of

December 31

 
   2 0 2 0   2 0 1 9 
         
Cost:          
Computers and related equipment  $34   $34 
Office furniture and equipment   9    9 
    43    43 
           
Accumulated depreciation   43    38 
           
Net book value  $-   $5 

 

Note 5. Other accounts payable and accrued liabilities

 

Composition:

 

  

As of

December 30

  

As of

December 31

 
   2 0 2 0   2 0 1 9 
         
Other payables and deferred revenues  $47   $91 
Accrued liabilities   130    149 
Other   -    6 
   $177   $246 

 

40

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

 

Note 6. Related Party Transactions.

 

Balances:

 

   December 31,   December 31, 
   2 0 2 0   2 0 1 9 
           
Gix – Parent Company Payable  $2,054   $1,611 

 

As part of the agreement with Gix, the parties agreed to have the Company’s operations outsourced to Gix from the agreement date and until the acquisition is consummated. The following term were included in the agreement pursuant to the above:

 

  (a) From May 2018 all of the Company’s employees will become employees of Gix.
  (b) Between the periods of May 2018 to October 2018, Gix will pay the full expenses of the employees as well as other related expenses.
  (c) From November 2018 until to the Closing Date, the employees transferred from the Company to Gix will dedicate half of their time to the Company’s operations and correspondingly 50% of the costs to be incurred by Gix in respect of these employees are to be charged to the Company.

 

From the closing date, the actual of the expenses incurred by Gix that related to the Company will be charged to the Company.

 

No amounts were paid by the Company to Gix during 2020 and 2019.

 

Note 7. Short term loan and Issues of shares

 

On December 18, 2020, the company entered into a Loan Agreement (the “Loan”) and Stock Subscription Agreement with certain Investors as described in note 1e, pursuant to which the Investors lent an aggregate amount of $69,000 (the “Principal Amount”). In accordance with the terms of the Loan, the company prepaid the interest on the Principal Amount of 8% compounded annually to the Investors as an issuance of 552,000 shares of Common Stock, at a price per share of $0.01. Under the Stock Subscription Agreement, the Investors transferred an amount of $ 30,587 to the company as consideration for the issued shares.

 

The Company allocated the total proceeds in respect of the shares issued and the Loan extended based on its relative fair values. As a result of the allocation, a discount of $19 was recorded on the loan. The discount is amortized over the term of the loan as finance expense.

 

41

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

 

Note 7. Short term loan and Issues of shares (Cont.)

 

The allocation of the proceeds to the fair value distribution of the liability and equity components on the transactions date was as follows:

 

Instrument  Fair Value   % of total fair  

Allocated

amount

 
Loan   55,200    49.45    49,246 
Shares   54,000    50.55    50,340 
Total   109,200    100    99,586 

 

The composition of short term loan balance as of the transaction is as follows:

 

     
Principal amount   69 
Discount on Short term loan   (19)
Short term loan, Net   50 

 

Note 8. Stockholders’ deficit.

 

Ordinary Shares:

 

Ordinary shares confer the right to participate in the general meetings, to one vote per share for any purpose, to an equal part, on share basis, in distribution of dividends and to equally participate, on share basis, in distribution of excess of assets and funds from the Company and they shall not confer other privileges unless stated hereunder or in the Companies Law otherwise. Some investors have standard anti-dilutive rights, registration rights, and information and representation rights.

 

On December 18, 2020, the company entered into a Stock Subscription Agreement (the “Subscription”) with certain investors (the “Investors”) in connection with the sale and issuance of an aggregate of 3,000,000 shares of Common Stock, at a purchase price of $0.01 per share, and for an aggregate purchase price of $30,000. In addition, and on the same date, the company entered into a Loan Agreement (the “Loan”) with the Investors, pursuant to which the Investors lent an aggregate amount of $69,000 (the “Principal Amount”). In accordance with the terms of the Loan, the company repaid the interest on the Principal Amount of 8% compounded annually to the Investors as an issuance of 552,000 shares of Common Stock, at a price per share of $0.01. The shares of Common Stock were issued to the Investors pursuant to Regulation S of the Securities Act of 1933, as amended. For more details, please see note 1e.

 

42

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

 

Note 8. Stockholders’ deficit. (Cont.)

 

Preferred shares (relating to Viewbix Ltd the prior to the Recapitalization Transaction):

 

Preferred shares may have been converted into ordinary shares of Viewbix Ltd at any time. The preferred shares would have automatically converted into ordinary shares if (a) the holders of at least (i) 67% (sixty seven percent) of the issued and outstanding Preferred C/C-1 shares, (ii) a majority of the issued and outstanding Preferred B shares, and (iii) a majority of the issued and outstanding Preferred A shares, so agree in writing; or (b) in the event of an IPO.

 

The conversion price for any class or series of preferred would have been subject to adjustment, as follows: at any time, upon each issuance or deemed issuance by the Company of any new securities at a price per share less than the applicable conversion price in effect on the date of and immediately prior to the issuance of such new securities, the conversion price shall be reduced.

 

Preferred shares had priority in the distribution of dividends and upon liquidation in accordance with the Company’s Articles of Association (“AOA”). These rights may be changed if a meeting of the Company’s stockholders gather up and decides on a change of regulations in this context.

 

The preference mechanism for liquidation and the distribution of dividends gave priority to the most recent preferred stockholders.

 

The preferred shares were convertible into 16,199,520 ordinary shares of the Company.

 

Redemption

 

The Company’s AOA do not provide redemption rights to the holders of the preferred shares. In the event of a liquidation event, all the funds and assets of the Company available for distribution among all the stockholders shall be distributed based on a certain mechanism as described in the Company’s AOA. Although the preferred shares are not redeemable, in the event of certain “deemed liquidation events” that are not solely within the Company’s control (including merger, acquisition, or sale of all or substantially all of the Company’s assets), the holders of the preferred shares would be entitled to preference amounts paid before distribution to other stockholders (as explained in the previous paragraph) and hence effectively redeeming the preference amount. In accordance with ASR 268 and ASC 480 “Distinguishing Liabilities from Equity”, the Company’s preferred shares are classified outside of stockholders’ deficit as a result of these in-substance contingent redemption rights. As of December 31, 2019 and 2018, the Company did not adjust the carrying values of the convertible preferred shares to the deemed liquidation values of such shares since a liquidation event was not probable of occurring.

 

Share Exchange

 

As detailed in Note 1, as part of the Recapitalization Transaction in July 2019, the Company issued 30,928,620 common shares in exchange for 99.83% of the issued and outstanding ordinary shares and all the preferred shares of Viewbix Israel. The number of shares prior to the reverse capitalization have been retroactively adjusted based on the equivalent number of shares received by the accounting acquirer in the Recapitalization Transaction.

 

Warrants

 

The following table summarizes information of outstanding warrants as of December 31, 2020:

 

   Warrants   Warrant Term  Exercise Price   Exercisable 
                   
Class J Warrants   3,649,318   July 2029   0.48    3,649,318 
Class K Warrants   3,649,318   July 2029   0.80    3,649,318 

 

Additionally, in connection with the Share Exchange Agreement, upon the earlier of: (a) the launch of a live video product to an American consumer in the United States by Viewbix Israel, or (b) the launch of an interactive television product to an American consumer in the United States by Viewbix Israel, the Company will issue to Gix an additional 1,642,193 shares of restricted common stock of the Company. All of the Company’s warrants meet the US GAAP criteria for equity classification. During January and March 2020, 50,000 class H warrants expired. During January 2020, 38,095 class I warrants expired. During April 2020, 142,857 Class G warrants expired.

 

43

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

 

Note 9. Commitments and Contingencies

 

During August 2019, a lawsuit was filed against the Company and its parent Company, Gix. The plaintiffs claim that they were entitled to receive shares of the Company as a part of the consideration in Gix’s acquisition of the Company. In management’s opinion, the plaintiffs’ claims are based on incorrect assumptions that relate to the distribution of shares between the plaintiffs and other former shareholders of the Company prior to Gix’s acquisition which would have resulted in the receipt of shares in the acquisition transaction. During September 2020, a settlement was reached between the parties which was later approved by the court. The settlement outlines that in exchange for the voluntary waiver of claims made by the plaintiffs, Gix will issue 63,350 shares of its common stock held in trust in favor of securing the transaction by which Gix acquired shares of ViewBix Ltd. in November 2018. The remaining shares in the trust account will be used to indemnify Gix for any expenses related to the litigation. Since the consideration was paid in Gix’s shares, and as the claims relate to the distribution of shares between the plaintiffs and other former shareholders of the Company, the settlement did not impact on the Company’s financial statements.

 

In June 2017, a lawsuit was filed by a former CEO of the Company with the Tel Aviv District Court (the “Tel Aviv Court”) against the Company claiming certain damages in the total amount of $225, under the assertion of wrongful termination by the Company and Emerald Israel. The Company believes these claims to be unsubstantiated and wholly without merit and accordingly filed its response with the Tel Aviv Court in October of 2017. The dispute was initially heard by the Tel Aviv Court on February 13, 2020. In a supplemental hearing on February 11, 2021 the former CEO provided data regarding his claims and his summaries were filed on that day. The Company’s summaries will be filed within 30 days of receiving the former CEO summaries. As of December 31, 2020, the company’s management, in consultation with its legal advisors, believes that the former CEO’s claims will not be Successful.

 

Note 10. Revenues.

 

   Year ended December 31, 
   2020   2019 
Individual Subscriptions   13    17 
Enterprise Subscriptions   83    191 
    96    208 

 

Note 11. Research and development expenses.

 

   Year ended December 31, 
   2020   2019 
         
Salaries and related expense   55    219 
Others   53    14 
    108    233 

 

44

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

 

Note 12. Seles and marketing expenses.

 

   Year ended December 31, 
   2020   2019 
         
Salaries and related expense   7    110 
Others   1    147 
    8    257 

 

Note 13. General and administrative expenses.

 

   Year ended December 31, 
   2020   2019 
         
Wages, salaries and related expenses   214    276 
Professional fees   176    213 
Depreciation   5    1 
Recapitalization Transaction costs   -    112 
Other   42    118 
    437    720 

 

Note 14. Financing (income) expenses, net

 

   Year ended December 31, 
   2020   2019 
         
Bank fees   1    3 
Exchange rate differences   (14)   107 
Other financial income   -    (12)
    (13)   98 

 

45

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

 

Note 15. Income Taxes.

 

The Company is subject to income taxes under the Israeli and U.S. tax laws:

 

Tax rates applicable to the income of the Company:

 

Viewbix Inc. is taxed according to U.S. tax laws. On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the “Act”), which among other provisions, reduced the U.S. corporate tax rate from 35% to 21%, effective January 1, 2018.

 

Viewbix Israel and Israeli subsidiaries are taxed according to Israeli tax laws. The Israeli corporate tax rate is 23% in the years 2020, 2019 and onwards.

 

Deferred income taxes:

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets are as follows:

 

  

As of

December 31

  

As of

December 31

 
   2 0 2 0   2 0 1 9 
         
Deferred R&D expenses  $114   $239 
Operating loss carryforward   32,256    32,443 
   $32,370   $32,682 
           
Net deferred tax asset before valuation allowance  $7,076   $7,149 
Valuation allowance   (7,076)   (7,149)
Net deferred tax asset  $-   $- 

 

As of December 31, 2020, the Company has provided valuation allowances of $7,076 in respect of deferred tax assets resulting from tax loss carryforward and other temporary differences. Management currently believes that because the Company has a history of losses, it is more likely than not that the deferred tax regarding the loss carryforward and other temporary differences will not be realized in the foreseeable future.

 

Available carryforward tax losses:

 

As of December 31, 2020, Viewbix Israel incurred operating losses in Israel of approximately $13,804 which may be carried forward and offset against taxable income in the future for an indefinite period.

 

As of December 31, 2020 the Company generated net operating losses in the U.S. of approximately $18,452 Net operating losses in the U.S. are available through 2035. Utilization of U.S. net operating losses may be subject to substantial annual limitation due to the “change in ownership” provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in the expiration of net operating losses before utilization.

 

46

 

 

VIEWBIX INC. (Formerly known as Virtual Crypto Technologies, Inc.)

Notes to Consolidated Financial Statements

U.S. dollars in thousands (except share and per share data)

 

Note 15. Income Taxes (cont.)

 

Loss (income) from continuing operations, before taxes on income, consists of the following:

 

   For the year ended December 31 
   2020   2019 
         
USA  $65   $113 
Israel   376    989 
   $441   $1,102 

 

NOTE 16. LOSS PER SHARE-BASIC AND DILUTED

 

Composition:

 

   For the year ended December 31 
   2 0 2 0   2 0 1 9 
Basic and diluted:          
Net loss attributable to ordinary stockholders   443    1,117 
           
Weighted-average ordinary shares   31,201,669    13,746,064 
           
Loss per share-basic and diluted   0.014    0.08 

 

NOTE 17. - COVID-19 PANDEMIC IMPLICATIONS

 

The COVID-19 pandemic, which originated in China in late 2019, has since spread across the globe and affected the economic condition of most, if not all, countries, including the United States, Israel and many countries in Europe. On March 11, 2020, the World Health Organization declared the outbreak a pandemic. While COVID-19 is still spreading and the final implications of the pandemic are difficult to estimate at this stage, it is clear that it has affected the lives of a large portion of the global population. As of December 31, 2020, the pandemic has caused repeated states of emergency to be declared in various countries, ongoing and extended travel restrictions have been imposed for several months, strict quarantines rules have been established and maintained for an extended period of time in a plethora of jurisdictions and various institutions and companies have been closed and rendered bankrupt. The Company is actively monitoring the pandemic and is taking any necessary measures to respond to the situation in cooperation with the various stakeholders. Due to the uncertainty surrounding the COVID-19 pandemic, the Company will continue to assess the situation, including government-imposed restrictions, market by market. It is not possible at this time to estimate the full impact that the COVID-19 pandemic could have on the Company’s business, the continued spread of COVID-19, and any additional measures taken by governments, health officials or by the Company in response to such spread, could have on the Company’s business, results of operations and financial condition. The COVID-19 pandemic and mitigation measures have also negatively impacted global economic conditions, which, in turn, could adversely affect the Company’s business, results of operations and financial condition. The extent to which the COVID-19 outbreak continues to impact the Company’s financial condition will depend on future developments that are highly uncertain and cannot be predicted, including new government actions or restrictions, new information that may emerge concerning the severity, longevity and impact of the COVID-19 pandemic on economic activity.

 

47

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None.

 

ITEM 9A. CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

 

Our management, including our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of December 31, 2020, the end of the period covered by this Annual Report on Form 10-K. Based on such evaluation, due to the material weakness discussed below, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective at a reasonable assurance level as of December 31, 2020.

 

48

 

 

Management’s Report on Internal Control over Financial Reporting

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. The Company’s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with U.S. GAAP.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Management evaluated the design and operating effectiveness of internal control over financial reporting based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO 2013”). Based on this evaluation, management concluded that our internal control over financial reporting as of December 31, 2019 was not effective due to the material weakness described below.

 

In connection with the preparation of our consolidated financial statements as of and for the year ended December 31, 2020, we have identified a material weakness in our internal control over financial reporting. The material weakness was identified in the period-end financial reporting process, and is associated with our history as a private company and a material weakness is a deficiency or combination of deficiencies in our internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our consolidated financial statements would not be prevented or detected on a timely basis. This deficiency could result in additional misstatements to our consolidated financial statements that would be material and would not be prevented or detected on a timely basis.

 

We are evaluating and implementing additional procedures in order to remediate this material weakness, however, we cannot assure you that these or other measures will fully remediate the material weakness in a timely manner.

 

Attestation Report of the Registered Public Accounting Firm

 

This annual report on Form 10-K does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the SEC that permit the Company, as a non-accelerated filer, to provide only management’s report in this annual report on Form 10-K.

 

Changes in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting or in other factors identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 or 15d-15 that occurred during the fourth quarter ended December 31, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

ITEM 9B. OTHER INFORMATION

 

None.

 

49

 

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

Our directors were elected to serve until the next annual meeting of shareholders and until his respective successors will have been elected and will have qualified. The following table sets forth the name, age and position held with respect to our present executive officers and directors:

 

Name   Age   Title
Amihay Hadad   43   Director, Chief Executive Officer and Chief Financial Officer
Alon Dayan   43   Director

 

Amihay Hadad has served as our chief executive officer since February 20, 2020, chief financial officer since July 25, 2019, and was appointed as a member of our board of directors on January 1, 2020. From 2011 until 2018, Mr. Hadad served as the chief financial officer of Yedioth Internet. As of January 30, 2020, Mr. Hadad serves as the chief executive officer of Gix, a controlling stockholder of the Company, in addition to his existing role as Gix’s chief financial officer. Mr. Hadad holds both a B.A. and an MBA from the College of Management Academic Studies in Rishon LeZion, Israel, and an M.A. in law from Bar-Ilan University, Israel. Mr. Hadad is also a certified public accountant in Israel.

 

Alon Dayan has served as a member of our board of directors since March 14, 2018, and from January 24, 2018 until July 25, 2019, he served as our chief executive officer. From July 2014 to the present, Mr. Dayan served as the chief executive officer and founder of L1 Systems Ltd., an Israeli based company engaged in the business of providing the public and private sectors with advanced security solutions. Since July 2013, Mr. Dayan has served as chief executive officer and was the founder of Polaris Star, an Israeli-based company which is engaged in providing advanced cyber security telecommunication for utilities world-wide. Mr. Dayan earned his B.Tech. degree in electronic engineering from Ariel University in Israel.

 

Involvement in Certain Legal Proceedings

 

Our director, officers or affiliates have not, within the past five years, filed any bankruptcy petition, been convicted in or been the subject of any pending criminal proceedings, or is any such person the subject or any order, judgment or decree involving the violation of any state or federal securities laws.

 

Family Relationships

 

There are no family relationships between or among any of our directors or executive officers.

 

Compliance with Section 16(a) Compliance.

 

Section 16(a) of the Securities and Exchange Act of 1934 requires that directors and executive officers, and persons who own beneficially more than ten percent (10%) of the Registrant’s Common Stock, to file reports of ownership and changes of ownership with the Securities and Exchange Commission. Copies of all filed reports are required to be furnished to the Registrant pursuant to Section 16(a). The Registrant’s officers and directors are current in their filings are required under Section 16(a).

 

Director Independence.

 

The Company does not currently have any independent directors.

 

Directors’ Term of Office.

 

Our directors are elected for a term of one year and serve until such director’s successor is duly elected and qualified. Each executive officer serves at the pleasure of the board.

 

50

 

 

Audit Committee and Financial Expert, Compensation Committee, Nominations Committee.

 

We do not have any of the above mentioned standing committees because our corporate financial affairs and corporate governance are simple in nature at this stage of development and each financial transaction is approved by our officers or board of directors.

 

Potential Conflicts of Interest.

 

Since we do not have an audit or compensation committee comprised of independent directors, the functions that would have been performed by such committees are performed by our board of directors. Thus, there is a potential conflict of interest in that our directors have the authority to determine issues concerning management compensation, in essence their own, and audit issues that may affect management decisions. We are not aware of any other conflicts of interest with any of our executives or directors.

 

Board’s Role in Risk Oversight.

 

Our board of directors assess on an ongoing basis the risks faced by the Company. These risks include financial, technological, competitive, and operational risks. In addition, since the Company does not have an audit committee, the board of directors is also responsible for the assessment and oversight of the Company’s financial risk exposures.

 

Involvement in Certain Legal Proceedings.

 

We are not aware of any material legal proceedings that have occurred within the past ten years concerning any director or control person which involved a criminal conviction, a pending criminal proceeding, a pending or concluded administrative or civil proceeding limiting one’s participation in the securities or banking industries, or a finding of securities or commodities law violations.

 

ITEM 11. EXECUTIVE COMPENSATION

 

Any compensation received by our officers, directors, and management personnel will be determined from time to time by our Board of Directors. Our officers, directors, and management personnel will be reimbursed for any out-of-pocket expenses incurred on our behalf.

 

The following table sets out the compensation paid for the fiscal years ended December 31, 2020, 2019 and 2018, as applicable, to the following Named Executive Officers:

 

  Mr. Amihay Hadad, our current Chief Executive Officer and Chief Financial Officer;
     
  Mr. Jonathan Stefansky, our former Chief Executive Officer, who resigned from such role on January 1, 2020; and

 

The table is in U.S. dollars
Name and principal position
  Year   Salary   Bonus   Stock Awards   Option Awards   All Other Compensation   Total 
Mr. Amihay Hadad   2020    47,072          -            -           -           -    47,072 
Current Chief Executive Officer, Chief Financial Officer   2019    -    -    -    -    -    - 
    2018    -    -    -    -    -    - 
                                    
Mr. Jonathan Stefansky   2020    59,805                        59,805 
Former Chief Executive Officer   2019    134,838    -    -    -    -    134,838 
    2018    160,370    -    -    -    -    160,370 

 

51

 

 

Director’s Compensation

 

Our directors are not entitled to receive compensation for service rendered to us or for meeting(s) attended except for reimbursement of out-of-pocket expenses. There is no formal or informal arrangements or agreements to compensate employee directors for service provided as a director; however, compensation for new non-employee directors is determined on an ad hoc basis by the existing members of the board of directors at the time a director is elected.

 

Compensation Policies and Practices as They Relate to the Company’s Risk Management

 

We believe that our compensation policies and practices for all employees, including executive officers, do not create risks that are reasonably likely to have a material adverse effect on us.

 

Employment Contracts

 

We do not have any formal employment agreement with any of our officers. Any future compensation will be determined by the Board of Directors, and, as appropriate, an employment agreement will be executed. We do not currently have plans to pay any compensation until such time as the Company maintains a positive cash flow.

 

Outstanding Equity Awards

 

There were no equity awards outstanding as of the end the year ended December 31, 2020.

 

Option Grants

 

During the year ended December 31, 2020, the board of directors did not authorize the issuance of stock options to executive officers and directors to purchase shares of Common Stock.

 

Aggregated Option Exercises and Fiscal Year-End Option Value

 

There were no stock options exercised during the year ending December 31, 2020 by our executive officers.

 

Long-Term Incentive Plan (“LTIP”) Awards

 

There were no awards made to named executive officers in the last completed fiscal year under any LTIP.

 

Indebtedness of Management

 

No officer, director or security holder known to us to own of record or beneficially more than 5% of our common stock or any member of the immediate family or sharing the household (other than a tenant or employee) of any of the foregoing persons is indebted to us in the years 2020 and 2019.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

The table below provides information regarding the beneficial ownership of our Common Stock as of December 31, 2020, of (i) each of our current directors, (ii) each of the Named Executive Officers, (iii) all of our current directors and officers as a group, and (iv) each person or entity known to us who owns more than 5% of our common stock.

 

52

 

 

The percentage of Common Stock beneficially owned is based on 34,753,669 shares of Common Stock outstanding as of December 31, 2020. The number and percentage of shares of Common Stock beneficially owned by a person or entity also include shares of Common Stock issuable upon exercise of warrants that are currently exercisable or will become exercisable within 60 days of December 31, 2020. However, these shares are not deemed to be outstanding for the purpose of computing the percentage of shares beneficially owned of any other person or entity.

Name and Address of Beneficial Owner  Title of Class  Amount and Nature
of Beneficial
Ownership(1)
   Percent of Class 
Gix Internet Ltd.  Common Stock   27,579,721(2)   79.36%
Alon Dayan  Common Stock   50,000    0.14%
L.I.A. Pure Capital Ltd.  Common Stock   2,631,571(3)   8.43%
Directors and officers as a group (2 individuals)  Common Stock   50,000    0.14%

 

(1) Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Each of the beneficial owners named in the table have, to our knowledge, direct ownership of and sole voting and investment power with respect to the shares of Common Stock beneficially owned by them.
   
(2) Includes (i) 20,281,085 of shares of Common Stock, (ii) warrants to purchase up to 3,649,318 shares of restricted Common Stock with an exercise price of $0.48 per share, and (iii) warrants to purchase up to 3,649,318 shares of restricted Common Stock with an exercise price of $0.80 per share, which are currently exercisable or will become exercisable within 60 days of December 31, 2020.
   
(3) The number of shares shown as beneficially owned by this stockholder is based on its Schedule 13G filed on February 8, 2021.

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTORS INDEPENDENCE

 

Certain Related Party Transactions

 

On December 18, 2020, L.I.A. Pure Capital Ltd. (“Pure Capital”), together with other Investors, entered into the Stock Subscription Agreement, pursuant to which Pure Capital was issued 1,000,000 shares of Common Stock in exchange for an investment of $10,000, at a purchase price of US$0.01 per share. Additionally, Pure Capital, together with other Investors, entered into the Loan Agreement, pursuant to which Pure Capital lent $23,000 and we repaid the interest on that amount in the form of an issuance of 184,000 shares of Common Stock to Pure Capital, at a price per share of $0.01. The shares of Common Stock were issued to the Investors pursuant to Regulation S of the Securities Act of 1933, as amended.

 

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

 

Independent Public Accountants

 

The Registrant’s Board of Directors has appointed Brightman Almagor Zohar & Co. as independent public accountant for the fiscal years ended December 31, 2020. Halperin had served as the Company’s independent registered public accounting firm for the fiscal periods beginning July 6, 2018 through November 7, 2019.

 

Principal Accounting Fees

 

The following table presents the fees for professional audit services rendered by (a) Brightman Almagor Zohar & Co. for the audit of the Registrant’s annual financial statements for the year ended December 31, 2020; (b) professional audit services rendered by (i) Halperin Ilanit CPA and (ii) Brightman Almagor Zohar & Co. for the audit of the Registrant’s annual financial statements for the year ended December 31, 2019; (c) fees billed for other services rendered by Brightman Almagor Zohar & Co. for the Registrant’s fiscal period beginning November 7, 2019 and ending December 31, 2019; and (c) the aggregate fees billed in each of the last two fiscal years as pertaining to, among others, tax compliance, tax advice and tax planning conferred to the Registrant.

 

53

 

 

   Year Ended   Year Ended 
  

December 31,

2020

  

December 31,

2019

 
Audit fees (1)   50,000    42,500(2)
Audit-related fees (3)   -    60,000(4)
Tax -related fees (5)   2,948    20,500 

 

(1) Audit fees consist of audit and review services, consents and review of documents filed with the SEC.
   
(2) Audit Fees consists of $12,500 in connection with the services rendered by Halperin Ilanit CPA, and $30,000 in connection with the services rendered by Brightman Almagor Zohar & Co Audit-related fees.
   
(3) Audit-related fees consist of assistance and discussion concerning financial accounting and reporting standards and other accounting issues in connection with the Share Exchange Agreement.
   
(4) Consists of $2,000 in connection with the services rendered by Halperin Ilanit CPA, and $58,000 in connection with the services rendered by Brightman Almagor Zohar & Co.
   
(5) Tax fees consist of, among other items, preparation of federal and state tax returns, review of quarterly estimated tax payments, Israeli tax rulings, consultation concerning tax compliance issues, and services rendered for purposes of a tax ruling filed with government agencies and institutions in connection with the Recapitalization Transaction.

 

54

 

 

PART IV

 

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

(a) The following documents are filed as exhibits to this report on Form 10-K or incorporated by reference herein. Any document incorporated by reference is identified by a parenthetical reference to the SEC filing that included such document.

 

Exhibit No. Description

 

Exhibit No.   Exhibit Description
3.1   Certificate of Incorporation (incorporated by reference to the Registrant’s registration statement on Form S-1 filed with the SEC on August 5, 2015)
3.2   Certificate of Amendment to the Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on July 25, 2019)
3.3   Bylaws (incorporated by reference to the Registrant’s registration statement on Form S-1 filed with the SEC on August 5, 2015)
4.1   Description of Registrant’s Securities (incorporated by reference to the Registrant’s annual report on Form 10-K filed for the fiscal year ended December 31, 2019 with the SEC on March 20, 2020)
4.2   Form of Warrant by and between the Company and Gix Ltd., dated July 25, 2019 (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on July 25, 2019)
10.1   2017 Employee Incentive Plan (incorporated by reference to the Registrant’s annual report on Form 10-K for the fiscal year ended December 31, 2017, filed with the SEC on April 17, 2018)
10.2   Form of Stock Subscription Agreement between the Company and the investors set forth therein (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on December 21, 2020)
10.3   Form of Loan Agreement between the Company and the investors set forth therein (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed on December 21, 2020)
21.1*   Subsidiaries of the Registrant
31.1*   Section 302 Certification under the Sarbanes-Oxley Act of 2002 of the Principal Executive Officer and Principal Financial Officer
32.1*   Section 906 Certification under the Sarbanes-Oxley Act of 2002 of the Principal Executive Officer and Principal Financial Officer
101.INS*   XBRL Instance Document
101.SCH*   XBRL Taxonomy Extension Schema Document
101.CAL*   XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*   XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   XBRL Taxonomy Extension Label Linkbase Document
101.PRE*   XBRL Taxonomy Extension Presentation Linkbase Document

 

* Filed herewith.
** Furnished herewith.

 

55

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned.

 

  VIEWBIX INC.
   
Date: March 16, 2021 By: /s/ Amihay Hadad
    Amihay Hadad
    Chief Executive Officer

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below on this 16th day of March 2021 by the following persons on behalf of the registrant and in the capacities indicated, including a majority of the directors.

 

Signature   Title
     
/s/ Amihay Hadad   Chief Executive Officer
Amihay Hadad   (Principal Executive Officer)
     
/s/ Amihay Hadad   Chief Financial Officer and Director
Amihay Hadad   (Principal Financial and Accounting Officer)
     
/s/ Amihay Hadad   Director
Amihay Hadad    
     
/s/ Alon Dayan   Director
Alon Dayan    

 

56

EX-21.1 2 ex21-1.htm

 

Exhibit 21.1

 

LIST OF SUBSIDIARIES

 

Company Name   Jurisdiction of Incorporation
Viewbix Ltd.(1)   Israel
Emerald Medical Applications Ltd.(2)   Israel

 

  (1) Following the consummation of that certain Share Exchange Agreement by and between Virtual Crypto Technologies Inc. and Algomizer Ltd., dated February 7, 2019, Algomizer Ltd. assigned, transferred and delivered 99.83% of Viewbix Ltd. to Virtual Crypto Technologies Inc. Virtual Crypto Technologies Inc. changed its name to Viewbix Inc. on July 24, 2019.
  (2) Emerald Medical Applications Ltd. is the wholly-owned subsidiary of Viewbix Inc.

 

   

 

EX-31.1 3 ex31-1.htm

 

Exhibit 31-1

 

CERTIFICATION PURSUANT TO

RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Amihay Hadad, certify that:

 

1. I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2020 of Viewbix Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the year-end covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the year-end presented in this report;
   
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
   
a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the year-end in which this report is being prepared;
   
b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the year-end covered by this report based on such evaluation; and
   
d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
   
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
   
a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
   
b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 16, 2021  
   
/s/ Amihay Hadad  
Amihay Hadad  
Chief Executive Officer and Chief Financial Officer  

 

   

 

EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Viewbix Inc. (the “Company”) on Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Amihay Hadad, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
   
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Amihay Hadad  
Amihay Hadad  
Chief Executive Officer and Chief Financial Officer  
Viewbix Inc.  
March 16, 2021  

 

   

 

GRAPHIC 5 form10-k_001.jpg begin 644 form10-k_001.jpg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end GRAPHIC 6 form10-k_002.jpg begin 644 form10-k_002.jpg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vbix-20201231.xml XBRL INSTANCE FILE 0000797542 2020-01-01 2020-12-31 0000797542 2018-12-31 0000797542 2019-12-31 0000797542 VBIX:ShareExchangeAgreementMember VBIX:GixLtdMember 2019-02-07 0000797542 VBIX:ShareExchangeAgreementMember VBIX:GixLtdMember us-gaap:RestrictedStockMember 2019-02-06 2019-02-07 0000797542 VBIX:ShareExchangeAgreementMember VBIX:ViewbixLtdMember 2019-02-07 0000797542 VBIX:GixLtdMember 2019-07-23 2019-07-24 0000797542 VBIX:ConvertibleNotesHoldersMember 2019-07-23 2019-07-24 0000797542 VBIX:GixLtdMember 2019-07-24 0000797542 VBIX:GixLtdMember VBIX:WarrantOneMember 2019-07-24 0000797542 VBIX:GixLtdMember VBIX:WarrantTwoMember 2019-07-24 0000797542 us-gaap:ComputerEquipmentMember 2019-12-31 0000797542 us-gaap:OfficeEquipmentMember 2019-12-31 0000797542 2019-07-31 0000797542 us-gaap:IsraelTaxAuthorityMember 2020-01-01 2020-12-31 0000797542 us-gaap:DomesticCountryMember 2019-01-01 2019-12-31 0000797542 us-gaap:ForeignCountryMember 2019-01-01 2019-12-31 0000797542 2019-07-25 0000797542 VBIX:PreferredStockAOneMember 2018-12-31 0000797542 VBIX:PreferredStockATwoMember 2018-12-31 0000797542 VBIX:PreferredStockBMember 2018-12-31 0000797542 VBIX:PreferredStockCMember 2018-12-31 0000797542 VBIX:PreferredStockCOneMember 2018-12-31 0000797542 VBIX:PreferredStockCTwoMember 2018-12-31 0000797542 VBIX:TotalTemporaryEquityMember 2018-12-31 0000797542 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000797542 us-gaap:RetainedEarningsMember 2018-12-31 0000797542 VBIX:PreferredStockAOneMember 2019-12-31 0000797542 VBIX:PreferredStockATwoMember 2019-12-31 0000797542 VBIX:PreferredStockBMember 2019-12-31 0000797542 VBIX:PreferredStockCMember 2019-12-31 0000797542 VBIX:PreferredStockCOneMember 2019-12-31 0000797542 VBIX:PreferredStockCTwoMember 2019-12-31 0000797542 VBIX:TotalTemporaryEquityMember 2019-12-31 0000797542 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000797542 us-gaap:RetainedEarningsMember 2019-12-31 0000797542 VBIX:PreferredStockAOneMember 2019-01-01 2019-12-31 0000797542 VBIX:PreferredStockATwoMember 2019-01-01 2019-12-31 0000797542 VBIX:PreferredStockBMember 2019-01-01 2019-12-31 0000797542 VBIX:PreferredStockCMember 2019-01-01 2019-12-31 0000797542 VBIX:PreferredStockCOneMember 2019-01-01 2019-12-31 0000797542 VBIX:PreferredStockCTwoMember 2019-01-01 2019-12-31 0000797542 VBIX:TotalTemporaryEquityMember 2019-01-01 2019-12-31 0000797542 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0000797542 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0000797542 VBIX:IndividualSubscriptionsMember 2019-01-01 2019-12-31 0000797542 VBIX:EnterpriseSubscriptionsMember 2019-01-01 2019-12-31 0000797542 VBIX:SalariesandRelatedExpenseMember 2019-01-01 2019-12-31 0000797542 VBIX:OtherMember 2019-01-01 2019-12-31 0000797542 VBIX:BankFeesMember 2019-01-01 2019-12-31 0000797542 VBIX:ExchangeRateDifferencesMember 2019-01-01 2019-12-31 0000797542 VBIX:OtherFinancialIncomeMember 2019-01-01 2019-12-31 0000797542 VBIX:OrdinaryShareMember 2019-01-01 2019-12-31 0000797542 VBIX:OrdinaryShareMember 2018-12-31 0000797542 VBIX:OrdinaryShareMember 2019-12-31 0000797542 VBIX:VirtualCryptoIsraelMember VBIX:NISMember 2020-01-27 0000797542 VBIX:VirtualCryptoIsraelMember 2020-01-27 0000797542 VBIX:ViewbixLtdMember 2019-06-24 0000797542 2019-07-01 2019-07-31 0000797542 us-gaap:ComputerEquipmentMember 2020-12-31 0000797542 us-gaap:OfficeEquipmentMember 2020-12-31 0000797542 VBIX:ClassHWarrantsMember 2020-01-01 2020-01-30 0000797542 VBIX:ClassHWarrantsMember 2020-03-01 2020-03-30 0000797542 VBIX:ClassIWarrantsMember 2020-01-01 2020-01-30 0000797542 2020-12-31 0000797542 VBIX:ClassJWarrantsMember 2020-12-31 0000797542 VBIX:ClassJWarrantsMember 2020-01-01 2020-12-31 0000797542 VBIX:ClassKWarrantsMember 2020-12-31 0000797542 VBIX:ClassKWarrantsMember 2020-01-01 2020-12-31 0000797542 VBIX:BankFeesMember 2020-01-01 2020-12-31 0000797542 VBIX:ExchangeRateDifferencesMember 2020-01-01 2020-12-31 0000797542 VBIX:OtherFinancialIncomeMember 2020-01-01 2020-12-31 0000797542 VBIX:ViewbixIsraelMember 2020-12-31 0000797542 country:US 2020-12-31 0000797542 us-gaap:DomesticCountryMember 2020-01-01 2020-12-31 0000797542 us-gaap:ForeignCountryMember 2020-01-01 2020-12-31 0000797542 VBIX:GixLtdMember 2020-01-01 2020-12-31 0000797542 2019-01-01 2019-12-31 0000797542 2020-06-30 0000797542 2020-02-12 0000797542 VBIX:ClassGWarrantsMember 2020-04-01 2020-04-30 0000797542 VBIX:TelAvivDistrictCourtMember 2017-06-01 2017-06-30 0000797542 2021-03-15 0000797542 VBIX:PreferredStockAOneMember 2020-01-01 2020-12-31 0000797542 VBIX:PreferredStockAOneMember 2020-12-31 0000797542 VBIX:PreferredStockATwoMember 2020-01-01 2020-12-31 0000797542 VBIX:PreferredStockATwoMember 2020-12-31 0000797542 VBIX:PreferredStockBMember 2020-01-01 2020-12-31 0000797542 VBIX:PreferredStockBMember 2020-12-31 0000797542 VBIX:PreferredStockCMember 2020-01-01 2020-12-31 0000797542 VBIX:PreferredStockCMember 2020-12-31 0000797542 VBIX:PreferredStockCOneMember 2020-01-01 2020-12-31 0000797542 VBIX:PreferredStockCOneMember 2020-12-31 0000797542 VBIX:PreferredStockCTwoMember 2020-01-01 2020-12-31 0000797542 VBIX:PreferredStockCTwoMember 2020-12-31 0000797542 VBIX:TotalTemporaryEquityMember 2020-01-01 2020-12-31 0000797542 VBIX:TotalTemporaryEquityMember 2020-12-31 0000797542 VBIX:OrdinaryShareMember 2020-01-01 2020-12-31 0000797542 VBIX:OrdinaryShareMember 2020-12-31 0000797542 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0000797542 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000797542 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0000797542 us-gaap:RetainedEarningsMember 2020-12-31 0000797542 VBIX:EmployeesMember 2020-01-01 2020-12-31 0000797542 VBIX:IndividualSubscriptionsMember 2020-01-01 2020-12-31 0000797542 VBIX:EnterpriseSubscriptionsMember 2020-01-01 2020-12-31 0000797542 VBIX:SalariesandRelatedExpenseMember 2020-01-01 2020-12-31 0000797542 VBIX:OtherMember 2020-01-01 2020-12-31 0000797542 VBIX:StockSubscriptionAgreementMember us-gaap:InvestorMember 2020-12-17 2020-12-18 0000797542 VBIX:StockSubscriptionAgreementMember us-gaap:InvestorMember 2020-12-18 0000797542 us-gaap:InvestorMember VBIX:LoanAgreementMember 2020-12-18 0000797542 VBIX:LoanAgreementMember us-gaap:InvestorMember 2020-12-17 2020-12-18 0000797542 VBIX:ComputersMember 2020-12-31 0000797542 VBIX:FurnitureAndOfficeEquipmentMember srt:MinimumMember 2020-12-31 0000797542 VBIX:FurnitureAndOfficeEquipmentMember srt:MaximumMember 2020-12-31 0000797542 VBIX:LoanAndStockSubscriptionAgreementMember VBIX:InvestorsMember 2020-12-17 2020-12-18 0000797542 VBIX:LoanAndStockSubscriptionAgreementMember VBIX:InvestorsMember 2020-12-18 0000797542 VBIX:StockSubscriptionAgreementMember VBIX:InvestorsMember 2020-12-17 2020-12-18 0000797542 VBIX:ShortTermLoanMember 2020-12-31 0000797542 VBIX:InvestmentSharesMember 2020-12-31 0000797542 VBIX:GixLtdMember 2020-12-31 0000797542 VBIX:GixLtdMember 2019-01-01 2019-12-31 0000797542 us-gaap:IsraelTaxAuthorityMember 2019-01-01 2019-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure 10-K false --12-31 Non-accelerated Filer 0.0001 0.0001 490000000 490000000 31201669 34753669 63350 31201669 34753669 -443000 -1117000 -1117000 -443000 2020 FY 0.48 0.80 0.48 0.80 3649318 3649318 July 2029 July 2029 3649318 3649318 false true Viewbix Inc. Yes No false 0.9983 -441000 113000 989000 65000 376000 -1102000 1642193 20281085 3434889 3000000 552000 552000 32443000 32256000 13804000 18452000 Preferred shares may have been converted into ordinary shares of Viewbix Ltd at any time. The preferred shares would have automatically converted into ordinary shares if (a) the holders of at least (i) 67% (sixty seven percent) of the issued and outstanding Preferred C/C-1 shares, (ii) a majority of the issued and outstanding Preferred B shares, and (iii) a majority of the issued and outstanding Preferred A shares, so agree in writing; or (b) in the event of an IPO. 16199520 1642193 Ordinary shares confer the right to participate in the general meetings, to one vote per share for any purpose, to an equal part, on share basis, in distribution of dividends and to equally participate, on share basis, in distribution of excess of assets and funds from the Company and they shall not confer other privileges unless stated hereunder or in the Companies Law otherwise. Some investors have standard anti-dilutive rights, registration rights, and information and representation rights. 199870 4881654 4556094 7222305 2755706 392407 279049 31201669 34753669 96000 17000 191000 208000 13000 83000 On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the "Act"), which among other provisions, reduced the U.S. corporate tax rate from 35% to 21%, effective January 1, 2018. Net operating losses in the U.S. are available through 2035. 30928620 50000 50000 38095 142857 0000797542 2020-12-31 225000 8000 -721000 -1693000 10000 9000 15000 11000 1000 46000 12872000 -13594000 13015000 -14711000 1000 3000 -2078000 3000 13073000 -15154000 8000 110000 147000 257000 7000 1000 108000 219000 14000 233000 55000 53000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.65in; text-align: justify"><b>Composition:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 30</b></p></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 31</b></p></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 2 0</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 1 9</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Government authorities</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">20</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">118</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Other</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; text-align: justify">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">20</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">119</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.65in; text-align: justify"><b>Composition:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 30</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 31</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 2 0</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 1 9</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font-size: 10pt"><b>Cost:</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Computers and related equipment</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">34</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">34</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Office furniture and equipment</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">9</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">9</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">43</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">43</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt"><b>Accumulated depreciation</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">43</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">38</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt"><b>Net book value</b></font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">5</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes information of outstanding warrants as of December 31, 2020:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Warrants</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Warrant Term</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise Price</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercisable</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 26%"><font style="font-size: 10pt">Class J Warrants</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">3,649,318</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 18%; text-align: right"><font style="font-size: 10pt">July 2029</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font-size: 10pt">0.48</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font-size: 10pt">3,649,318</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Class K Warrants</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,649,318</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">July 2029</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.80</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,649,318</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Significant components of the Company&#8217;s deferred tax assets are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 31</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 31</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 2 0</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 1 9</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Deferred R&#38;D expenses</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">114</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">239</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Operating loss carryforward</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">32,256</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">32,443</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">32,370</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">32,682</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Net deferred tax asset before valuation allowance</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">7,076</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">7,149</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Valuation allowance</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(7,076</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(7,149</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt"><b>Net deferred tax asset</b></font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Loss (income) from continuing operations, before taxes on income, consists of the following:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the year ended December 31</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%"><font style="font-size: 10pt">USA</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">65</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">113</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Israel</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">376</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">989</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">441</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,102</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> 32682000 32370000 239000 114000 7149000 7076000 7149000 7076000 0.21 0.23 0.23 No No 344778000 34753669 -10000 -9000 -15000 -11000 -1000 -46000 143000 2000 145000 -199870 -4881654 -4556094 -7222305 -2755708 -392407 30928620 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 12. Sales and marketing expenses. </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Salaries and related expense</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">7</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">110</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Others</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">147</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">257</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Individual Subscriptions</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">13</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">17</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Enterprise Subscriptions</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">83</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">191</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">96</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">208</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> 214000 276000 176000 213000 112000 42000 118000 5000 225000 225000 119000 20000 17000 42000 15000 2000 87000 148000 230000 225000 66000 22000 246000 177000 1611000 2054000 50000 1923000 2303000 230000 225000 -14711000 -15154000 13015000 13073000 3000 3000 31201669 13746064 -0.014 -0.08 2000 15000 -454000 -1004000 545000 1210000 437000 720000 91000 206000 5000 2000 3552000 58000 58000 -53000 -135000 -55000 139000 443000 822000 -55000 36000 -100000 21000 40000 -5000 5000 1000 13000 -1000 1000 2000 13000 99000 174000 50000 49000 30587000 174000 51000 89000 148000 59000 38000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.65in; text-align: justify"><b>Composition:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 30</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 31</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 2 0</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 1 9</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Other payables and deferred revenues</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">47</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">91</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Accrued liabilities</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">130</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">149</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Other</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">6</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; text-align: justify">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">177</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">246</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> -20000 -12000 -7000 -110000 -13000 3000 107000 -12000 1000 -14000 98000 0.01 0.01 0.01 0.08 0.08 30000 69000 69000 <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 62px; padding-left: 10pt; text-align: justify; text-indent: -10pt"><font style="font-size: 10pt"><b>Note 3.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; text-indent: -10pt"><font style="font-size: 10pt"><b>Other Accounts receivables</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.65in; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.65in; text-align: justify"><b>Composition:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 30</b></p></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 31</b></p></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 2 0</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 1 9</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Government authorities</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">20</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">118</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Other</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; text-align: justify">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">20</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">119</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 62px; text-align: justify"><font style="font-size: 10pt"><b>Note 4.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt"><b>Property and equipment</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.65in; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.65in; text-align: justify"><b>Composition:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 30</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 31</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 2 0</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 1 9</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font-size: 10pt"><b>Cost:</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Computers and related equipment</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">34</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">34</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Office furniture and equipment</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">9</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">9</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">43</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">43</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt"><b>Accumulated depreciation</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">43</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">38</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt"><b>Net book value</b></font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">5</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 62px; text-align: justify"><font style="font-size: 10pt"><b>Note 5.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt"><b>Other accounts payable and accrued liabilities</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.65in; text-align: justify"><b>Composition:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 30</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 31</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 2 0</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 1 9</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Other payables and deferred revenues</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">47</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">91</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Accrued liabilities</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">130</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">149</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Other</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">6</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; text-align: justify">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">177</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">246</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 9. Commitments and Contingencies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During August 2019, a lawsuit was filed against the Company and its parent Company, Gix. The plaintiffs claim that they were entitled to receive shares of the Company as a part of the consideration in Gix&#8217;s acquisition of the Company. In management&#8217;s opinion, the plaintiffs&#8217; claims are based on incorrect assumptions that relate to the distribution of shares between the plaintiffs and other former shareholders of the Company prior to Gix&#8217;s acquisition which would have resulted in the receipt of shares in the acquisition transaction. During September 2020, a settlement was reached between the parties which was later approved by the court. The settlement outlines that in exchange for the voluntary waiver of claims made by the plaintiffs, Gix will issue 63,350 shares of its common stock held in trust in favor of securing the transaction by which Gix acquired shares of ViewBix Ltd. in November 2018. The remaining shares in the trust account will be used to indemnify Gix for any expenses related to the litigation. Since the consideration was paid in Gix&#8217;s shares, and as the claims relate to the distribution of shares between the plaintiffs and other former shareholders of the Company, the settlement did not impact on the Company&#8217;s financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2017, a lawsuit was filed by a former CEO of the Company with the Tel Aviv District Court (the &#8220;Tel Aviv Court&#8221;) against the Company claiming certain damages in the total amount of $225, under the assertion of wrongful termination by the Company and Emerald Israel. The Company believes these claims to be unsubstantiated and wholly without merit and accordingly filed its response with the Tel Aviv Court in October of 2017. The dispute was initially heard by the Tel Aviv Court on February 13, 2020. In a supplemental hearing on February 11, 2021 the former CEO provided data regarding his claims and his summaries were filed on that day. The Company&#8217;s summaries will be filed within 30 days of receiving the former CEO summaries. As of December 31, 2020, the company&#8217;s management, in consultation with its legal advisors, believes that the former CEO&#8217;s claims will not be Successful.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 10. Revenues. </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-indent: -56.7pt"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Individual Subscriptions</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">13</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">17</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Enterprise Subscriptions</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">83</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">191</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">96</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">208</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt"><b>Note 11. Research and development expenses. </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-indent: -56.7pt"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Salaries and related expense</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">55</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">219</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Others</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">53</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">14</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">108</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">233</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 68.05pt; text-align: justify; text-indent: -68.05pt"><b>Note 13. General and administrative expenses.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 68.05pt; text-align: justify; text-indent: -68.05pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Wages, salaries and related expenses</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">214</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">276</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Professional fees</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">176</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">213</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Depreciation</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Recapitalization Transaction costs</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">112</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Other</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">42</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">118</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">437</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">720</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 14. Financing (income) expenses, net</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Bank fees</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">3</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Exchange rate differences</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(14</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">107</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Other financial income</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(12</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(13</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">98</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 15. Income Taxes.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is subject to income taxes under the Israeli and U.S. tax laws:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Tax rates applicable to the income of the Company:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Viewbix Inc. is taxed according to U.S. tax laws. On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the &#8220;Act&#8221;), which among other provisions, reduced the U.S. corporate tax rate from 35% to 21%, effective January 1, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Viewbix Israel and Israeli subsidiaries are taxed according to Israeli tax laws. The Israeli corporate tax rate is 23% in the years 2020, 2019 and onwards.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Deferred income taxes:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#8217;s deferred tax assets are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 31</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 31</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 2 0</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 1 9</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Deferred R&#38;D expenses</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">114</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">239</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Operating loss carryforward</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">32,256</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">32,443</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">32,370</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">32,682</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Net deferred tax asset before valuation allowance</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">7,076</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">7,149</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Valuation allowance</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(7,076</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(7,149</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt"><b>Net deferred tax asset</b></font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2020, the Company has provided valuation allowances of $7,076 in respect of deferred tax assets resulting from tax loss carryforward and other temporary differences. Management currently believes that because the Company has a history of losses, it is more likely than not that the deferred tax regarding the loss carryforward and other temporary differences will not be realized in the foreseeable future.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Available carryforward tax losses:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2020, Viewbix Israel incurred operating losses in Israel of approximately $13,804 which may be carried forward and offset against taxable income in the future for an indefinite period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2020 the Company generated net operating losses in the U.S. of approximately $18,452 Net operating losses in the U.S. are available through 2035. Utilization of U.S. net operating losses may be subject to substantial annual limitation due to the &#8220;change in ownership&#8221; provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in the expiration of net operating losses before utilization.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Loss (income) from continuing operations, before taxes on income, consists of the following:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the year ended December 31</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%"><font style="font-size: 10pt">USA</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">65</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">113</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Israel</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">376</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">989</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">441</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,102</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 16. LOSS PER SHARE-BASIC AND DILUTED</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Composition:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the year ended December 31</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 2 0</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 1 9</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt"><b>Basic and diluted:</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 66%; padding-bottom: 2.5pt"><font style="font-size: 10pt"><b>Net loss attributable to ordinary stockholders</b></font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right"><font style="font-size: 10pt">443</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right"><font style="font-size: 10pt">1,117</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Weighted-average ordinary shares</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">31,201,669</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">13,746,064</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt"><b>Loss per share-basic and diluted</b></font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.014</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.08</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt"><b>NOTE 17. - COVID-19 PANDEMIC IMPLICATIONS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify; text-indent: -56.7pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The COVID-19 pandemic, which originated in China in late 2019, has since spread across the globe and affected the economic condition of most, if not all, countries, including the United States, Israel and many countries in Europe. On March 11, 2020, the World Health Organization declared the outbreak a pandemic. While COVID-19 is still spreading and the final implications of the pandemic are difficult to estimate at this stage, it is clear that it has affected the lives of a large portion of the global population. As of December 31, 2020, the pandemic has caused repeated states of emergency to be declared in various countries, ongoing and extended travel restrictions have been imposed for several months, strict quarantines rules have been established and maintained for an extended period of time in a plethora of jurisdictions and various institutions and companies have been closed and rendered bankrupt. The Company is actively monitoring the pandemic and is taking any necessary measures to respond to the situation in cooperation with the various stakeholders. Due to the uncertainty surrounding the COVID-19 pandemic, the Company will continue to assess the situation, including government-imposed restrictions, market by market. It is not possible at this time to estimate the full impact that the COVID-19 pandemic could have on the Company&#8217;s business, the continued spread of COVID-19, and any additional measures taken by governments, health officials or by the Company in response to such spread, could have on the Company&#8217;s business, results of operations and financial condition. The COVID-19 pandemic and mitigation measures have also negatively impacted global economic conditions, which, in turn, could adversely affect the Company&#8217;s business, results of operations and financial condition. The extent to which the COVID-19 outbreak continues to impact the Company&#8217;s financial condition will depend on future developments that are highly uncertain and cannot be predicted, including new government actions or restrictions, new information that may emerge concerning the severity, longevity and impact of the COVID-19 pandemic on economic activity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Functional currency</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The functional currency of the Company and its subsidiary is the US dollar, which is the currency of the primary economic environment in which it operates. In accordance with ASC 830, &#8220;Foreign Currency Matters&#8221; (ASC 830), balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing at the applicable balance sheet date. For foreign currency transactions included in the statement of operations, the exchange rates applicable on the relevant transaction dates are used. Gains or losses arising from changes in the exchange rates used in the translation of such transactions are carried as financing income or expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Principles of consolidation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Cash and cash equivalents</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Group considers all short-term investments, which are highly liquid investments with original maturities of three months or less at the date of purchase, to be cash equivalents.<i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Property and equipment</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1. Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. When an asset is retired or otherwise disposed of, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected in the statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2. Rates of depreciation:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">%</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%"><font style="font-size: 10pt">Computers</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 15%; text-align: center"><font style="font-size: 10pt">33</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Furniture and office equipment</font></td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">7-15</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Impairment of long-lived assets</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s long-lived assets are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. To date the Group did not incur any material impairment losses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Share-based compensation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company applies ASC 718-10, &#8220;Share-Based Payment,&#8221; which requires the measurement and recognition of compensation expenses for all share-based payment awards made to employees and directors (including employee stock options under the Company&#8217;s stock plans) based on estimated fair values.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 718-10 requires companies to estimate the fair value of equity-based payment awards on the date of grant. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company&#8217;s statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes compensation expenses for the value of non-employee awards based on the straight-line method over the requisite service period of each award, net of estimated forfeitures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company estimates the fair value of stock options granted as equity awards using a Black-Scholes options pricing model. The option-pricing model requires a number of assumptions, of which the most significant are share price, expected volatility and the expected option term (the time from the grant date until the options are exercised or expire). Expected volatility is estimated based on volatility of similar companies in the technology sector. The Company has historically not paid dividends and has no foreseeable plans to issue dividends. The risk-free interest rate is based on the yield from governmental zero-coupon bonds with an equivalent term. The expected option term is calculated for options granted to employees and directors using the &#8220;simplified&#8221; method. Grants to non-employees are based on the contractual term. Changes in the determination of each of the inputs can affect the fair value of the options granted and the results of operations of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Earnings per Common Share</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Earnings or loss per share (&#8220;EPS&#8221;) is the amount of earnings attributable to each share of common stock. For convenience, the term is used to refer to either earnings or loss per share. EPS is computed pursuant to ASC 260-10-45. Pursuant to ASC 260-10-45-10 through 260-10-45-16 Basic EPS is computed by dividing income available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Income available to common stockholders shall be computed by deducting both the dividends declared in the period on preferred stock (whether or not paid) from income from continuing operations (if that amount appears in the income statement) and also from net income. The computation of diluted EPS is similar to the computation of basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Revenue recognition</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company applies the provisions of Accounting Standards Codification (or &#8220;ASC&#8221;) 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;). The Company adopted the provisions of ASC 606 effective January 1, 2018 using the modified retrospective application method for all uncompleted contracts as of that date. The adoption of ASC 606 did not have a material impact on the Company&#8217;s consolidated financial statements. In addition, the adoption of ASC 606 had no impact on the Company&#8217;s trade receivables, deferred revenues and accumulated deficit balances balance as of December 31, 2018 or on the Company&#8217;s revenues, cost of revenues or its operating expenses during 2018, compared to ASC 605.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company generates revenues primarily by granting customers the right to access software products through the Company&#8217;s cloud-based SaaS subscription offerings. Under a SaaS subscription agreement, the customer receives a right to access the software for a specified period of time in an environment hosted, supported, and maintained by the Company. SaaS subscription services are a single performance obligation satisfied over time, and associated revenue is generally recognized ratably over the contract term once the software is made available to the customer. The SaaS subscription offerings are typically sold with one year subscription terms, generally invoiced in advance of each annual subscription period, and are non-cancelable during the committed subscription term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Research and development expenses, net:</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development expenses are charged to the statement of operations as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Income Taxes: </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221;, and (&#8220;ASC 740&#8221;). ASC 740 prescribes the use of the asset and liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities and for carry forward tax losses. Deferred taxes are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more-likely-than-not that some portion or all of the deferred tax asset will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 85.05pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, ASC 740 prescribes a recognition threshold and measurement attribute for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The first step is to evaluate the tax position taken or expected to be taken in a tax return. This is done by determining if the weight of available evidence indicates that it is more-likely-than-not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Contingencies</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company records accruals for loss contingencies arising from claims, litigation and other sources when it is probable that a liability has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.65in; text-align: justify"><b>Balances:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 2 0</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 1 9</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; text-align: justify">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right">&#160;</td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font-size: 10pt">Gix &#8211; Parent Company Payable</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">2,054</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1,611</font></td> <td>&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31,</b></font></td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 61%"><font style="font-size: 10pt">Salaries and related expense</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">55</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">219</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Others</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">53</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">14</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">108</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">233</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Salaries and related expense</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">7</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">110</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Others</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">147</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">257</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Wages, salaries and related expenses</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">214</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">276</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Professional fees</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">176</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">213</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Depreciation</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Recapitalization Transaction costs</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">112</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Other</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">42</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">118</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">437</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">720</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year ended December 31,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Bank fees</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">3</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Exchange rate differences</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(14</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">107</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Other financial income</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(12</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(13</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">98</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Composition:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the year ended December 31</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 2 0</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2 0 1 9</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt"><b>Basic and diluted:</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 66%; padding-bottom: 2.5pt"><font style="font-size: 10pt"><b>Net loss attributable to ordinary stockholders</b></font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right"><font style="font-size: 10pt">443</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 14%; text-align: right"><font style="font-size: 10pt">1,117</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Weighted-average ordinary shares</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">31,201,669</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">13,746,064</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt"><b>Loss per share-basic and diluted</b></font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.014</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.08</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> 1611000 50000 14459000 2054000 0.9983 0.9983 0.65 0.05 7298636 3649318 3649318 -61000 0.33 0.07 0.15 118000 20000 1000 43000 34000 9000 34000 9000 43000 38000 43000 91000 47000 149000 130000 6000 From November 2018 until the Closing Date, the employees that transferred from the Company to Algomizer dedicated half of their time to the Company's operations and correspondingly 50% of the costs to be incurred by Algomizer in respect of these employees are to be charged to the Company. 109200 55200 54000 100 0.4945 0.5055 99586 49246 50340 69000 -19000 20000 6000 -95000 -1000 8000 13000 -99000 174000 The Company believes these claims to be unsubstantiated and wholly without merit and accordingly filed its response with the Tel Aviv Court in October of 2017. The dispute was initially heard by the Tel Aviv Court on February 13, 2020. In a supplemental hearing on February 11, 2021 the former CEO provided data regarding his claims and his summaries were filed on that day. The Company's summaries will be filed within 30 days of receiving the former CEO summaries. As of December 31, 2020, the company's management, in consultation with its legal advisors, believes that the former CEO's claims will not be Successful. <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">%</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%"><font style="font-size: 10pt">Computers</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 15%; text-align: center"><font style="font-size: 10pt">33</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Furniture and office equipment</font></td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">7-15</font></td> <td>&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 62px; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note 6.</b></font></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Related Party Transactions.</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.65in; text-align: justify"><b>Balances:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31,</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31,</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2 0 2 0</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2 0 1 9</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 63%; text-align: justify">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right">&#160;</td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Gix &#8211; Parent Company Payable</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,054</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,611</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As part of the agreement with Gix, the parties agreed to have the Company&#8217;s operations outsourced to Gix from the agreement date and until the acquisition is consummated. The following term were included in the agreement pursuant to the above:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 72px">&#160;</td> <td style="width: 24px; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">(a)</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">From May 2018 all of the Company&#8217;s employees will become employees of Gix.</font></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">(b)</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Between the periods of May 2018 to October 2018, Gix will pay the full expenses of the employees as well as other related expenses.</font></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">(c)</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">From November 2018 until to the Closing Date, the employees transferred from the Company to Gix will dedicate half of their time to the Company&#8217;s operations and correspondingly 50% of the costs to be incurred by Gix in respect of these employees are to be charged to the Company.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From the closing date, the actual of the expenses incurred by Gix that related to the Company will be charged to the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">No amounts were paid by the Company to Gix during 2020 and 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The composition of short term loan balance as of the transaction is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 77%"><font style="font-size: 10pt">Principal amount</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">69</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Discount on Short term loan</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(19</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Short term loan, Net</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">50</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> 19000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 1. General </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 72px">&#160;</td> <td style="width: 48px; text-align: justify"><font style="font-size: 10pt"><b>A.</b></font></td> <td style="text-align: justify"><font style="font-size: 10pt"><b>Organizational Background</b></font></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Viewbix Inc. (formerly known as Virtual Crypto Technologies, Inc.) (the &#8220;Company&#8221;) was incorporated in the State of Ohio in 1989 under a predecessor name, Zaxis International, Inc. (&#8220;Zaxis&#8221;). On August 25, 1995, Zaxis merged with a subsidiary of The InFerGene Company, a Delaware corporation, which entity changed its name to Zaxis International, Inc. and the Company was reincorporated in Delaware under the name of Zaxis International, Inc. On December 30, 2014, Zaxis entered into an agreement with Emerald Medical Applications Ltd., a private limited liability company organized under the laws of the State of Israel (&#8220;Emerald Israel&#8221;).</font></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt"><b>B.</b></font></td> <td style="text-align: justify"><font style="font-size: 10pt"><b>Emerald Medical Applications Ltd.</b></font></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 16, 2015, Zaxis and Emerald Israel executed a share exchange agreement, which closed on July 14, 2015, and Emerald Israel became the Company&#8217;s wholly-owned subsidiary. Emerald Israel was engaged in the business of developing Emerald Israel&#8217;s DermaCompare technology and the development, sale and service of imaging solutions utilizing its DermaCompare software for use in derma imaging and analytics for the detection of skin cancer. On January 29, 2018, the Company ceased the DermaCompare operations of its former subsidiary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 2, 2018, the District Court of Lod, Israel issued a winding-up order for Emerald Israel and appointed an Israeli attorney as special executor for Emerald Israel.</p></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt"><b>C.</b></font></td> <td style="text-align: justify"><font style="font-size: 10pt"><b>Virtual Crypto Technologies Ltd.</b></font></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td style="text-align: justify">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td style="text-align: justify">&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 17, 2018, the Company formed a new wholly-owned subsidiary under the laws of the State of Israel, Virtual Crypto Technologies Ltd. (the &#8220;VCT Israel&#8221;), to develop and market software and hardware products facilitating, allowing and supporting purchase and/or sale of cryptocurrencies through ATMs, tablets, personal computers (&#8220;PCs&#8221;) and/or mobile devices.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">VCT Israel ceased its business operation prior to consummation of the Recapitalization Transaction. On January 27, 2020, Virtual Crypto Israel was sold to a third party for NIS 50,000 ($14,459).</p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 72px; text-align: justify">&#160;</td> <td style="width: 48px; text-align: justify"><font style="font-size: 10pt"><b>D.</b></font></td> <td style="text-align: justify"><font style="font-size: 10pt"><b>Transaction with Gix Internet Ltd. (formerly known as Algomizer Ltd.), or Gix (the &#8220;Recapitalization Transaction&#8221;)</b></font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">On June 6, 2020, Algomizer changed its name to Gix Internet Ltd., or Gix.</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">On February 7, 2019, the Company entered into a share exchange agreement (the &#8220;Share Exchange Agreement&#8221;) with Gix Internet Ltd. (TASE:ALMO), a company organized under the laws of the State of Israel (&#8220;Gix&#8221;), pursuant to which on July 25, 2019 (the &#8220;Closing Date&#8221;), Gix assigned, transferred and delivered its 99.83% holdings in Viewbix Ltd. (&#8220;Viewbix Israel&#8221;) to the Company in exchange for shares of restricted common stock of the Company, representing 65% of the issued and outstanding share capital of the Company on a fully diluted basis as of the Closing Date following the conversion of certain convertible notes of the Company and excluding certain warrants to purchase shares of the Common Stock expiring in 2020 and additional warrants as further described below (the &#8220;Fully Diluted Share Capital&#8221;). In addition, upon the earlier of: (a) the launch of a live video product to an American consumer in the United States by Viewbix Israel, or (b) the launch of an interactive television product to an American consumer in the United States by Viewbix Israel, the Company will issue to Gix an additional 1,642,193 shares of restricted common stock of the Company representing 5% of the Fully Diluted Share Capital immediately following the Closing Date.</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">On July 24, 2019, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of Delaware reflecting its name change from Virtual Crypto Technologies, Inc. to Viewbix Inc. to reflect its new operations and business focus and, effective on August 7, 2019, FINRA approved the Registrant&#8217;s name change and its trading symbol was changed from &#8220;VRCP&#8221; to &#8220;VBIX&#8221; on the OTCQB.</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">On the Closing Date, the Company (i) issued 20,281,085 shares of its common stock to Gix in exchange for consideration consisting of consideration for its 99.83% holdings in Viewbix Israel, and (ii) 3,434,889 shares of its common stock to holders of convertible notes, which were issued by the Company prior to the Reverse Recapitalization, and which were converted upon the Closing Date. The shares of common stock were issued under Regulation S. The Company also issued a total of 7,298,636 warrants to Gix to purchase the Company&#8217;s common stock, whereby (i) 3,649,318 of such warrants were issued with an exercise price of $0.48, and (ii) 3,649,318 of such warrants were issued with an exercise price of $0.80.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 72px; text-align: justify">&#160;</td> <td style="width: 48px; text-align: justify"><font style="font-size: 10pt"><b>D.</b></font></td> <td style="text-align: justify"><font style="font-size: 10pt"><b>Transaction with Gix Internet Ltd. (formerly known as Algomizer Ltd.), or Gix (the &#8220;Recapitalization Transaction&#8221;): (Cont.)</b></font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">As a result of the Recapitalization Transaction, Viewbix Israel became a subsidiary of the Company. As the shareholders of Viewbix Israel received the largest ownership interest in the Company, Viewbix Israel was determined to be the &#8220;accounting acquirer&#8221; in the Recapitalization Transaction. As a result, the historical financial statements of the Company were replaced with the historical financial statements of Viewbix Israel. The number of shares prior to the reverse recapitalization have been retroactively adjusted based on the equivalent number of shares received by the accounting acquirer in the Recapitalization Transaction.</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">The Company and its subsidiaries are collectively referred to as the &#8220;Company&#8221;. Viewbix Israel was incorporated on February 2006 in Israel. The Company has developed an interactive video platform based on Software as a Service (&#8220;SaaS&#8221;) business model with interactive elements, and the ability to collect and analyze information about each interactive action performed during the viewing of the video clip. The interactive elements and information gathered, allowing the advertiser to analyze user viewing habits and optimize real-time throughout the campaign while increasing the effectiveness of online and live video advertising.</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">On January 1, 2020, the Company announced certain cost reduction measures due the Company not achieving certain revenues goals.</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt"><b>E.</b></font></td> <td style="text-align: justify"><font style="font-size: 10pt"><b>Stock Subscription Agreement and Loan Agreement</b></font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">On December 18, 2020, the company entered into a Stock Subscription Agreement (the &#8220;Subscription&#8221;) with certain investors (the &#8220;Investors&#8221;) in connection with the sale and issuance of an aggregate of 3,000,000 shares of Common Stock, at a purchase price of $0.01 per share, and for an aggregate purchase price of $30,000. In addition, and on the same date, the company entered into a Loan Agreement (the &#8220;Loan&#8221;) with the Investors, pursuant to which the Investors lent an aggregate amount of $69,000 (the &#8220;Principal Amount&#8221;). In accordance with the terms of the Loan, the company repaid the interest on the Principal Amount (8% compounded annually) to the Investors as an issuance of 552,000 shares of Common Stock, at a price per share of $0.01. The shares of Common Stock were issued to the Investors pursuant to Regulation S of the Securities Act of 1933, as amended.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 72px; text-align: justify">&#160;</td> <td style="width: 48px; text-align: justify"><font style="font-size: 10pt"><b>F.</b></font></td> <td style="text-align: justify"><font style="font-size: 10pt"><b>Going Concern</b></font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">The Company has incurred $ 443 in net loss for the year ended December 31, 2020, has $2,078 stockholders&#8217; deficit as of December 31, 2020 and $1,693 in total stockholders&#8217; deficit as of December 31, 2019 and $61 in negative cash flows from operations for the year ended December 31, 2020. On July 25, 2019, the Company ceased the operations of VCT Israel and since January 2020, the Company has significantly reduced its operations and expenses of Viewbix Israel. Management expects the Company to continue to generate substantial operating losses and to continue to fund its operations primarily through utilization of its current financial resources and through additional raises of capital.</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Such conditions raise substantial doubts about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plan includes raising funds from outside potential investors. However, there is no assurance such funding will be available to the Company or that it will be obtained on terms favorable to the Company or will provide the Company with sufficient funds to meet its objectives. These financial statements do not include any adjustments relating to the recoverability and classification of assets, carrying amounts or the amount and classification of liabilities that may be required should the Company be unable to continue as a going concern.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE. 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The significant accounting policies used in the preparation of the financial statements are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Functional currency</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The functional currency of the Company and its subsidiary is the US dollar, which is the currency of the primary economic environment in which it operates. In accordance with ASC 830, &#8220;Foreign Currency Matters&#8221; (ASC 830), balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing at the applicable balance sheet date. For foreign currency transactions included in the statement of operations, the exchange rates applicable on the relevant transaction dates are used. Gains or losses arising from changes in the exchange rates used in the translation of such transactions are carried as financing income or expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Principles of consolidation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Cash and cash equivalents</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Group considers all short-term investments, which are highly liquid investments with original maturities of three months or less at the date of purchase, to be cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Property and equipment</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1. Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. When an asset is retired or otherwise disposed of, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected in the statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2. Rates of depreciation:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">%</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%"><font style="font-size: 10pt">Computers</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 15%; text-align: center"><font style="font-size: 10pt">33</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Furniture and office equipment</font></td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">7-15</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Impairment of long-lived assets</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s long-lived assets are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. To date the Group did not incur any material impairment losses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Share-based compensation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company applies ASC 718-10, &#8220;Share-Based Payment,&#8221; which requires the measurement and recognition of compensation expenses for all share-based payment awards made to employees and directors (including employee stock options under the Company&#8217;s stock plans) based on estimated fair values.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 718-10 requires companies to estimate the fair value of equity-based payment awards on the date of grant. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company&#8217;s statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes compensation expenses for the value of non-employee awards based on the straight-line method over the requisite service period of each award, net of estimated forfeitures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company estimates the fair value of stock options granted as equity awards using a Black-Scholes options pricing model. The option-pricing model requires a number of assumptions, of which the most significant are share price, expected volatility and the expected option term (the time from the grant date until the options are exercised or expire). Expected volatility is estimated based on volatility of similar companies in the technology sector. The Company has historically not paid dividends and has no foreseeable plans to issue dividends. The risk-free interest rate is based on the yield from governmental zero-coupon bonds with an equivalent term. The expected option term is calculated for options granted to employees and directors using the &#8220;simplified&#8221; method. Grants to non-employees are based on the contractual term. Changes in the determination of each of the inputs can affect the fair value of the options granted and the results of operations of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Earnings per Common Share</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Earnings or loss per share (&#8220;EPS&#8221;) is the amount of earnings attributable to each share of common stock. For convenience, the term is used to refer to either earnings or loss per share. EPS is computed pursuant to ASC 260-10-45. Pursuant to ASC 260-10-45-10 through 260-10-45-16 Basic EPS is computed by dividing income available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Income available to common stockholders shall be computed by deducting both the dividends declared in the period on preferred stock (whether or not paid) from income from continuing operations (if that amount appears in the income statement) and also from net income. The computation of diluted EPS is similar to the computation of basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Revenue recognition</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company applies the provisions of Accounting Standards Codification (or &#8220;ASC&#8221;) 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;). The Company adopted the provisions of ASC 606 effective January 1, 2018 using the modified retrospective application method for all uncompleted contracts as of that date. The adoption of ASC 606 did not have a material impact on the Company&#8217;s consolidated financial statements. In addition, the adoption of ASC 606 had no impact on the Company&#8217;s trade receivables, deferred revenues and accumulated deficit balances balance as of December 31, 2018 or on the Company&#8217;s revenues, cost of revenues or its operating expenses during 2018, compared to ASC 605.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company generates revenues primarily by granting customers the right to access software products through the Company&#8217;s cloud-based SaaS subscription offerings. Under a SaaS subscription agreement, the customer receives a right to access the software for a specified period of time in an environment hosted, supported, and maintained by the Company. SaaS subscription services are a single performance obligation satisfied over time, and associated revenue is generally recognized ratably over the contract term once the software is made available to the customer. The SaaS subscription offerings are typically sold with one year subscription terms, generally invoiced in advance of each annual subscription period, and are non-cancelable during the committed subscription term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Research and development expenses, net:</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development expenses are charged to the statement of operations as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Income Taxes: </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221;, and (&#8220;ASC 740&#8221;). ASC 740 prescribes the use of the asset and liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities and for carry forward tax losses. Deferred taxes are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more-likely-than-not that some portion or all of the deferred tax asset will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 85.05pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, ASC 740 prescribes a recognition threshold and measurement attribute for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The first step is to evaluate the tax position taken or expected to be taken in a tax return. This is done by determining if the weight of available evidence indicates that it is more-likely-than-not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Contingencies</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company records accruals for loss contingencies arising from claims, litigation and other sources when it is probable that a liability has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Recently issued accounting pronouncements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Financial Instruments &#8211; Credit Losses</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2016, the FASB issued ASU No. 2016-13, &#8220;Financial Instruments&#8212;Credit Losses (Topic 326).&#8221; The guidance replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The guidance will be effective for the Company&#8217;s fiscal year beginning January 1, 2023, including interim periods within that year. The Company is currently evaluating the potential effect of the adoption of ASU 2019-10 on our financial position and results of operations. The Company does not expect the adoption of this ASU to have a material impact on the Company&#8217;s financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Accounting for Income Taxes</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In December 2019, the FASB issued a new standard to simplify the accounting for income taxes. The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences related to changes in ownership of equity method investments and foreign subsidiaries. The guidance also simplifies aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard will be effective for us beginning July 1, 2021, with early adoption permitted. Adoption of the standard will not have a material impact on our consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Recently issued accounting pronouncements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Financial Instruments &#8211; Credit Losses</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2016, the FASB issued ASU No. 2016-13, &#8220;Financial Instruments&#8212;Credit Losses (Topic 326).&#8221; The guidance replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The guidance will be effective for the Company&#8217;s fiscal year beginning January 1, 2023, including interim periods within that year. The Company is currently evaluating the potential effect of the adoption of ASU 2019-10 on our financial position and results of operations. The Company does not expect the adoption of this ASU to have a material impact on the Company&#8217;s financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Accounting for Income Taxes</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In December 2019, the FASB issued a new standard to simplify the accounting for income taxes. The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences related to changes in ownership of equity method investments and foreign subsidiaries. The guidance also simplifies aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard will be effective for us beginning July 1, 2021, with early adoption permitted. Adoption of the standard will not have a material impact on our consolidated financial statements.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 62px; text-align: justify"><font style="font-size: 10pt"><b>Note 7.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt"><b>Short term loan and Issues of shares</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 18, 2020, the company entered into a Loan Agreement (the &#8220;Loan&#8221;) and Stock Subscription Agreement with certain Investors as described in note 1e, pursuant to which the Investors lent an aggregate amount of $69,000 (the &#8220;Principal Amount&#8221;). In accordance with the terms of the Loan, the company prepaid the interest on the Principal Amount of 8% compounded annually to the Investors as an issuance of 552,000 shares of Common Stock, at a price per share of $0.01. Under the Stock Subscription Agreement, the Investors transferred an amount of $ 30,587 to the company as consideration for the issued shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company allocated the total proceeds in respect of the shares issued and the Loan extended based on its relative fair values. As a result of the allocation, a discount of $19 was recorded on the loan. The discount is amortized over the term of the loan as finance expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The allocation of the proceeds to the fair value distribution of the liability and equity components on the transactions date was as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Instrument</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Fair Value</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>% of total fair</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Allocated</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>amount</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%"><font style="font-size: 10pt">Loan</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt"><b>55,200</b></font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt"><b>49.45</b></font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt"><b>49,246</b></font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Shares</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt"><b>54,000</b></font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt"><b>50.55</b></font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt"><b>50,340</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font-size: 10pt">Total</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt"><b>109,200</b></font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt"><b>100</b></font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt"><b>99,586</b></font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The composition of short term loan balance as of the transaction is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 77%"><font style="font-size: 10pt">Principal amount</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">69</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Discount on Short term loan</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(19</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Short term loan, Net</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">50</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 8. Stockholders&#8217; deficit.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Ordinary Shares:</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ordinary shares confer the right to participate in the general meetings, to one vote per share for any purpose, to an equal part, on share basis, in distribution of dividends and to equally participate, on share basis, in distribution of excess of assets and funds from the Company and they shall not confer other privileges unless stated hereunder or in the Companies Law otherwise. Some investors have standard anti-dilutive rights, registration rights, and information and representation rights.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 18, 2020, the company entered into a Stock Subscription Agreement (the &#8220;Subscription&#8221;) with certain investors (the &#8220;Investors&#8221;) in connection with the sale and issuance of an aggregate of 3,000,000 shares of Common Stock, at a purchase price of $0.01 per share, and for an aggregate purchase price of $30,000. In addition, and on the same date, the company entered into a Loan Agreement (the &#8220;Loan&#8221;) with the Investors, pursuant to which the Investors lent an aggregate amount of $69,000 (the &#8220;Principal Amount&#8221;). In accordance with the terms of the Loan, the company repaid the interest on the Principal Amount of 8% compounded annually to the Investors as an issuance of 552,000 shares of Common Stock, at a price per share of $0.01. The shares of Common Stock were issued to the Investors pursuant to Regulation S of the Securities Act of 1933, as amended. For more details, please see note 1e.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Preferred shares (relating to Viewbix Ltd the prior to the Recapitalization Transaction</i>)<i>:</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Preferred shares may have been converted into ordinary shares of Viewbix Ltd at any time. The preferred shares would have automatically converted into ordinary shares if (a) the holders of at least (i) 67% (sixty seven percent) of the issued and outstanding Preferred C/C-1 shares, (ii) a majority of the issued and outstanding Preferred B shares, and (iii) a majority of the issued and outstanding Preferred A shares, so agree in writing; or (b) in the event of an IPO.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The conversion price for any class or series of preferred would have been subject to adjustment, as follows: at any time, upon each issuance or deemed issuance by the Company of any new securities at a price per share less than the applicable conversion price in effect on the date of and immediately prior to the issuance of such new securities, the conversion price shall be reduced.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Preferred shares had priority in the distribution of dividends and upon liquidation in accordance with the Company&#8217;s Articles of Association (&#8220;AOA&#8221;). These rights may be changed if a meeting of the Company&#8217;s stockholders gather up and decides on a change of regulations in this context.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preference mechanism for liquidation and the distribution of dividends gave priority to the most recent preferred stockholders.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preferred shares were convertible into 16,199,520 ordinary shares of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Redemption</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s AOA do not provide redemption rights to the holders of the preferred shares. In the event of a liquidation event, all the funds and assets of the Company available for distribution among all the stockholders shall be distributed based on a certain mechanism as described in the Company&#8217;s AOA. Although the preferred shares are not redeemable, in the event of certain &#8220;deemed liquidation events&#8221; that are not solely within the Company&#8217;s control (including merger, acquisition, or sale of all or substantially all of the Company&#8217;s assets), the holders of the preferred shares would be entitled to preference amounts paid before distribution to other stockholders (as explained in the previous paragraph) and hence effectively redeeming the preference amount. In accordance with ASR 268 and ASC 480 &#8220;Distinguishing Liabilities from Equity&#8221;, the Company&#8217;s preferred shares are classified outside of stockholders&#8217; deficit as a result of these in-substance contingent redemption rights. As of December 31, 2019 and 2018, the Company did not adjust the carrying values of the convertible preferred shares to the deemed liquidation values of such shares since a liquidation event was not probable of occurring.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Share Exchange</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As detailed in Note 1, as part of the Recapitalization Transaction in July 2019, the Company issued 30,928,620 common shares in exchange for 99.83% of the issued and outstanding ordinary shares and all the preferred shares of Viewbix Israel. The number of shares prior to the reverse capitalization have been retroactively adjusted based on the equivalent number of shares received by the accounting acquirer in the Recapitalization Transaction.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Warrants</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes information of outstanding warrants as of December 31, 2020:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Warrants</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Warrant Term</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise Price</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercisable</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 26%"><font style="font-size: 10pt">Class J Warrants</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">3,649,318</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 18%; text-align: right"><font style="font-size: 10pt">July 2029</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font-size: 10pt">0.48</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font-size: 10pt">3,649,318</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Class K Warrants</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,649,318</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">July 2029</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.80</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,649,318</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt">Additionally, in connection with the Share Exchange Agreement, upon the earlier of: (a) the launch of a live video product to an American consumer in the United States by Viewbix Israel, or (b) the launch of an interactive television product to an American consumer in the United States by Viewbix Israel, the Company will issue to Gix an additional 1,642,193 shares of restricted common stock of the Company. All of the Company&#8217;s warrants meet the US GAAP criteria for equity classification. During January and March 2020, 50,000 class H warrants expired. During January 2020, 38,095 class I warrants expired. During April 2020, 142,857 Class G warrants expired.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The allocation of the proceeds to the fair value distribution of the liability and equity components on the transactions date was as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Instrument</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Fair Value</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>% of total fair</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Allocated</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>amount</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%"><font style="font-size: 10pt">Loan</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt"><b>55,200</b></font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt"><b>49.45</b></font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt"><b>49,246</b></font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Shares</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt"><b>54,000</b></font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt"><b>50.55</b></font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt"><b>50,340</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font-size: 10pt">Total</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt"><b>109,200</b></font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt"><b>100</b></font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt"><b>99,586</b></font></td> <td>&#160;</td></tr> </table> Representing an amount less than $ 1. EX-101.SCH 8 vbix-20201231.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Deficit link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - General link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Other Accounts Receivables link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Other Accounts Payables And Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Short Term Loan and Issues of Shares link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Stockholders Deficit link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Revenues link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Research and Development Expenses link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Sales and Marketing Expenses link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - General and Administrative Expenses link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Financing (Income) Expenses, Net link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Loss Per Share-Basic and Diluted link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - COVID-19 Pandemic Implications link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Other Accounts Receivables (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Other Accounts Payables and Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Related Party Transactions (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Short Term Loans and Issue of Shares (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Stockholders Deficit (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Revenues (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Research and Development Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Sales and Marketing Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - General and Administrative Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Financing (Income) Expenses, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Loss Per Share-Basic and Diluted (Tables) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - General (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Summary of Significant Accounting Policies - Schedule of Rates os Depreciation on Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Other Accounts Receivables - Schedule of Other Accounts Receivables (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Other Accounts Payables - Schedule of Other Accounts Payables and Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Related Party Transactions - Schedule of Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Short Term Loan and Issues of Shares (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Short Term Loan and Issues of Shares - Schedule of Fair Value Distribution of Liability and Equity Components (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Short Term Loan and Issues of Shares - Schedule of Composition of Short Term Loan (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Stockholders Deficit (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Stockholders Deficit - Summary of Outstanding Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Revenues - Schedule of Revenues (Details) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Research and Development Expenses - Schedule of Research and Development Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Sales and Marketing Expenses - Schedule of Sales and Marketing Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - General and Administrative Expenses - Schedule of General and Administrative Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - Financing (Income) Expenses, Net - Schedule of Financing (Income) Expenses, Net (Details) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - Income Taxes - Schedule of Deferred Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - Income Taxes - Schedule of Loss (Income) from Continuing Operations, Before Taxes on Income (Details) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - Loss Per Share-Basic and Diluted - Schedule of Loss Per Share-Basic and Diluted (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 vbix-20201231_cal.xml XBRL CALCULATION FILE EX-101.DEF 10 vbix-20201231_def.xml XBRL DEFINITION FILE EX-101.LAB 11 vbix-20201231_lab.xml XBRL LABEL FILE Type of Arrangement and Non-arrangement Transactions [Axis] Share Exchange Agreement [Member] Legal Entity [Axis] Gix Ltd [Member] Award Type [Axis] Restricted Common Stock [Member] Viewbix Ltd [Member] Title of Individual [Axis] Convertible Notes Holders [Member] Equity Components [Axis] Warrant One [Member] Warrant Two [Member] Property, Plant and Equipment, Type [Axis] Computers and Related Equipment [Member] Office Furniture and Equipment [Member] Income Tax Authority, Name [Axis] Israeli Corporate Tax [Member] Income Tax Authority [Axis] USA [Member] Israel [Member] Class of Stock [Axis] Preferred Stock A-1 [Member] Preferred Stock A-2 [Member] Preferred Stock B [Member] Prefered Stock C [Member] Preferred Stock C-1 [Member] Preferred Stock C-2 [Member] Total Temporary Equity [Member] Additional Paid-in Capital [Member] Accumulated Stockholders' Deficit [Member] Product and Service [Axis] Individual Subscriptions [Member] Enterprise Subscriptions [Member] Income Statement Location [Axis] Salaries and Related Expense [Member] Other [Member] Credit Facility [Axis] Bank Fees [Member] Exchange Rate Differences [Member] Other Financial Income [Member] Ordinary Shares [Member] Virtual Crypto Israel [Member] NIS [Member] Class H Warrants [Member] Class I Warrants [Member] Class J Warrants [Member] Class K Warrants [Member] Viewbix Israel [Member] Geographical [Axis] US [Member] Class G Warrants [Member] Litigation Status [Axis] Tel Aviv District Court [Member] Employees [Member] Stock Subscription Agreement [Member] Related Party [Axis] Investor [Member] Loan Agreement [Member] Computers [Member] Furniture And Office Equipment [Member] Range [Axis] Minimum [Member] Maximum [Member] Loan and Stock Subscription Agreement [Member] Investors [Member] Debt Instrument [Axis] Loan [Member] Shares [Member] Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash and cash equivalents Restricted cash Trade receivables Other accounts receivable Prepaid expenses Total current assets NON CURRENT ASSETS Property and equipment, net Total assets LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS' DEFICIT CURRENT LIABILITIES Trade payables Other accounts payable and accrued liabilities Payable to parent company Short term loan Total current liabilities Commitments and contingencies STOCKHOLDERS' DEFICIT Share Capital Common stock, $0.0001 par value; 490,000,000 shares authorized; 34,753,669 shares issued and outstanding at December 31, 2020 and 31,201,669 at December 31, 2019 Additional paid-in capital Accumulated deficit Total stockholders' deficit Total liabilities, temporary equity and stockholders' deficit Common stock , par value Common stock, shares authorized Common stock, shares issued Common stock , shares outstanding Income Statement [Abstract] Revenues Cost of revenues Gross profit Expenses: Research and development Sales and marketing General and administrative Gain from sale of a subsidiary Total operating expenses Loss from operations Finance income Finance expense Loss Before taxes on income Taxes on income Net Loss Basic and diluted net loss per share: Weighted average shares outstanding - basic and diluted Statement [Table] Statement [Line Items] Balance Balance, shares Effect of reverse recapitalization Effect of reverse recapitalization, shares Issuance of shares Issuance of shares, shares Net loss for the period Balance Balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Depreciation Changes in operating assets and liabilities: Decrease (Increase) in trade receivables and prepaid expenses Decrease (Increase) in other accounts receivable Increase (decrease) in trade payables Increase in payable to parent company (See Note 6) Increase (decrease) in other accounts payables and accrued liabilities Net cash used in operating activities Cash flows from investing activities Cash received from the sale of a subsidiary Purchase of property and equipment Proceeds from sale of property and equipment Net cash used in investing activities Cash flows from financing activities Cash acquired in connection with the reverse recapitalization Issuance of shares Short term loan received Net cash provided by financing activities Increase (decrease) in cash and cash equivalents and restricted cash Cash and cash equivalents and restricted cash at the beginning of the period Cash and cash equivalents and restricted cash at the end of the period Supplemental information for Cash Flow: Assets acquired (liabilities assumed): Current assets excluding cash and cash equivalents Current liabilities Gain from sale of a subsidiary Cash received from the sale of a subsidiary Reverse recapitalization effect on equity Cash acquired in connection with Recapitalization Transaction Accounting Policies [Abstract] General Summary of Significant Accounting Policies Debt Disclosure [Abstract] Other Accounts Receivables Property, Plant and Equipment [Abstract] Property and Equipment Payables and Accruals [Abstract] Other Accounts Payables and Accrued Liabilities Related Party Transactions [Abstract] Related Party Transactions Short Term Loan and Issues of Shares Equity [Abstract] Stockholders Deficit Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Revenues [Abstract] Revenues Research and Development [Abstract] Research and development expenses Sales And Marketing Expenses Sales and Marketing Expenses General And Administrative Expenses General and Administrative Expenses Financing Income Expenses Net Financing (Income) Expenses, Net Income Tax Disclosure [Abstract] Income Taxes Earnings Per Share [Abstract] Loss Per Share-Basic and Diluted Covid-19 Pandemic Implications COVID-19 Pandemic Implications Functional Currency Principles of Consolidation Cash and Cash Equivalents Property and Equipment Impairment of Long-lived Assets Share-based compensation Earnings Per Common Share Revenue Recognition Research and Development Expenses, Net Income Taxes Contingencies Recently Issued Accounting Pronouncements Schedule of Rates of Depreciation on Property and Equipment Schedule of Other Accounts Receivables Composition Schedule of Property and Equipment Schedule of Other Accounts Payables and Accrued Liabilities Related Party Transactions Schedule of Related Party Transactions Schedule of Fair Value Distribution of Liability and Equity Components Schedule of Composition of Short Term Loan Summary of Outstanding Warrants Schedule of Revenues Schedule of Research and Development Expenses Schedule of Sales and Marketing Expenses Schedule of General and Administrative Expenses Schedule of Financing (Income) Expenses, Net Schedule of Deferred Income Taxes Schedule of Loss (Income) from Continuing Operations, Before Taxes on Income Schedule of Loss Per Share-Basic and Diluted Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Due to related party Ownership percentage Share issued and outstanding, percentage Number of stock issued Fully diluted share capital, percentage Warrants to purchase common stock Warrants exercise price Net loss Stockholders' deficit Common stock purchase price per share Sale of issuance common stock value Debt instrument face amount Debt instrument stated percentage Cash flow from operation Long-Lived Tangible Asset [Axis] Statistical Measurement [Axis] Rates of depreciation Government authorities Other Total Property and equipment, gross Accumulated depreciation Net book value Other payables and deferred revenues Accrued liabilities Other Total other accounts payables Related party description Due to related party Gix - Parent Company Payable Debt Instrument face amount Issuance of common stock shares Common stock price per share Transferred amount Loan discount Fair Value Percentage of fair value Allocated amount Principal amount Discount on Short term loan Short term loan, Net Common stock shares voting description Number of common stock issued Sale of stock, price per share Aggregate purchase price Debt instrument, face amount Debt instrument, interest rate Preferred shares conversion description Conversion of preferred stock into common shares Preferred shares, outstanding Deemed to issued common shares Shares exchange rate Number of restricted common stock shares issued Number of warrants expired during period Warrants Warrant Term Warrant Exercise Price Warrant Exercisable Number of common stock issuable Claiming of damages value Loss contingency description Sales and marketing expenses General And Administrative Expenses - Schedule Of General And Administrative Expenses Wages, salaries and related expenses Professional fees Recapitalization Transaction costs Other General and administrative expenses Financing (income) expenses, net Income tax examination description Corporate tax rate Valuation allowances, deferred tax assets Operating loss carryforwards Deferred R&D expenses Operating loss carryforward Total Net deferred tax asset before valuation allowance Valuation allowance Net deferred tax asset Total loss before taxes on income Net loss attributable to ordinary stockholders Weighted-average ordinary shares Loss per share-basic and diluted Algomizer Ltd [Member] Bank Fees [Member] Cash acquired in connection with Recapitalization Transaction. Class G Warrant [Member] Class G Warrants [Member] Class H warrant [Member] Class H Warrants [Member] Class I Warrant [Member] Class I Warrants [Member] Class J Warrant [Member]. Class J Warrants [Member] Class K Warrant [Member]. Class K Warrants [Member] Computers [Member] Convertible Notes Holders [Member] COVID-19 pandemic implications [Text Block] Current assets excluding cash and cash equivalents. Deemed to issued common shares. Effect of reverse recapitalization. Effect of reverse recapitalization, shares. Employees [Member]. Enterprise Subscriptions [Member] Exchange Rate Differences [Member] Finance expense. Finance income. Financing (Income) Expenses, Net. Financing (Income) Expenses, Net. Former Employees [Member]. Furniture And Office Equipment [Member] Gain from sale of a subsidiary General and administrative expenses [Text Block] Gix Ltd [Member] Increase (decrease) in other accounts payables and accrued liabilities. Individual Subscriptions [Member] Current liabilities assumed. Loan Agreement [Member] Loss contingency description. Mr. Wayn [Member] NIS [Member] Ordinary Shares [Member] Other accounts receivables [Text Block] Other Financial Income [Member] Other [Member] Preferred Stock A-1 [Member]. Preferred Stock A-2 [Member]. Preferred Stock B [Member]. Prefered Stock C [Member]. Preferred Stock C-1 [Member]. Preferred Stock C-2 [Member]. Cash acquired in connection with the reverse recapitalization. Revenues [Disclosure Text Block]. Reverse recapitalization effect on equity. Salaries and Related Expense [Member] Seles and Marketing Expenses [Disclosure Text Block]. Schedule of General and Administrative Expenses [Table Text Block]. Schedule of other accounts receivables composition [Table Text Block] Schedule of Research and Development Expenses [Table Text Block] Schedule of Sales and Marketing Expenses [Table Text Block]. Series A-1 Preferred Convertible Stock [Member]. Series A Preferrred Convertible Stock [Member] Series A-2 Preferred Convertible Stock [Member]. Series B Preferred Convertible Stock [Member]. Series C-1 Preferred Convertible Stock [Member]. Series C Preferred Convertible Stock [Member]. Series C-2 Preferred Convertible Stock [Member]. Number of warrants expired during period. Share Capital. Share Exchange Agreement [Member] Stock Subscription Agreement [Member] Supplemental cash flow, cash received from the sale of a subsidiary. Supplemental gain from sale of a subsidiary. Tac Cuts and Jobs Act [Member]. Tel Aviv District Court [Member] Shares exchange rate. Total Temporary Equity [Member]. Viewbix Israel [Member] Viewbix Ltd [Member] Virtual Crypto Israel [Member] Warrant Exercisable. Warrant One [Member] Warrant term. Warrant Two [Member] Share issued and outstanding, percentage. Fully diluted share capital, percentage. Net cash provided by used in operating activities excluding gain from sale of subsidiary. Government authorities. Other receivables current. Other payables and deferred revenues. Loan And Stock Subscription Agreement [Member] Investors [Member] Short Term Loan [Member] Investment Shares [Member] Percentage of fair value. Allocated amount. Short term loan. Discount on Short term loan. Assets acquired (liabilities assumed). Schedule of Property and Equipment Rates of Depreciation [Table Text Block]. Schedule of Fair Value Distribution of The Liability and Equity Components On Transactions Date. Assets, Current Assets Liabilities, Current Liabilities and Equity Gross Profit GainFromSaleOfSubsidiary Operating Expenses Operating Income (Loss) FinanceExpense Shares, Outstanding Increase (Decrease) in Prepaid Expense Increase (Decrease) in Other Receivables Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations SupplementalCashReceivedFromSaleOfSubsidiaries RevenueDisclosureTextBlock Property, Plant and Equipment, Policy [Policy Text Block] Income Tax, Policy [Policy Text Block] Due to Related Parties Other Accrued Liabilities Other General and Administrative Expense Deferred Tax Assets, Operating Loss Carryforwards Deferred Tax Assets, Net of Valuation Allowance EX-101.PRE 12 vbix-20201231_pre.xml XBRL PRESENTATION FILE XML 13 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Document and Entity Information - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Mar. 15, 2021
Jun. 30, 2020
Cover [Abstract]      
Entity Registrant Name Viewbix Inc.    
Entity Central Index Key 0000797542    
Document Type 10-K    
Document Period End Date Dec. 31, 2020    
Amendment Flag false    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting status Yes    
Entity Interactive Data Current No    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 344,778
Entity Common Stock, Shares Outstanding   34,753,669  
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2020    
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
CURRENT ASSETS    
Cash and cash equivalents $ 148 $ 87
Restricted cash 2
Trade receivables 15
Other accounts receivable 20 119
Prepaid expenses 42 17
Total current assets 225 225
NON CURRENT ASSETS    
Property and equipment, net 5
Total assets 225 230
CURRENT LIABILITIES    
Trade payables 22 66
Other accounts payable and accrued liabilities 177 246
Payable to parent company 2,054 1,611
Short term loan 50
Total current liabilities 2,303 1,923
Share Capital    
Common stock, $0.0001 par value; 490,000,000 shares authorized; 34,753,669 shares issued and outstanding at December 31, 2020 and 31,201,669 at December 31, 2019 3 3
Additional paid-in capital 13,073 13,015
Accumulated deficit (15,154) (14,711)
Total stockholders' deficit (2,078) (1,693)
Total liabilities, temporary equity and stockholders' deficit $ 225 $ 230
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2020
Dec. 31, 2019
Statement of Financial Position [Abstract]    
Common stock , par value $ 0.0001 $ 0.0001
Common stock, shares authorized 490,000,000 490,000,000
Common stock, shares issued 34,753,669 31,201,669
Common stock , shares outstanding 34,753,669 31,201,669
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]    
Revenues $ 96 $ 208
Cost of revenues 5 2
Gross profit 91 206
Expenses:    
Research and development 108 233
Sales and marketing 8 257
General and administrative 437 720
Gain from sale of a subsidiary (8)
Total operating expenses 545 1,210
Loss from operations (454) (1,004)
Finance income (20) (12)
Finance expense 7 110
Loss Before taxes on income (441) (1,102)
Taxes on income 2 15
Net Loss $ (443) $ (1,117)
Basic and diluted net loss per share: $ (0.014) $ (0.08)
Weighted average shares outstanding - basic and diluted 31,201,669 13,746,064
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Changes in Stockholders' Deficit - USD ($)
$ in Thousands
Preferred Stock A-1 [Member]
Preferred Stock A-2 [Member]
Preferred Stock B [Member]
Prefered Stock C [Member]
Preferred Stock C-1 [Member]
Preferred Stock C-2 [Member]
Total Temporary Equity [Member]
Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Accumulated Stockholders' Deficit [Member]
Total
Balance at Dec. 31, 2018 [1] $ 10 $ 9 $ 15 $ 11 $ 1 $ 46 $ 1 $ 12,872 $ (13,594) $ (721)
Balance, shares at Dec. 31, 2018 199,870 4,881,654 4,556,094 7,222,305 2,755,706 392,407   279,049      
Effect of reverse recapitalization $ (10) $ (9) $ (15) $ (11) $ (1) (46) $ 2 143 145
Effect of reverse recapitalization, shares (199,870) (4,881,654) (4,556,094) (7,222,305) (2,755,708) (392,407)   30,928,620      
Issuance of shares
Issuance of shares, shares
Net loss for the period $ (1,117) $ (1,117)
Balance at Dec. 31, 2019 $ 3 13,015 (14,711) (1,693)
Balance, shares at Dec. 31, 2019 31,201,669      
Effect of reverse recapitalization
Effect of reverse recapitalization, shares
Issuance of shares $ 58 $ 58
Issuance of shares, shares 3,552,000      
Net loss for the period (443) (443)
Balance at Dec. 31, 2020 $ 3 $ 13,073 $ (15,154) $ (2,078)
Balance, shares at Dec. 31, 2020   34,753,669      
[1] Representing an amount less than $ 1.
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Feb. 12, 2020
Jul. 25, 2019
Cash flows from operating activities        
Net loss for the period $ (443) $ (1,117)    
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:        
Gain from sale of a subsidiary (8)    
Depreciation 5 1    
Changes in operating assets and liabilities:        
Decrease (Increase) in trade receivables and prepaid expenses (40) 5    
Decrease (Increase) in other accounts receivable 100 (21)    
Increase (decrease) in trade payables (55) 36    
Increase in payable to parent company (See Note 6) 443 822    
Increase (decrease) in other accounts payables and accrued liabilities (55) 139    
Net cash used in operating activities (53) (135)    
Cash flows from investing activities        
Cash received from the sale of a subsidiary 13    
Purchase of property and equipment (2)    
Proceeds from sale of property and equipment 1    
Net cash used in investing activities 13 (1)    
Cash flows from financing activities        
Cash acquired in connection with the reverse recapitalization 174    
Issuance of shares 49    
Short term loan received 50    
Net cash provided by financing activities 99 174    
Increase (decrease) in cash and cash equivalents and restricted cash 59 38    
Cash and cash equivalents and restricted cash at the beginning of the period 89 51    
Cash and cash equivalents and restricted cash at the end of the period $ 148 $ 89    
Assets acquired (liabilities assumed):        
Current assets excluding cash and cash equivalents     $ 6 $ 20
Current liabilities     (1) (95)
Gain from sale of a subsidiary     8
Cash received from the sale of a subsidiary     13
Reverse recapitalization effect on equity     (99)
Cash acquired in connection with Recapitalization Transaction     $ 174
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.20.4
General
12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
General

Note 1. General

 

  A. Organizational Background
     
    Viewbix Inc. (formerly known as Virtual Crypto Technologies, Inc.) (the “Company”) was incorporated in the State of Ohio in 1989 under a predecessor name, Zaxis International, Inc. (“Zaxis”). On August 25, 1995, Zaxis merged with a subsidiary of The InFerGene Company, a Delaware corporation, which entity changed its name to Zaxis International, Inc. and the Company was reincorporated in Delaware under the name of Zaxis International, Inc. On December 30, 2014, Zaxis entered into an agreement with Emerald Medical Applications Ltd., a private limited liability company organized under the laws of the State of Israel (“Emerald Israel”).
     
  B. Emerald Medical Applications Ltd.
     
   

On March 16, 2015, Zaxis and Emerald Israel executed a share exchange agreement, which closed on July 14, 2015, and Emerald Israel became the Company’s wholly-owned subsidiary. Emerald Israel was engaged in the business of developing Emerald Israel’s DermaCompare technology and the development, sale and service of imaging solutions utilizing its DermaCompare software for use in derma imaging and analytics for the detection of skin cancer. On January 29, 2018, the Company ceased the DermaCompare operations of its former subsidiary.

 

On May 2, 2018, the District Court of Lod, Israel issued a winding-up order for Emerald Israel and appointed an Israeli attorney as special executor for Emerald Israel.

     
  C. Virtual Crypto Technologies Ltd.
     
   

On January 17, 2018, the Company formed a new wholly-owned subsidiary under the laws of the State of Israel, Virtual Crypto Technologies Ltd. (the “VCT Israel”), to develop and market software and hardware products facilitating, allowing and supporting purchase and/or sale of cryptocurrencies through ATMs, tablets, personal computers (“PCs”) and/or mobile devices.

 

VCT Israel ceased its business operation prior to consummation of the Recapitalization Transaction. On January 27, 2020, Virtual Crypto Israel was sold to a third party for NIS 50,000 ($14,459).

 

  D. Transaction with Gix Internet Ltd. (formerly known as Algomizer Ltd.), or Gix (the “Recapitalization Transaction”)
     
    On June 6, 2020, Algomizer changed its name to Gix Internet Ltd., or Gix.
     
    On February 7, 2019, the Company entered into a share exchange agreement (the “Share Exchange Agreement”) with Gix Internet Ltd. (TASE:ALMO), a company organized under the laws of the State of Israel (“Gix”), pursuant to which on July 25, 2019 (the “Closing Date”), Gix assigned, transferred and delivered its 99.83% holdings in Viewbix Ltd. (“Viewbix Israel”) to the Company in exchange for shares of restricted common stock of the Company, representing 65% of the issued and outstanding share capital of the Company on a fully diluted basis as of the Closing Date following the conversion of certain convertible notes of the Company and excluding certain warrants to purchase shares of the Common Stock expiring in 2020 and additional warrants as further described below (the “Fully Diluted Share Capital”). In addition, upon the earlier of: (a) the launch of a live video product to an American consumer in the United States by Viewbix Israel, or (b) the launch of an interactive television product to an American consumer in the United States by Viewbix Israel, the Company will issue to Gix an additional 1,642,193 shares of restricted common stock of the Company representing 5% of the Fully Diluted Share Capital immediately following the Closing Date.
     
    On July 24, 2019, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of Delaware reflecting its name change from Virtual Crypto Technologies, Inc. to Viewbix Inc. to reflect its new operations and business focus and, effective on August 7, 2019, FINRA approved the Registrant’s name change and its trading symbol was changed from “VRCP” to “VBIX” on the OTCQB.
     
    On the Closing Date, the Company (i) issued 20,281,085 shares of its common stock to Gix in exchange for consideration consisting of consideration for its 99.83% holdings in Viewbix Israel, and (ii) 3,434,889 shares of its common stock to holders of convertible notes, which were issued by the Company prior to the Reverse Recapitalization, and which were converted upon the Closing Date. The shares of common stock were issued under Regulation S. The Company also issued a total of 7,298,636 warrants to Gix to purchase the Company’s common stock, whereby (i) 3,649,318 of such warrants were issued with an exercise price of $0.48, and (ii) 3,649,318 of such warrants were issued with an exercise price of $0.80.

 

  D. Transaction with Gix Internet Ltd. (formerly known as Algomizer Ltd.), or Gix (the “Recapitalization Transaction”): (Cont.)
     
    As a result of the Recapitalization Transaction, Viewbix Israel became a subsidiary of the Company. As the shareholders of Viewbix Israel received the largest ownership interest in the Company, Viewbix Israel was determined to be the “accounting acquirer” in the Recapitalization Transaction. As a result, the historical financial statements of the Company were replaced with the historical financial statements of Viewbix Israel. The number of shares prior to the reverse recapitalization have been retroactively adjusted based on the equivalent number of shares received by the accounting acquirer in the Recapitalization Transaction.
     
    The Company and its subsidiaries are collectively referred to as the “Company”. Viewbix Israel was incorporated on February 2006 in Israel. The Company has developed an interactive video platform based on Software as a Service (“SaaS”) business model with interactive elements, and the ability to collect and analyze information about each interactive action performed during the viewing of the video clip. The interactive elements and information gathered, allowing the advertiser to analyze user viewing habits and optimize real-time throughout the campaign while increasing the effectiveness of online and live video advertising.
     
    On January 1, 2020, the Company announced certain cost reduction measures due the Company not achieving certain revenues goals.
     
  E. Stock Subscription Agreement and Loan Agreement
     
    On December 18, 2020, the company entered into a Stock Subscription Agreement (the “Subscription”) with certain investors (the “Investors”) in connection with the sale and issuance of an aggregate of 3,000,000 shares of Common Stock, at a purchase price of $0.01 per share, and for an aggregate purchase price of $30,000. In addition, and on the same date, the company entered into a Loan Agreement (the “Loan”) with the Investors, pursuant to which the Investors lent an aggregate amount of $69,000 (the “Principal Amount”). In accordance with the terms of the Loan, the company repaid the interest on the Principal Amount (8% compounded annually) to the Investors as an issuance of 552,000 shares of Common Stock, at a price per share of $0.01. The shares of Common Stock were issued to the Investors pursuant to Regulation S of the Securities Act of 1933, as amended.

 

  F. Going Concern
     
    The Company has incurred $ 443 in net loss for the year ended December 31, 2020, has $2,078 stockholders’ deficit as of December 31, 2020 and $1,693 in total stockholders’ deficit as of December 31, 2019 and $61 in negative cash flows from operations for the year ended December 31, 2020. On July 25, 2019, the Company ceased the operations of VCT Israel and since January 2020, the Company has significantly reduced its operations and expenses of Viewbix Israel. Management expects the Company to continue to generate substantial operating losses and to continue to fund its operations primarily through utilization of its current financial resources and through additional raises of capital.
     
    Such conditions raise substantial doubts about the Company’s ability to continue as a going concern. Management’s plan includes raising funds from outside potential investors. However, there is no assurance such funding will be available to the Company or that it will be obtained on terms favorable to the Company or will provide the Company with sufficient funds to meet its objectives. These financial statements do not include any adjustments relating to the recoverability and classification of assets, carrying amounts or the amount and classification of liabilities that may be required should the Company be unable to continue as a going concern.
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

NOTE. 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The significant accounting policies used in the preparation of the financial statements are as follows:

 

Functional currency

 

The functional currency of the Company and its subsidiary is the US dollar, which is the currency of the primary economic environment in which it operates. In accordance with ASC 830, “Foreign Currency Matters” (ASC 830), balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing at the applicable balance sheet date. For foreign currency transactions included in the statement of operations, the exchange rates applicable on the relevant transaction dates are used. Gains or losses arising from changes in the exchange rates used in the translation of such transactions are carried as financing income or expenses.

 

Principles of consolidation

 

The consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions have been eliminated in consolidation.

 

Cash and cash equivalents

 

The Group considers all short-term investments, which are highly liquid investments with original maturities of three months or less at the date of purchase, to be cash equivalents.

 

Property and equipment

 

1. Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. When an asset is retired or otherwise disposed of, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected in the statements of operations.

 

2. Rates of depreciation:

 

    %  
Computers     33  
Furniture and office equipment     7-15  

 

Impairment of long-lived assets

 

The Company’s long-lived assets are reviewed for impairment in accordance with ASC 360, “Property, Plant and Equipment”, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. To date the Group did not incur any material impairment losses.

 

Share-based compensation

 

The Company applies ASC 718-10, “Share-Based Payment,” which requires the measurement and recognition of compensation expenses for all share-based payment awards made to employees and directors (including employee stock options under the Company’s stock plans) based on estimated fair values.

 

ASC 718-10 requires companies to estimate the fair value of equity-based payment awards on the date of grant. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company’s statement of operations.

 

The Company recognizes compensation expenses for the value of non-employee awards based on the straight-line method over the requisite service period of each award, net of estimated forfeitures.

 

The Company estimates the fair value of stock options granted as equity awards using a Black-Scholes options pricing model. The option-pricing model requires a number of assumptions, of which the most significant are share price, expected volatility and the expected option term (the time from the grant date until the options are exercised or expire). Expected volatility is estimated based on volatility of similar companies in the technology sector. The Company has historically not paid dividends and has no foreseeable plans to issue dividends. The risk-free interest rate is based on the yield from governmental zero-coupon bonds with an equivalent term. The expected option term is calculated for options granted to employees and directors using the “simplified” method. Grants to non-employees are based on the contractual term. Changes in the determination of each of the inputs can affect the fair value of the options granted and the results of operations of the Company.

 

Earnings per Common Share

 

Earnings or loss per share (“EPS”) is the amount of earnings attributable to each share of common stock. For convenience, the term is used to refer to either earnings or loss per share. EPS is computed pursuant to ASC 260-10-45. Pursuant to ASC 260-10-45-10 through 260-10-45-16 Basic EPS is computed by dividing income available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Income available to common stockholders shall be computed by deducting both the dividends declared in the period on preferred stock (whether or not paid) from income from continuing operations (if that amount appears in the income statement) and also from net income. The computation of diluted EPS is similar to the computation of basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.

 

Revenue recognition

 

The Company applies the provisions of Accounting Standards Codification (or “ASC”) 606, Revenue from Contracts with Customers (“ASC 606”). The Company adopted the provisions of ASC 606 effective January 1, 2018 using the modified retrospective application method for all uncompleted contracts as of that date. The adoption of ASC 606 did not have a material impact on the Company’s consolidated financial statements. In addition, the adoption of ASC 606 had no impact on the Company’s trade receivables, deferred revenues and accumulated deficit balances balance as of December 31, 2018 or on the Company’s revenues, cost of revenues or its operating expenses during 2018, compared to ASC 605.

 

The Company generates revenues primarily by granting customers the right to access software products through the Company’s cloud-based SaaS subscription offerings. Under a SaaS subscription agreement, the customer receives a right to access the software for a specified period of time in an environment hosted, supported, and maintained by the Company. SaaS subscription services are a single performance obligation satisfied over time, and associated revenue is generally recognized ratably over the contract term once the software is made available to the customer. The SaaS subscription offerings are typically sold with one year subscription terms, generally invoiced in advance of each annual subscription period, and are non-cancelable during the committed subscription term.

 

Research and development expenses, net:

 

Research and development expenses are charged to the statement of operations as incurred.

 

Income Taxes:

 

The Company accounts for income taxes in accordance with ASC 740, “Income Taxes”, and (“ASC 740”). ASC 740 prescribes the use of the asset and liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities and for carry forward tax losses. Deferred taxes are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more-likely-than-not that some portion or all of the deferred tax asset will not be realized.

 

In addition, ASC 740 prescribes a recognition threshold and measurement attribute for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The first step is to evaluate the tax position taken or expected to be taken in a tax return. This is done by determining if the weight of available evidence indicates that it is more-likely-than-not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement.

 

Contingencies

 

The Company records accruals for loss contingencies arising from claims, litigation and other sources when it is probable that a liability has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.

 

Recently issued accounting pronouncements

 

Financial Instruments – Credit Losses

 

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments—Credit Losses (Topic 326).” The guidance replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The guidance will be effective for the Company’s fiscal year beginning January 1, 2023, including interim periods within that year. The Company is currently evaluating the potential effect of the adoption of ASU 2019-10 on our financial position and results of operations. The Company does not expect the adoption of this ASU to have a material impact on the Company’s financial statements.

 

Accounting for Income Taxes

 

In December 2019, the FASB issued a new standard to simplify the accounting for income taxes. The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences related to changes in ownership of equity method investments and foreign subsidiaries. The guidance also simplifies aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard will be effective for us beginning July 1, 2021, with early adoption permitted. Adoption of the standard will not have a material impact on our consolidated financial statements.

XML 21 R9.htm IDEA: XBRL DOCUMENT v3.20.4
Other Accounts Receivables
12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
Other Accounts Receivables
Note 3. Other Accounts receivables

 

Composition:

 

   

As of

December 30

   

As of

December 31

 
    2 0 2 0     2 0 1 9  
             
Government authorities   $ 20     $ 118  
Other     -       1  
    $ 20     $ 119  
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.20.4
Property and Equipment
12 Months Ended
Dec. 31, 2020
Property, Plant and Equipment [Abstract]  
Property and Equipment
Note 4. Property and equipment

 

Composition:

 

   

As of

December 30

   

As of

December 31

 
    2 0 2 0     2 0 1 9  
             
Cost:                
Computers and related equipment   $ 34     $ 34  
Office furniture and equipment     9       9  
      43       43  
                 
Accumulated depreciation     43       38  
                 
Net book value   $ -     $ 5  
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.20.4
Other Accounts Payables And Accrued Liabilities
12 Months Ended
Dec. 31, 2020
Payables and Accruals [Abstract]  
Other Accounts Payables and Accrued Liabilities
Note 5. Other accounts payable and accrued liabilities

 

Composition:

 

   

As of

December 30

   

As of

December 31

 
    2 0 2 0     2 0 1 9  
             
Other payables and deferred revenues   $ 47     $ 91  
Accrued liabilities     130       149  
Other     -       6  
    $ 177     $ 246  
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.20.4
Related Party Transactions
12 Months Ended
Dec. 31, 2020
Related Party Transactions [Abstract]  
Related Party Transactions
Note 6. Related Party Transactions.

 

Balances:

 

    December 31,     December 31,  
    2 0 2 0     2 0 1 9  
                 
Gix – Parent Company Payable   $ 2,054     $ 1,611  

 

As part of the agreement with Gix, the parties agreed to have the Company’s operations outsourced to Gix from the agreement date and until the acquisition is consummated. The following term were included in the agreement pursuant to the above:

 

  (a) From May 2018 all of the Company’s employees will become employees of Gix.
  (b) Between the periods of May 2018 to October 2018, Gix will pay the full expenses of the employees as well as other related expenses.
  (c) From November 2018 until to the Closing Date, the employees transferred from the Company to Gix will dedicate half of their time to the Company’s operations and correspondingly 50% of the costs to be incurred by Gix in respect of these employees are to be charged to the Company.

 

From the closing date, the actual of the expenses incurred by Gix that related to the Company will be charged to the Company.

 

No amounts were paid by the Company to Gix during 2020 and 2019.

XML 25 R13.htm IDEA: XBRL DOCUMENT v3.20.4
Short Term Loan and Issues of Shares
12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
Short Term Loan and Issues of Shares
Note 7. Short term loan and Issues of shares

 

On December 18, 2020, the company entered into a Loan Agreement (the “Loan”) and Stock Subscription Agreement with certain Investors as described in note 1e, pursuant to which the Investors lent an aggregate amount of $69,000 (the “Principal Amount”). In accordance with the terms of the Loan, the company prepaid the interest on the Principal Amount of 8% compounded annually to the Investors as an issuance of 552,000 shares of Common Stock, at a price per share of $0.01. Under the Stock Subscription Agreement, the Investors transferred an amount of $ 30,587 to the company as consideration for the issued shares.

 

The Company allocated the total proceeds in respect of the shares issued and the Loan extended based on its relative fair values. As a result of the allocation, a discount of $19 was recorded on the loan. The discount is amortized over the term of the loan as finance expense.

 

The allocation of the proceeds to the fair value distribution of the liability and equity components on the transactions date was as follows:

 

Instrument   Fair Value     % of total fair    

Allocated

amount

 
Loan     55,200       49.45       49,246  
Shares     54,000       50.55       50,340  
Total     109,200       100       99,586  

 

The composition of short term loan balance as of the transaction is as follows:

 

       
Principal amount     69  
Discount on Short term loan     (19 )
Short term loan, Net     50  
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders Deficit
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Stockholders Deficit

Note 8. Stockholders’ deficit.

 

Ordinary Shares:

 

Ordinary shares confer the right to participate in the general meetings, to one vote per share for any purpose, to an equal part, on share basis, in distribution of dividends and to equally participate, on share basis, in distribution of excess of assets and funds from the Company and they shall not confer other privileges unless stated hereunder or in the Companies Law otherwise. Some investors have standard anti-dilutive rights, registration rights, and information and representation rights.

 

On December 18, 2020, the company entered into a Stock Subscription Agreement (the “Subscription”) with certain investors (the “Investors”) in connection with the sale and issuance of an aggregate of 3,000,000 shares of Common Stock, at a purchase price of $0.01 per share, and for an aggregate purchase price of $30,000. In addition, and on the same date, the company entered into a Loan Agreement (the “Loan”) with the Investors, pursuant to which the Investors lent an aggregate amount of $69,000 (the “Principal Amount”). In accordance with the terms of the Loan, the company repaid the interest on the Principal Amount of 8% compounded annually to the Investors as an issuance of 552,000 shares of Common Stock, at a price per share of $0.01. The shares of Common Stock were issued to the Investors pursuant to Regulation S of the Securities Act of 1933, as amended. For more details, please see note 1e.

 

Preferred shares (relating to Viewbix Ltd the prior to the Recapitalization Transaction):

 

Preferred shares may have been converted into ordinary shares of Viewbix Ltd at any time. The preferred shares would have automatically converted into ordinary shares if (a) the holders of at least (i) 67% (sixty seven percent) of the issued and outstanding Preferred C/C-1 shares, (ii) a majority of the issued and outstanding Preferred B shares, and (iii) a majority of the issued and outstanding Preferred A shares, so agree in writing; or (b) in the event of an IPO.

 

The conversion price for any class or series of preferred would have been subject to adjustment, as follows: at any time, upon each issuance or deemed issuance by the Company of any new securities at a price per share less than the applicable conversion price in effect on the date of and immediately prior to the issuance of such new securities, the conversion price shall be reduced.

 

Preferred shares had priority in the distribution of dividends and upon liquidation in accordance with the Company’s Articles of Association (“AOA”). These rights may be changed if a meeting of the Company’s stockholders gather up and decides on a change of regulations in this context.

 

The preference mechanism for liquidation and the distribution of dividends gave priority to the most recent preferred stockholders.

 

The preferred shares were convertible into 16,199,520 ordinary shares of the Company.

 

Redemption

 

The Company’s AOA do not provide redemption rights to the holders of the preferred shares. In the event of a liquidation event, all the funds and assets of the Company available for distribution among all the stockholders shall be distributed based on a certain mechanism as described in the Company’s AOA. Although the preferred shares are not redeemable, in the event of certain “deemed liquidation events” that are not solely within the Company’s control (including merger, acquisition, or sale of all or substantially all of the Company’s assets), the holders of the preferred shares would be entitled to preference amounts paid before distribution to other stockholders (as explained in the previous paragraph) and hence effectively redeeming the preference amount. In accordance with ASR 268 and ASC 480 “Distinguishing Liabilities from Equity”, the Company’s preferred shares are classified outside of stockholders’ deficit as a result of these in-substance contingent redemption rights. As of December 31, 2019 and 2018, the Company did not adjust the carrying values of the convertible preferred shares to the deemed liquidation values of such shares since a liquidation event was not probable of occurring.

 

Share Exchange

 

As detailed in Note 1, as part of the Recapitalization Transaction in July 2019, the Company issued 30,928,620 common shares in exchange for 99.83% of the issued and outstanding ordinary shares and all the preferred shares of Viewbix Israel. The number of shares prior to the reverse capitalization have been retroactively adjusted based on the equivalent number of shares received by the accounting acquirer in the Recapitalization Transaction.

 

Warrants

 

The following table summarizes information of outstanding warrants as of December 31, 2020:

 

    Warrants     Warrant Term   Exercise Price     Exercisable  
                             
Class J Warrants     3,649,318     July 2029     0.48       3,649,318  
Class K Warrants     3,649,318     July 2029     0.80       3,649,318  

 

Additionally, in connection with the Share Exchange Agreement, upon the earlier of: (a) the launch of a live video product to an American consumer in the United States by Viewbix Israel, or (b) the launch of an interactive television product to an American consumer in the United States by Viewbix Israel, the Company will issue to Gix an additional 1,642,193 shares of restricted common stock of the Company. All of the Company’s warrants meet the US GAAP criteria for equity classification. During January and March 2020, 50,000 class H warrants expired. During January 2020, 38,095 class I warrants expired. During April 2020, 142,857 Class G warrants expired.

XML 27 R15.htm IDEA: XBRL DOCUMENT v3.20.4
Commitments and Contingencies
12 Months Ended
Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 9. Commitments and Contingencies

 

During August 2019, a lawsuit was filed against the Company and its parent Company, Gix. The plaintiffs claim that they were entitled to receive shares of the Company as a part of the consideration in Gix’s acquisition of the Company. In management’s opinion, the plaintiffs’ claims are based on incorrect assumptions that relate to the distribution of shares between the plaintiffs and other former shareholders of the Company prior to Gix’s acquisition which would have resulted in the receipt of shares in the acquisition transaction. During September 2020, a settlement was reached between the parties which was later approved by the court. The settlement outlines that in exchange for the voluntary waiver of claims made by the plaintiffs, Gix will issue 63,350 shares of its common stock held in trust in favor of securing the transaction by which Gix acquired shares of ViewBix Ltd. in November 2018. The remaining shares in the trust account will be used to indemnify Gix for any expenses related to the litigation. Since the consideration was paid in Gix’s shares, and as the claims relate to the distribution of shares between the plaintiffs and other former shareholders of the Company, the settlement did not impact on the Company’s financial statements.

 

In June 2017, a lawsuit was filed by a former CEO of the Company with the Tel Aviv District Court (the “Tel Aviv Court”) against the Company claiming certain damages in the total amount of $225, under the assertion of wrongful termination by the Company and Emerald Israel. The Company believes these claims to be unsubstantiated and wholly without merit and accordingly filed its response with the Tel Aviv Court in October of 2017. The dispute was initially heard by the Tel Aviv Court on February 13, 2020. In a supplemental hearing on February 11, 2021 the former CEO provided data regarding his claims and his summaries were filed on that day. The Company’s summaries will be filed within 30 days of receiving the former CEO summaries. As of December 31, 2020, the company’s management, in consultation with its legal advisors, believes that the former CEO’s claims will not be Successful.

XML 28 R16.htm IDEA: XBRL DOCUMENT v3.20.4
Revenues
12 Months Ended
Dec. 31, 2020
Revenues [Abstract]  
Revenues

Note 10. Revenues.

 

    Year ended December 31,  
    2020     2019  
Individual Subscriptions     13       17  
Enterprise Subscriptions     83       191  
      96       208  
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.20.4
Research and Development Expenses
12 Months Ended
Dec. 31, 2020
Research and Development [Abstract]  
Research and development expenses

Note 11. Research and development expenses.

 

    Year ended December 31,  
    2020     2019  
             
Salaries and related expense     55       219  
Others     53       14  
      108       233  
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.20.4
Sales and Marketing Expenses
12 Months Ended
Dec. 31, 2020
Sales And Marketing Expenses  
Sales and Marketing Expenses

Note 12. Sales and marketing expenses.

 

    Year ended December 31,  
    2020     2019  
             
Salaries and related expense     7       110  
Others     1       147  
      8       257  
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.20.4
General and Administrative Expenses
12 Months Ended
Dec. 31, 2020
General And Administrative Expenses  
General and Administrative Expenses

Note 13. General and administrative expenses.

 

    Year ended December 31,  
    2020     2019  
             
Wages, salaries and related expenses     214       276  
Professional fees     176       213  
Depreciation     5       1  
Recapitalization Transaction costs     -       112  
Other     42       118  
      437       720  
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.20.4
Financing (Income) Expenses, Net
12 Months Ended
Dec. 31, 2020
Financing Income Expenses Net  
Financing (Income) Expenses, Net

Note 14. Financing (income) expenses, net

 

    Year ended December 31,  
    2020     2019  
             
Bank fees     1       3  
Exchange rate differences     (14 )     107  
Other financial income     -       (12 )
      (13 )     98  
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes
12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Income Taxes

Note 15. Income Taxes.

 

The Company is subject to income taxes under the Israeli and U.S. tax laws:

 

Tax rates applicable to the income of the Company:

 

Viewbix Inc. is taxed according to U.S. tax laws. On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the “Act”), which among other provisions, reduced the U.S. corporate tax rate from 35% to 21%, effective January 1, 2018.

 

Viewbix Israel and Israeli subsidiaries are taxed according to Israeli tax laws. The Israeli corporate tax rate is 23% in the years 2020, 2019 and onwards.

 

Deferred income taxes:

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets are as follows:

 

   

As of

December 31

   

As of

December 31

 
    2 0 2 0     2 0 1 9  
             
Deferred R&D expenses   $ 114     $ 239  
Operating loss carryforward     32,256       32,443  
    $ 32,370     $ 32,682  
                 
Net deferred tax asset before valuation allowance   $ 7,076     $ 7,149  
Valuation allowance     (7,076 )     (7,149 )
Net deferred tax asset   $ -     $ -  

 

As of December 31, 2020, the Company has provided valuation allowances of $7,076 in respect of deferred tax assets resulting from tax loss carryforward and other temporary differences. Management currently believes that because the Company has a history of losses, it is more likely than not that the deferred tax regarding the loss carryforward and other temporary differences will not be realized in the foreseeable future.

 

Available carryforward tax losses:

 

As of December 31, 2020, Viewbix Israel incurred operating losses in Israel of approximately $13,804 which may be carried forward and offset against taxable income in the future for an indefinite period.

 

As of December 31, 2020 the Company generated net operating losses in the U.S. of approximately $18,452 Net operating losses in the U.S. are available through 2035. Utilization of U.S. net operating losses may be subject to substantial annual limitation due to the “change in ownership” provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in the expiration of net operating losses before utilization.

  

Loss (income) from continuing operations, before taxes on income, consists of the following:

 

    For the year ended December 31  
    2020     2019  
             
USA   $ 65     $ 113  
Israel     376       989  
    $ 441     $ 1,102  
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.20.4
Loss Per Share-Basic and Diluted
12 Months Ended
Dec. 31, 2020
Earnings Per Share [Abstract]  
Loss Per Share-Basic and Diluted

NOTE 16. LOSS PER SHARE-BASIC AND DILUTED

 

Composition:

 

    For the year ended December 31  
    2 0 2 0     2 0 1 9  
Basic and diluted:                
Net loss attributable to ordinary stockholders     443       1,117  
                 
Weighted-average ordinary shares     31,201,669       13,746,064  
                 
Loss per share-basic and diluted     0.014       0.08  
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.20.4
COVID-19 Pandemic Implications
12 Months Ended
Dec. 31, 2020
Covid-19 Pandemic Implications  
COVID-19 Pandemic Implications

NOTE 17. - COVID-19 PANDEMIC IMPLICATIONS

 

The COVID-19 pandemic, which originated in China in late 2019, has since spread across the globe and affected the economic condition of most, if not all, countries, including the United States, Israel and many countries in Europe. On March 11, 2020, the World Health Organization declared the outbreak a pandemic. While COVID-19 is still spreading and the final implications of the pandemic are difficult to estimate at this stage, it is clear that it has affected the lives of a large portion of the global population. As of December 31, 2020, the pandemic has caused repeated states of emergency to be declared in various countries, ongoing and extended travel restrictions have been imposed for several months, strict quarantines rules have been established and maintained for an extended period of time in a plethora of jurisdictions and various institutions and companies have been closed and rendered bankrupt. The Company is actively monitoring the pandemic and is taking any necessary measures to respond to the situation in cooperation with the various stakeholders. Due to the uncertainty surrounding the COVID-19 pandemic, the Company will continue to assess the situation, including government-imposed restrictions, market by market. It is not possible at this time to estimate the full impact that the COVID-19 pandemic could have on the Company’s business, the continued spread of COVID-19, and any additional measures taken by governments, health officials or by the Company in response to such spread, could have on the Company’s business, results of operations and financial condition. The COVID-19 pandemic and mitigation measures have also negatively impacted global economic conditions, which, in turn, could adversely affect the Company’s business, results of operations and financial condition. The extent to which the COVID-19 outbreak continues to impact the Company’s financial condition will depend on future developments that are highly uncertain and cannot be predicted, including new government actions or restrictions, new information that may emerge concerning the severity, longevity and impact of the COVID-19 pandemic on economic activity.

XML 36 R24.htm IDEA: XBRL DOCUMENT v3.20.4
Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Functional Currency

Functional currency

 

The functional currency of the Company and its subsidiary is the US dollar, which is the currency of the primary economic environment in which it operates. In accordance with ASC 830, “Foreign Currency Matters” (ASC 830), balances denominated in or linked to foreign currency are stated on the basis of the exchange rates prevailing at the applicable balance sheet date. For foreign currency transactions included in the statement of operations, the exchange rates applicable on the relevant transaction dates are used. Gains or losses arising from changes in the exchange rates used in the translation of such transactions are carried as financing income or expenses.

Principles of Consolidation

Principles of consolidation

 

The consolidated financial statements include the accounts of the Company and its subsidiary. All intercompany balances and transactions have been eliminated in consolidation.

Cash and Cash Equivalents

Cash and cash equivalents

 

The Group considers all short-term investments, which are highly liquid investments with original maturities of three months or less at the date of purchase, to be cash equivalents. 

Property and Equipment

Property and equipment

 

1. Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. When an asset is retired or otherwise disposed of, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition is reflected in the statements of operations.

 

2. Rates of depreciation:

 

    %  
Computers     33  
Furniture and office equipment     7-15  
Impairment of Long-lived Assets

Impairment of long-lived assets

 

The Company’s long-lived assets are reviewed for impairment in accordance with ASC 360, “Property, Plant and Equipment”, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. To date the Group did not incur any material impairment losses.

Share-based compensation

Share-based compensation

 

The Company applies ASC 718-10, “Share-Based Payment,” which requires the measurement and recognition of compensation expenses for all share-based payment awards made to employees and directors (including employee stock options under the Company’s stock plans) based on estimated fair values.

 

ASC 718-10 requires companies to estimate the fair value of equity-based payment awards on the date of grant. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company’s statement of operations.

 

The Company recognizes compensation expenses for the value of non-employee awards based on the straight-line method over the requisite service period of each award, net of estimated forfeitures.

 

The Company estimates the fair value of stock options granted as equity awards using a Black-Scholes options pricing model. The option-pricing model requires a number of assumptions, of which the most significant are share price, expected volatility and the expected option term (the time from the grant date until the options are exercised or expire). Expected volatility is estimated based on volatility of similar companies in the technology sector. The Company has historically not paid dividends and has no foreseeable plans to issue dividends. The risk-free interest rate is based on the yield from governmental zero-coupon bonds with an equivalent term. The expected option term is calculated for options granted to employees and directors using the “simplified” method. Grants to non-employees are based on the contractual term. Changes in the determination of each of the inputs can affect the fair value of the options granted and the results of operations of the Company.

Earnings Per Common Share

Earnings per Common Share

 

Earnings or loss per share (“EPS”) is the amount of earnings attributable to each share of common stock. For convenience, the term is used to refer to either earnings or loss per share. EPS is computed pursuant to ASC 260-10-45. Pursuant to ASC 260-10-45-10 through 260-10-45-16 Basic EPS is computed by dividing income available to common stockholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) during the period. Income available to common stockholders shall be computed by deducting both the dividends declared in the period on preferred stock (whether or not paid) from income from continuing operations (if that amount appears in the income statement) and also from net income. The computation of diluted EPS is similar to the computation of basic EPS except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.

Revenue Recognition

Revenue recognition

 

The Company applies the provisions of Accounting Standards Codification (or “ASC”) 606, Revenue from Contracts with Customers (“ASC 606”). The Company adopted the provisions of ASC 606 effective January 1, 2018 using the modified retrospective application method for all uncompleted contracts as of that date. The adoption of ASC 606 did not have a material impact on the Company’s consolidated financial statements. In addition, the adoption of ASC 606 had no impact on the Company’s trade receivables, deferred revenues and accumulated deficit balances balance as of December 31, 2018 or on the Company’s revenues, cost of revenues or its operating expenses during 2018, compared to ASC 605.

 

The Company generates revenues primarily by granting customers the right to access software products through the Company’s cloud-based SaaS subscription offerings. Under a SaaS subscription agreement, the customer receives a right to access the software for a specified period of time in an environment hosted, supported, and maintained by the Company. SaaS subscription services are a single performance obligation satisfied over time, and associated revenue is generally recognized ratably over the contract term once the software is made available to the customer. The SaaS subscription offerings are typically sold with one year subscription terms, generally invoiced in advance of each annual subscription period, and are non-cancelable during the committed subscription term.

Research and Development Expenses, Net

Research and development expenses, net:

 

Research and development expenses are charged to the statement of operations as incurred.

Income Taxes

Income Taxes:

 

The Company accounts for income taxes in accordance with ASC 740, “Income Taxes”, and (“ASC 740”). ASC 740 prescribes the use of the asset and liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities and for carry forward tax losses. Deferred taxes are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more-likely-than-not that some portion or all of the deferred tax asset will not be realized.

 

In addition, ASC 740 prescribes a recognition threshold and measurement attribute for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The first step is to evaluate the tax position taken or expected to be taken in a tax return. This is done by determining if the weight of available evidence indicates that it is more-likely-than-not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement.

Contingencies

Contingencies

 

The Company records accruals for loss contingencies arising from claims, litigation and other sources when it is probable that a liability has been incurred and the amount can be reasonably estimated. These accruals are adjusted periodically as assessments change or additional information becomes available. Legal costs incurred in connection with loss contingencies are expensed as incurred.

Recently Issued Accounting Pronouncements

Recently issued accounting pronouncements

 

Financial Instruments – Credit Losses

 

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments—Credit Losses (Topic 326).” The guidance replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The guidance will be effective for the Company’s fiscal year beginning January 1, 2023, including interim periods within that year. The Company is currently evaluating the potential effect of the adoption of ASU 2019-10 on our financial position and results of operations. The Company does not expect the adoption of this ASU to have a material impact on the Company’s financial statements.

 

Accounting for Income Taxes

 

In December 2019, the FASB issued a new standard to simplify the accounting for income taxes. The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences related to changes in ownership of equity method investments and foreign subsidiaries. The guidance also simplifies aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard will be effective for us beginning July 1, 2021, with early adoption permitted. Adoption of the standard will not have a material impact on our consolidated financial statements.

XML 37 R25.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Schedule of Rates of Depreciation on Property and Equipment
    %  
Computers     33  
Furniture and office equipment     7-15  
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.20.4
Other Accounts Receivables (Tables)
12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
Schedule of Other Accounts Receivables Composition

Composition:

 

   

As of

December 30

   

As of

December 31

 
    2 0 2 0     2 0 1 9  
             
Government authorities   $ 20     $ 118  
Other     -       1  
    $ 20     $ 119  
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.20.4
Property and Equipment (Tables)
12 Months Ended
Dec. 31, 2020
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment

Composition:

 

   

As of

December 30

   

As of

December 31

 
    2 0 2 0     2 0 1 9  
             
Cost:                
Computers and related equipment   $ 34     $ 34  
Office furniture and equipment     9       9  
      43       43  
                 
Accumulated depreciation     43       38  
                 
Net book value   $ -     $ 5  
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.20.4
Other Accounts Payables and Accrued Liabilities (Tables)
12 Months Ended
Dec. 31, 2020
Payables and Accruals [Abstract]  
Schedule of Other Accounts Payables and Accrued Liabilities

Composition:

 

   

As of

December 30

   

As of

December 31

 
    2 0 2 0     2 0 1 9  
             
Other payables and deferred revenues   $ 47     $ 91  
Accrued liabilities     130       149  
Other     -       6  
    $ 177     $ 246  
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.20.4
Related Party Transactions (Tables)
12 Months Ended
Dec. 31, 2020
Related Party Transactions Tables Abstract  
Schedule of Related Party Transactions

Balances:

 

    December 31,     December 31,  
    2 0 2 0     2 0 1 9  
                 
Gix – Parent Company Payable   $ 2,054     $ 1,611  
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.20.4
Short Term Loans and Issue of Shares (Tables)
12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
Schedule of Fair Value Distribution of Liability and Equity Components

The allocation of the proceeds to the fair value distribution of the liability and equity components on the transactions date was as follows:

 

Instrument   Fair Value     % of total fair    

Allocated

amount

 
Loan     55,200       49.45       49,246  
Shares     54,000       50.55       50,340  
Total     109,200       100       99,586  
Schedule of Composition of Short Term Loan

The composition of short term loan balance as of the transaction is as follows:

 

       
Principal amount     69  
Discount on Short term loan     (19 )
Short term loan, Net     50  
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders Deficit (Tables)
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Summary of Outstanding Warrants

The following table summarizes information of outstanding warrants as of December 31, 2020:

 

    Warrants     Warrant Term   Exercise Price     Exercisable  
                             
Class J Warrants     3,649,318     July 2029     0.48       3,649,318  
Class K Warrants     3,649,318     July 2029     0.80       3,649,318  
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.20.4
Revenues (Tables)
12 Months Ended
Dec. 31, 2020
Revenues [Abstract]  
Schedule of Revenues
    Year ended December 31,  
    2020     2019  
Individual Subscriptions     13       17  
Enterprise Subscriptions     83       191  
      96       208  
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.20.4
Research and Development Expenses (Tables)
12 Months Ended
Dec. 31, 2020
Research and Development [Abstract]  
Schedule of Research and Development Expenses
    Year ended December 31,
    2020     2019
           
Salaries and related expense     55       219
Others     53       14
      108       233
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.20.4
Sales and Marketing Expenses (Tables)
12 Months Ended
Dec. 31, 2020
Sales And Marketing Expenses  
Schedule of Sales and Marketing Expenses

 

    Year ended December 31,  
    2020     2019  
             
Salaries and related expense     7       110  
Others     1       147  
      8       257  
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.20.4
General and Administrative Expenses (Tables)
12 Months Ended
Dec. 31, 2020
General And Administrative Expenses  
Schedule of General and Administrative Expenses
    Year ended December 31,  
    2020     2019  
             
Wages, salaries and related expenses     214       276  
Professional fees     176       213  
Depreciation     5       1  
Recapitalization Transaction costs     -       112  
Other     42       118  
      437       720  
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.20.4
Financing (Income) Expenses, Net (Tables)
12 Months Ended
Dec. 31, 2020
Financing Income Expenses Net  
Schedule of Financing (Income) Expenses, Net
    Year ended December 31,  
    2020     2019  
             
Bank fees     1       3  
Exchange rate differences     (14 )     107  
Other financial income     -       (12 )
      (13 )     98  
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Schedule of Deferred Income Taxes

Significant components of the Company’s deferred tax assets are as follows:

 

   

As of

December 31

   

As of

December 31

 
    2 0 2 0     2 0 1 9  
             
Deferred R&D expenses   $ 114     $ 239  
Operating loss carryforward     32,256       32,443  
    $ 32,370     $ 32,682  
                 
Net deferred tax asset before valuation allowance   $ 7,076     $ 7,149  
Valuation allowance     (7,076 )     (7,149 )
Net deferred tax asset   $ -     $ -  
Schedule of Loss (Income) from Continuing Operations, Before Taxes on Income

Loss (income) from continuing operations, before taxes on income, consists of the following:

 

    For the year ended December 31  
    2020     2019  
             
USA   $ 65     $ 113  
Israel     376       989  
    $ 441     $ 1,102  
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.20.4
Loss Per Share-Basic and Diluted (Tables)
12 Months Ended
Dec. 31, 2020
Earnings Per Share [Abstract]  
Schedule of Loss Per Share-Basic and Diluted

Composition:

 

    For the year ended December 31  
    2 0 2 0     2 0 1 9  
Basic and diluted:                
Net loss attributable to ordinary stockholders     443       1,117  
                 
Weighted-average ordinary shares     31,201,669       13,746,064  
                 
Loss per share-basic and diluted     0.014       0.08  
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.20.4
General (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 18, 2020
Jul. 24, 2019
Feb. 07, 2019
Dec. 31, 2020
Dec. 31, 2019
Jan. 27, 2020
Jun. 24, 2019
Dec. 31, 2018
Due to related party       $ (2,054) $ (1,611)      
Net loss       (443) (1,117)      
Stockholders' deficit       (2,078) $ (1,693)     $ (721)
Cash flow from operation       $ (61)        
Convertible Notes Holders [Member]                
Number of stock issued   3,434,889            
Viewbix Ltd [Member]                
Ownership percentage             99.83%  
Gix Ltd [Member]                
Number of stock issued   20,281,085            
Warrants to purchase common stock   7,298,636            
Gix Ltd [Member] | Warrant One [Member]                
Warrants to purchase common stock   3,649,318            
Warrants exercise price   $ 0.48            
Gix Ltd [Member] | Warrant Two [Member]                
Warrants to purchase common stock   3,649,318            
Warrants exercise price   $ 0.80            
Share Exchange Agreement [Member] | Viewbix Ltd [Member]                
Ownership percentage     99.83%          
Share Exchange Agreement [Member] | Gix Ltd [Member]                
Share issued and outstanding, percentage     65.00%          
Fully diluted share capital, percentage     5.00%          
Stock Subscription Agreement [Member] | Investor [Member]                
Number of stock issued 3,000,000              
Common stock purchase price per share $ 0.01              
Sale of issuance common stock value $ 30              
Loan Agreement [Member] | Investor [Member]                
Number of stock issued 552,000              
Common stock purchase price per share $ 0.01              
Debt instrument face amount $ 69              
Debt instrument stated percentage 8.00%              
Restricted Common Stock [Member] | Share Exchange Agreement [Member] | Gix Ltd [Member]                
Number of stock issued     1,642,193          
Virtual Crypto Israel [Member]                
Due to related party           $ (14,459)    
Virtual Crypto Israel [Member] | NIS [Member]                
Due to related party           $ (50)    
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies - Schedule of Rates os Depreciation on Property and Equipment (Details)
Dec. 31, 2020
Computers [Member]  
Rates of depreciation 33.00%
Furniture And Office Equipment [Member] | Minimum [Member]  
Rates of depreciation 7.00%
Furniture And Office Equipment [Member] | Maximum [Member]  
Rates of depreciation 15.00%
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.20.4
Other Accounts Receivables - Schedule of Other Accounts Receivables (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Debt Disclosure [Abstract]    
Government authorities $ 20 $ 118
Other 1
Total $ 20 $ 119
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.20.4
Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Property and equipment, gross $ 43 $ 43
Accumulated depreciation 43 38
Net book value 5
Computers and Related Equipment [Member]    
Property and equipment, gross 34 34
Office Furniture and Equipment [Member]    
Property and equipment, gross $ 9 $ 9
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.20.4
Other Accounts Payables - Schedule of Other Accounts Payables and Accrued Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Payables and Accruals [Abstract]    
Other payables and deferred revenues $ 47 $ 91
Accrued liabilities 130 149
Other 6
Total other accounts payables $ 177 $ 246
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.20.4
Related Party Transactions (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Gix Ltd [Member]    
Due to related party
Employees [Member]    
Related party description From November 2018 until the Closing Date, the employees that transferred from the Company to Algomizer dedicated half of their time to the Company's operations and correspondingly 50% of the costs to be incurred by Algomizer in respect of these employees are to be charged to the Company.  
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.20.4
Related Party Transactions - Schedule of Related Party Transactions (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Related Party Transactions [Abstract]    
Gix - Parent Company Payable $ 2,054 $ 1,611
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.20.4
Short Term Loan and Issues of Shares (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 18, 2020
Dec. 31, 2020
Dec. 31, 2019
Transferred amount   $ 49
Loan and Stock Subscription Agreement [Member] | Investors [Member]      
Debt Instrument face amount $ 69    
Debt instrument stated percentage 8.00%    
Issuance of common stock shares 552,000    
Common stock price per share $ 0.01    
Loan discount $ 19    
Stock Subscription Agreement [Member] | Investors [Member]      
Transferred amount $ 30,587    
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.20.4
Short Term Loan and Issues of Shares - Schedule of Fair Value Distribution of Liability and Equity Components (Details)
Dec. 31, 2020
USD ($)
Fair Value $ 109,200
Percentage of fair value 10000.00%
Allocated amount $ 99,586
Loan [Member]  
Fair Value $ 55,200
Percentage of fair value 49.45%
Allocated amount $ 49,246
Shares [Member]  
Fair Value $ 54,000
Percentage of fair value 50.55%
Allocated amount $ 50,340
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.20.4
Short Term Loan and Issues of Shares - Schedule of Composition of Short Term Loan (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Debt Disclosure [Abstract]    
Principal amount $ 69  
Discount on Short term loan (19)  
Short term loan, Net $ 50
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders Deficit (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Dec. 18, 2020
Jul. 24, 2019
Apr. 30, 2020
Mar. 30, 2020
Jan. 30, 2020
Jul. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Common stock shares voting description             Ordinary shares confer the right to participate in the general meetings, to one vote per share for any purpose, to an equal part, on share basis, in distribution of dividends and to equally participate, on share basis, in distribution of excess of assets and funds from the Company and they shall not confer other privileges unless stated hereunder or in the Companies Law otherwise. Some investors have standard anti-dilutive rights, registration rights, and information and representation rights.  
Preferred shares conversion description             Preferred shares may have been converted into ordinary shares of Viewbix Ltd at any time. The preferred shares would have automatically converted into ordinary shares if (a) the holders of at least (i) 67% (sixty seven percent) of the issued and outstanding Preferred C/C-1 shares, (ii) a majority of the issued and outstanding Preferred B shares, and (iii) a majority of the issued and outstanding Preferred A shares, so agree in writing; or (b) in the event of an IPO.  
Conversion of preferred stock into common shares             16,199,520  
Preferred shares, outstanding              
Deemed to issued common shares           30,928,620    
Shares exchange rate           99.83%    
Class H Warrants [Member]                
Number of warrants expired during period       50,000 50,000      
Class I Warrants [Member]                
Number of warrants expired during period         38,095      
Class G Warrants [Member]                
Number of warrants expired during period     142,857          
Gix Ltd [Member]                
Number of common stock issued   20,281,085            
Number of restricted common stock shares issued             1,642,193  
Stock Subscription Agreement [Member] | Investor [Member]                
Number of common stock issued 3,000,000              
Sale of stock, price per share $ 0.01              
Aggregate purchase price $ 30              
Loan Agreement [Member] | Investor [Member]                
Number of common stock issued 552,000              
Sale of stock, price per share $ 0.01              
Debt instrument, face amount $ 69              
Debt instrument, interest rate 8.00%              
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders Deficit - Summary of Outstanding Warrants (Details)
12 Months Ended
Dec. 31, 2020
$ / shares
shares
Class J Warrants [Member]  
Warrants 3,649,318
Warrant Term July 2029
Warrant Exercise Price | $ / shares $ 0.48
Warrant Exercisable 3,649,318
Class K Warrants [Member]  
Warrants 3,649,318
Warrant Term July 2029
Warrant Exercise Price | $ / shares $ 0.80
Warrant Exercisable 3,649,318
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.20.4
Commitments and Contingencies (Details Narrative) - USD ($)
$ in Thousands
1 Months Ended
Jun. 30, 2017
Dec. 31, 2020
Dec. 31, 2019
Number of common stock issuable   34,753,669 31,201,669
Tel Aviv District Court [Member]      
Claiming of damages value $ 225    
Loss contingency description The Company believes these claims to be unsubstantiated and wholly without merit and accordingly filed its response with the Tel Aviv Court in October of 2017. The dispute was initially heard by the Tel Aviv Court on February 13, 2020. In a supplemental hearing on February 11, 2021 the former CEO provided data regarding his claims and his summaries were filed on that day. The Company's summaries will be filed within 30 days of receiving the former CEO summaries. As of December 31, 2020, the company's management, in consultation with its legal advisors, believes that the former CEO's claims will not be Successful.    
Gix Ltd [Member]      
Number of common stock issuable   63,350  
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.20.4
Revenues - Schedule of Revenues (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Revenues $ 96 $ 208
Individual Subscriptions [Member]    
Revenues 13 17
Enterprise Subscriptions [Member]    
Revenues $ 83 $ 191
XML 65 R53.htm IDEA: XBRL DOCUMENT v3.20.4
Research and Development Expenses - Schedule of Research and Development Expenses (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Research and development $ 108 $ 233
Salaries and Related Expense [Member]    
Research and development 55 219
Other [Member]    
Research and development $ 53 $ 14
XML 66 R54.htm IDEA: XBRL DOCUMENT v3.20.4
Sales and Marketing Expenses - Schedule of Sales and Marketing Expenses (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Sales and marketing expenses $ 8 $ 257
Salaries and Related Expense [Member]    
Sales and marketing expenses 7 110
Other [Member]    
Sales and marketing expenses $ 1 $ 147
XML 67 R55.htm IDEA: XBRL DOCUMENT v3.20.4
General and Administrative Expenses - Schedule of General and Administrative Expenses (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
General And Administrative Expenses    
Wages, salaries and related expenses $ 214 $ 276
Professional fees 176 213
Depreciation 5 1
Recapitalization Transaction costs 112
Other 42 118
General and administrative expenses $ 437 $ 720
XML 68 R56.htm IDEA: XBRL DOCUMENT v3.20.4
Financing (Income) Expenses, Net - Schedule of Financing (Income) Expenses, Net (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Financing (income) expenses, net $ (13) $ 98
Bank Fees [Member]    
Financing (income) expenses, net 1 3
Exchange Rate Differences [Member]    
Financing (income) expenses, net (14) 107
Other Financial Income [Member]    
Financing (income) expenses, net $ (12)
XML 69 R57.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income tax examination description On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the "Act"), which among other provisions, reduced the U.S. corporate tax rate from 35% to 21%, effective January 1, 2018.  
Corporate tax rate 21.00%  
Valuation allowances, deferred tax assets $ 7,076 $ 7,149
Operating loss carryforwards $ 32,256 $ 32,443
USA [Member]    
Income tax examination description Net operating losses in the U.S. are available through 2035.  
US [Member]    
Operating loss carryforwards $ 18,452  
Viewbix Israel [Member]    
Operating loss carryforwards $ 13,804  
Israeli Corporate Tax [Member]    
Corporate tax rate 23.00% 23.00%
XML 70 R58.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Schedule of Deferred Income Taxes (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Income Tax Disclosure [Abstract]    
Deferred R&D expenses $ 114 $ 239
Operating loss carryforward 32,256 32,443
Total 32,370 32,682
Net deferred tax asset before valuation allowance 7,076 7,149
Valuation allowance (7,076) (7,149)
Net deferred tax asset
XML 71 R59.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Schedule of Loss (Income) from Continuing Operations, Before Taxes on Income (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Total loss before taxes on income $ (441) $ (1,102)
USA [Member]    
Total loss before taxes on income 65 113
Israel [Member]    
Total loss before taxes on income $ 376 $ 989
XML 72 R60.htm IDEA: XBRL DOCUMENT v3.20.4
Loss Per Share-Basic and Diluted - Schedule of Loss Per Share-Basic and Diluted (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Earnings Per Share [Abstract]    
Net loss attributable to ordinary stockholders $ (443) $ (1,117)
Weighted-average ordinary shares 31,201,669 13,746,064
Loss per share-basic and diluted $ (0.014) $ (0.08)
EXCEL 73 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 74 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 75 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 76 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 123 264 1 true 51 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://corp.viewbix.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://corp.viewbix.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://corp.viewbix.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Comprehensive Loss Sheet http://corp.viewbix.com/role/StatementsOfComprehensiveLoss Consolidated Statements of Comprehensive Loss Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Deficit Sheet http://corp.viewbix.com/role/StatementsOfChangesInStockholdersDeficit Consolidated Statements of Changes in Stockholders' Deficit Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://corp.viewbix.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - General Sheet http://corp.viewbix.com/role/General General Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://corp.viewbix.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Other Accounts Receivables Sheet http://corp.viewbix.com/role/OtherAccountsReceivables Other Accounts Receivables Notes 9 false false R10.htm 00000010 - Disclosure - Property and Equipment Sheet http://corp.viewbix.com/role/PropertyAndEquipment Property and Equipment Notes 10 false false R11.htm 00000011 - Disclosure - Other Accounts Payables And Accrued Liabilities Sheet http://corp.viewbix.com/role/OtherAccountsPayablesAndAccruedLiabilities Other Accounts Payables And Accrued Liabilities Notes 11 false false R12.htm 00000012 - Disclosure - Related Party Transactions Sheet http://corp.viewbix.com/role/RelatedPartyTransactions Related Party Transactions Notes 12 false false R13.htm 00000013 - Disclosure - Short Term Loan and Issues of Shares Sheet http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfShares Short Term Loan and Issues of Shares Notes 13 false false R14.htm 00000014 - Disclosure - Stockholders Deficit Sheet http://corp.viewbix.com/role/StockholdersDeficit Stockholders Deficit Notes 14 false false R15.htm 00000015 - Disclosure - Commitments and Contingencies Sheet http://corp.viewbix.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 00000016 - Disclosure - Revenues Sheet http://corp.viewbix.com/role/Revenues Revenues Notes 16 false false R17.htm 00000017 - Disclosure - Research and Development Expenses Sheet http://corp.viewbix.com/role/ResearchAndDevelopmentExpenses Research and Development Expenses Notes 17 false false R18.htm 00000018 - Disclosure - Sales and Marketing Expenses Sheet http://corp.viewbix.com/role/SalesAndMarketingExpenses Sales and Marketing Expenses Notes 18 false false R19.htm 00000019 - Disclosure - General and Administrative Expenses Sheet http://corp.viewbix.com/role/GeneralAndAdministrativeExpenses General and Administrative Expenses Notes 19 false false R20.htm 00000020 - Disclosure - Financing (Income) Expenses, Net Sheet http://corp.viewbix.com/role/FinancingIncomeExpensesNet Financing (Income) Expenses, Net Notes 20 false false R21.htm 00000021 - Disclosure - Income Taxes Sheet http://corp.viewbix.com/role/IncomeTaxes Income Taxes Notes 21 false false R22.htm 00000022 - Disclosure - Loss Per Share-Basic and Diluted Sheet http://corp.viewbix.com/role/LossPerShare-basicAndDiluted Loss Per Share-Basic and Diluted Notes 22 false false R23.htm 00000023 - Disclosure - COVID-19 Pandemic Implications Sheet http://corp.viewbix.com/role/Covid-19PandemicImplications COVID-19 Pandemic Implications Notes 23 false false R24.htm 00000024 - Disclosure - Significant Accounting Policies (Policies) Sheet http://corp.viewbix.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://corp.viewbix.com/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 00000025 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://corp.viewbix.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://corp.viewbix.com/role/SummaryOfSignificantAccountingPolicies 25 false false R26.htm 00000026 - Disclosure - Other Accounts Receivables (Tables) Sheet http://corp.viewbix.com/role/OtherAccountsReceivablesTables Other Accounts Receivables (Tables) Tables http://corp.viewbix.com/role/OtherAccountsReceivables 26 false false R27.htm 00000027 - Disclosure - Property and Equipment (Tables) Sheet http://corp.viewbix.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://corp.viewbix.com/role/PropertyAndEquipment 27 false false R28.htm 00000028 - Disclosure - Other Accounts Payables and Accrued Liabilities (Tables) Sheet http://corp.viewbix.com/role/OtherAccountsPayablesAndAccruedLiabilitiesTables Other Accounts Payables and Accrued Liabilities (Tables) Tables 28 false false R29.htm 00000029 - Disclosure - Related Party Transactions (Tables) Sheet http://corp.viewbix.com/role/RelatedPartyTransactionsTables Related Party Transactions (Tables) Tables http://corp.viewbix.com/role/RelatedPartyTransactions 29 false false R30.htm 00000030 - Disclosure - Short Term Loans and Issue of Shares (Tables) Sheet http://corp.viewbix.com/role/ShortTermLoansAndIssueOfSharesTables Short Term Loans and Issue of Shares (Tables) Tables 30 false false R31.htm 00000031 - Disclosure - Stockholders Deficit (Tables) Sheet http://corp.viewbix.com/role/StockholdersDeficitTables Stockholders Deficit (Tables) Tables http://corp.viewbix.com/role/StockholdersDeficit 31 false false R32.htm 00000032 - Disclosure - Revenues (Tables) Sheet http://corp.viewbix.com/role/RevenuesTables Revenues (Tables) Tables http://corp.viewbix.com/role/Revenues 32 false false R33.htm 00000033 - Disclosure - Research and Development Expenses (Tables) Sheet http://corp.viewbix.com/role/ResearchAndDevelopmentExpensesTables Research and Development Expenses (Tables) Tables http://corp.viewbix.com/role/ResearchAndDevelopmentExpenses 33 false false R34.htm 00000034 - Disclosure - Sales and Marketing Expenses (Tables) Sheet http://corp.viewbix.com/role/SalesAndMarketingExpensesTables Sales and Marketing Expenses (Tables) Tables http://corp.viewbix.com/role/SalesAndMarketingExpenses 34 false false R35.htm 00000035 - Disclosure - General and Administrative Expenses (Tables) Sheet http://corp.viewbix.com/role/GeneralAndAdministrativeExpensesTables General and Administrative Expenses (Tables) Tables http://corp.viewbix.com/role/GeneralAndAdministrativeExpenses 35 false false R36.htm 00000036 - Disclosure - Financing (Income) Expenses, Net (Tables) Sheet http://corp.viewbix.com/role/FinancingIncomeExpensesNetTables Financing (Income) Expenses, Net (Tables) Tables http://corp.viewbix.com/role/FinancingIncomeExpensesNet 36 false false R37.htm 00000037 - Disclosure - Income Taxes (Tables) Sheet http://corp.viewbix.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://corp.viewbix.com/role/IncomeTaxes 37 false false R38.htm 00000038 - Disclosure - Loss Per Share-Basic and Diluted (Tables) Sheet http://corp.viewbix.com/role/LossPerShare-basicAndDilutedTables Loss Per Share-Basic and Diluted (Tables) Tables http://corp.viewbix.com/role/LossPerShare-basicAndDiluted 38 false false R39.htm 00000039 - Disclosure - General (Details Narrative) Sheet http://corp.viewbix.com/role/GeneralDetailsNarrative General (Details Narrative) Details http://corp.viewbix.com/role/GeneralAndAdministrativeExpensesTables 39 false false R40.htm 00000040 - Disclosure - Summary of Significant Accounting Policies - Schedule of Rates os Depreciation on Property and Equipment (Details) Sheet http://corp.viewbix.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfRatesOsDepreciationOnPropertyAndEquipmentDetails Summary of Significant Accounting Policies - Schedule of Rates os Depreciation on Property and Equipment (Details) Details 40 false false R41.htm 00000041 - Disclosure - Other Accounts Receivables - Schedule of Other Accounts Receivables (Details) Sheet http://corp.viewbix.com/role/OtherAccountsReceivables-ScheduleOfOtherAccountsReceivablesDetails Other Accounts Receivables - Schedule of Other Accounts Receivables (Details) Details 41 false false R42.htm 00000042 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details) Sheet http://corp.viewbix.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails Property and Equipment - Schedule of Property and Equipment (Details) Details 42 false false R43.htm 00000043 - Disclosure - Other Accounts Payables - Schedule of Other Accounts Payables and Accrued Liabilities (Details) Sheet http://corp.viewbix.com/role/OtherAccountsPayables-ScheduleOfOtherAccountsPayablesAndAccruedLiabilitiesDetails Other Accounts Payables - Schedule of Other Accounts Payables and Accrued Liabilities (Details) Details 43 false false R44.htm 00000044 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://corp.viewbix.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://corp.viewbix.com/role/RelatedPartyTransactionsTables 44 false false R45.htm 00000045 - Disclosure - Related Party Transactions - Schedule of Related Party Transactions (Details) Sheet http://corp.viewbix.com/role/RelatedPartyTransactions-ScheduleOfRelatedPartyTransactionsDetails Related Party Transactions - Schedule of Related Party Transactions (Details) Details 45 false false R46.htm 00000046 - Disclosure - Short Term Loan and Issues of Shares (Details Narrative) Sheet http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfSharesDetailsNarrative Short Term Loan and Issues of Shares (Details Narrative) Details http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfShares 46 false false R47.htm 00000047 - Disclosure - Short Term Loan and Issues of Shares - Schedule of Fair Value Distribution of Liability and Equity Components (Details) Sheet http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfShares-ScheduleOfFairValueDistributionOfLiabilityAndEquityComponentsDetails Short Term Loan and Issues of Shares - Schedule of Fair Value Distribution of Liability and Equity Components (Details) Details 47 false false R48.htm 00000048 - Disclosure - Short Term Loan and Issues of Shares - Schedule of Composition of Short Term Loan (Details) Sheet http://corp.viewbix.com/role/ShortTermLoanAndIssuesOfShares-ScheduleOfCompositionOfShortTermLoanDetails Short Term Loan and Issues of Shares - Schedule of Composition of Short Term Loan (Details) Details 48 false false R49.htm 00000049 - Disclosure - Stockholders Deficit (Details Narrative) Sheet http://corp.viewbix.com/role/StockholdersDeficitDetailsNarrative Stockholders Deficit (Details Narrative) Details http://corp.viewbix.com/role/StockholdersDeficitTables 49 false false R50.htm 00000050 - Disclosure - Stockholders Deficit - Summary of Outstanding Warrants (Details) Sheet http://corp.viewbix.com/role/StockholdersDeficit-SummaryOfOutstandingWarrantsDetails Stockholders Deficit - Summary of Outstanding Warrants (Details) Details 50 false false R51.htm 00000051 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://corp.viewbix.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://corp.viewbix.com/role/CommitmentsAndContingencies 51 false false R52.htm 00000052 - Disclosure - Revenues - Schedule of Revenues (Details) Sheet http://corp.viewbix.com/role/Revenues-ScheduleOfRevenuesDetails Revenues - Schedule of Revenues (Details) Details 52 false false R53.htm 00000053 - Disclosure - Research and Development Expenses - Schedule of Research and Development Expenses (Details) Sheet http://corp.viewbix.com/role/ResearchAndDevelopmentExpenses-ScheduleOfResearchAndDevelopmentExpensesDetails Research and Development Expenses - Schedule of Research and Development Expenses (Details) Details 53 false false R54.htm 00000054 - Disclosure - Sales and Marketing Expenses - Schedule of Sales and Marketing Expenses (Details) Sheet http://corp.viewbix.com/role/SalesAndMarketingExpenses-ScheduleOfSalesAndMarketingExpensesDetails Sales and Marketing Expenses - Schedule of Sales and Marketing Expenses (Details) Details 54 false false R55.htm 00000055 - Disclosure - General and Administrative Expenses - Schedule of General and Administrative Expenses (Details) Sheet http://corp.viewbix.com/role/GeneralAndAdministrativeExpenses-ScheduleOfGeneralAndAdministrativeExpensesDetails General and Administrative Expenses - Schedule of General and Administrative Expenses (Details) Details 55 false false R56.htm 00000056 - Disclosure - Financing (Income) Expenses, Net - Schedule of Financing (Income) Expenses, Net (Details) Sheet http://corp.viewbix.com/role/FinancingIncomeExpensesNet-ScheduleOfFinancingIncomeExpensesNetDetails Financing (Income) Expenses, Net - Schedule of Financing (Income) Expenses, Net (Details) Details http://corp.viewbix.com/role/FinancingIncomeExpensesNetTables 56 false false R57.htm 00000057 - Disclosure - Income Taxes (Details Narrative) Sheet http://corp.viewbix.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://corp.viewbix.com/role/IncomeTaxesTables 57 false false R58.htm 00000058 - Disclosure - Income Taxes - Schedule of Deferred Income Taxes (Details) Sheet http://corp.viewbix.com/role/IncomeTaxes-ScheduleOfDeferredIncomeTaxesDetails Income Taxes - Schedule of Deferred Income Taxes (Details) Details 58 false false R59.htm 00000059 - Disclosure - Income Taxes - Schedule of Loss (Income) from Continuing Operations, Before Taxes on Income (Details) Sheet http://corp.viewbix.com/role/IncomeTaxes-ScheduleOfLossIncomeFromContinuingOperationsBeforeTaxesOnIncomeDetails Income Taxes - Schedule of Loss (Income) from Continuing Operations, Before Taxes on Income (Details) Details 59 false false R60.htm 00000060 - Disclosure - Loss Per Share-Basic and Diluted - Schedule of Loss Per Share-Basic and Diluted (Details) Sheet http://corp.viewbix.com/role/LossPerShare-basicAndDiluted-ScheduleOfLossPerShare-basicAndDilutedDetails Loss Per Share-Basic and Diluted - Schedule of Loss Per Share-Basic and Diluted (Details) Details 60 false false All Reports Book All Reports vbix-20201231.xml vbix-20201231.xsd vbix-20201231_cal.xml vbix-20201231_def.xml vbix-20201231_lab.xml vbix-20201231_pre.xml http://fasb.org/srt/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/country/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 true true ZIP 78 0001493152-21-006123-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-21-006123-xbrl.zip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end